<SEC-DOCUMENT>0001654954-19-011705.txt : 20191015
<SEC-HEADER>0001654954-19-011705.hdr.sgml : 20191015
<ACCEPTANCE-DATETIME>20191015070023
ACCESSION NUMBER:		0001654954-19-011705
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20191015
DATE AS OF CHANGE:		20191015

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			cbdMD, Inc.
		CENTRAL INDEX KEY:			0001644903
		STANDARD INDUSTRIAL CLASSIFICATION:	PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
		IRS NUMBER:				473414576
		STATE OF INCORPORATION:			NC
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-228773
		FILM NUMBER:		191149093

	BUSINESS ADDRESS:	
		STREET 1:		4521 SHARON ROAD
		STREET 2:		SUITE 450
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28211
		BUSINESS PHONE:		704-807-4032

	MAIL ADDRESS:	
		STREET 1:		4521 SHARON ROAD
		STREET 2:		SUITE 450
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Level Brands, Inc.
		DATE OF NAME CHANGE:	20170202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEVEL BEAUTY GROUP, INC.
		DATE OF NAME CHANGE:	20150611
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>ycbd_424b5.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<html>
<head>
<!-- Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com -->
<!-- Copyright 2019 Issuer Direct Corporation -->
<title>Blueprint</title>
</head>
<body style="font-family: Times New Roman; font-size: 13px;">
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<font style="font-weight: bold">Filed Pursuant to Rule
424(b)(5)</font></font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-weight: bold">Registration No. 333-228773</font></font></div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: middle; width: 33%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #ff0000; font-size: 13px; font-family: Times New Roman">
<font style="color: #000000">PROSPECTUS
SUPPLEMENT</font><br></font></div>
</td>
<td style="vertical-align: middle; width: 34%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><br>
</font></font></div>
</td>
<td style="vertical-align: middle; width: 34%">
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #ff0000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
<br></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">(To the Prospectus
dated April 9, 2019)</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">500,000
Shares</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">8.0%
Series A Cumulative Convertible Preferred Stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Liquidation
Preference $10.00 Per Share</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5000.jpg"></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 24px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: auto; margin-right: auto; text-indent: 0px; width: 100%; height: 1px; background-color: #000000"><!--line--><br></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We are offering
500,000 shares of our 8.0% Series A Cumulative Convertible
Preferred Stock, which we refer to as the Series A Convertible
Preferred Stock, in this offering <font style="color: #000000">pursuant to this prospectus supplement and the
accompanying prospectus.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Dividends on our
Series A Convertible Preferred Stock accrue daily and will be
cumulative from the first day of the calendar month in which they
are issued, and shall be payable monthly in arrears on the 15th day
of each calendar month, when, as and if declared by our board of
directors, at the rate of 8.0% per annum of its liquidation
preference, which is the equivalent to $0.80 per annum per
share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock has no stated maturity, is not subject
to any sinking fund, and will remain outstanding indefinitely
unless a holder chooses to convert the Series A Convertible
Preferred Stock into shares of our common stock, we elect to
automatically convert it into shares of our common stock upon a
Market Trigger, on or after October 16, 2023 we elect to redeem it,
or a Change of Control occurs resulting in a mandatory
redemption.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Each share of
Series A Convertible Preferred Stock is convertible into shares of
our common stock at a conversion price of $6.00 per common share,
or 1.667 shares of our common stock, at any time at the option of
the holder, subject to certain customary adjustments as described
later in this prospectus supplement. The initial conversion price
and the conversion price as adjusted are referred to as the
&#x201C;Conversion Price&#x201D;. We may elect to automatically
convert some or all of the Series A Convertible Preferred Stock
into shares of our common stock if the closing price of the common
stock has exceeded $8.25 (137.5% of the Conversion Price) for at
least 20 out of 30 consecutive trading days ending within five
trading days prior to the notice of automatic conversion, which we
refer to as the Market Trigger.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; width: 100%; height: 1px; background-color: #ffffff"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock will not be redeemable before October
16, 2023 except as described below upon the occurrence of a Change
of Control. Commencing on October 16, 2023, we may redeem, at our
option, the Series A Convertible Preferred Stock, in whole or in
part, at a cash redemption price of $10.00 per share, plus all
accrued and unpaid dividends to, but not including, the redemption
date. Holders of the Series A Convertible Preferred Stock will have
the right to convert such shares after the optional redemption
notice but prior to the redemption date into shares of our common
stock at the Conversion Price. In addition, upon the occurrence of
a Change of Control (as hereinafter defined) we are required to
redeem any or all of the shares of Series A Convertible Preferred
Stock at a redemption price of $11.00 per share, plus any accrued
but unpaid dividends to, but excluding, the redemption date.
Holders of the Series A Convertible Preferred Stock will have the
right to convert such shares after the notice of the Change of
Control but prior to the redemption date into shares of our common
stock at the Conversion Price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the event of our
liquidation, dissolution or winding up, holders of our Series A
Convertible Preferred Stock will receive a payment equal to $10.00
per share of Series A Convertible Preferred Stock plus accrued but
unpaid dividends before any proceeds are distributed to the holders
of our common stock. Shares of Series A Convertible Preferred Stock
will generally have no voting rights, except as required by law or
upon certain other events as described later in this prospectus
supplement. In the event dividends on the Series A Convertible
Preferred Stock are in arrears for each of 12 or more consecutive
monthly periods, the holders of the Series A Convertible Preferred
Stock will be entitled to vote for the election of two additional
directors to serve on our board of directors until all dividends
that are owed have been paid.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Currently, no
market exists for the Series A Convertible Preferred Stock. We have
filed an application to list the Series A Convertible Preferred
Stock on the NYSE American under the symbol &#x201C;YCBDPRA.&#x201D;
If the application is approved, trading of the Series A Convertible
Preferred Stock is expected to begin on October 21, 2019, within
three business days after the initial issuance of the Series A
Convertible Preferred Stock.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
Investing in our Series A Convertible Preferred Stock involves a
high degree of risk. &#xA0;See &#x201C;Risk Factors&#x201D; beginning
on page S-9 of this prospectus supplement and on page&#xA0;5 of the
accompanying prospectus for a discussion of information that should
be considered in connection with an investment in our Series A
Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or
determined if this prospectus is truthful or complete. Any
representation to the contrary is a criminal offense.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are an &#x201C;emerging growth company&#x201D; as that term is used
in the Jumpstart Our Business Startups Act of 2012 (the &#x201C;JOBS
Act&#x201D;) and, as such, have elected to comply with certain
reduced public company reporting requirements. &#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; margin-left: 0px; margin-right: 0px; width: 100%;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000; font-size: 11px">
<div><font style="font-weight: bold; font-family: Times New Roman">Per
Share</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000; font-size: 11px">
<div><font style="font-weight: bold; font-family: Times New Roman">Total</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Public offering
price</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">10.00<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">5,000,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Underwriting
discounts and commissions (1)</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">0.75<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">375,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Proceeds, before
expenses, to us</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">9.25<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">4,625,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 51px">
<font style="font-size: 13px; font-family: Times New Roman">(1)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">In addition, we
have agreed to issue to the representative of the underwriters as a
portion of the underwriting compensation warrants to purchase
shares of common stock and to reimburse the underwriters for
certain expenses. See &#x201C;Underwriting&#x201D; on page S-43 of
this prospectus supplement for additional information.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have granted the
representative of the underwriters an option to purchase up to an
additional 75,000 shares of Series A Convertible Preferred Stock
from us at the public offering price, less the underwriting
discounts and commissions, within 45 days from the date of this
prospectus to cover over-allotments, if any.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriters
expect to deliver the shares of Series A Convertible Preferred
Stock to the purchasers on or about October 16, 2019.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 24px; font-family: Times New Roman">ThinkEquity</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">a
division of Fordham Financial Management, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0 auto;width: 100%;; font-family: inherit; font-size: inherit">
<tr>
<td style="width: 50%">
<div style="text-align: center"><font style="font-weight: bold; font-size: 19px;"><font style="font-weight: bold;">&#xA0;</font><font style="font-family: Times New Roman; font-weight: bold;">Benchmark
Company</font></font></div>
</td>
<td style="width: 50%">
<div style="text-align: center"><font style="font-weight: bold; font-size: 19px;">&#xA0;WestPark Capital,
Inc.<br></font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The date of this
prospectus supplement is October 10, 2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5001.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5002.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5003.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><br></font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">TABLE
OF CONTENTS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Prospectus
Supplement</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ABOUT THIS
PROSPECTUS SUPPLEMENT</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-ii</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAUTIONARY
STATEMENTS REGARDING FORWARD-LOOKING INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-iii</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT SUMMARY</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-1</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">THE
OFFERING</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-4</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-9</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">USE OF
PROCEEDS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-16</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAPITALIZATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-17</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DESCRIPTION OF THE
SERIES A CONVERTIBLE PREFERRED STOCK</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-18</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CERTAIN U.S.
FEDERAL INCOME TAX CONSIDERATIONS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-32</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">UNDERWRITING</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-38</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">LEGAL
MATTERS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-43</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">EXPERTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-43</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">WHERE YOU CAN FIND
MORE INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-43</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">INFORMATION
INCORPORATED BY REFERENCE</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-44</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Prospectus</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ABOUT THIS
PROSPECTUS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">AVAILABLE
INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">OUR
COMPANY</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">3</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">CAUTIONARY
STATEMENTS REGARDING FORWARD-LOOKING INFORMATION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">4</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">5</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">USE OF
PROCEEDS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">17</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DESCRIPTION OF
CAPITAL STOCK</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">17</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DESCRIPTION OF
WARRANTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">18</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">MATERIAL FEDERAL
INCOME TAX CONSEQUENCES</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">PLAN OF
DISTRIBUTION</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">LEGAL
MATTERS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">20</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">EXPERTS</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">20</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: top; width: 92%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">INFORMATION
INCORPORATED BY REFERENCE</font></div>
</td>
<td style="vertical-align: top; width: 8%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-i</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">ABOUT
THIS PROSPECTUS SUPPLEMENT</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">This document is in
two parts. The first part is the prospectus supplement, including
the documents incorporated by reference, which describes the
specific terms of this offering. The second part, the accompanying
prospectus, including the documents incorporated by reference,
provides more general information. Before you invest, you should
carefully read this prospectus supplement, the accompanying
prospectus, all information incorporated by reference herein and
therein, as well as the additional information described under
&#x201C;Where You Can Find More Information&#x201D; on page S-43 of
this prospectus supplement. These documents contain information you
should consider when making your investment decision. This
prospectus supplement may add, update or change information
contained in the accompanying prospectus. To the extent there is a
conflict between the information contained in this prospectus
supplement, on the one hand, and the information contained in the
accompanying prospectus or any document incorporated by reference
therein filed prior to the date of this prospectus supplement, on
the other hand, you should rely on the information in this
prospectus supplement. If any statement in one of these documents
is inconsistent with a statement in another document having a later
date &#x2014; for example, a document filed after the date of this
prospectus supplement and incorporated by reference in this
prospectus supplement and the accompanying prospectus &#x2014; the
statement in the document having the later date modifies or
supersedes the earlier statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">You should rely
only on the information contained or incorporated by reference in
this prospectus supplement, the accompanying prospectus and in any
free writing prospectuses we may provide to you in connection with
this offering. We have not, and the underwriters in this offering,
including the representative of the underwriters, ThinkEquity, a
division of Fordham Financial Management, Inc., or ThinkEquity,
have not, authorized any other person to provide you with any
information that is different. If anyone provides you with
different or inconsistent information, you should not rely on it.
We are offering to sell, and seeking offers to buy, shares of our
Series A Convertible Preferred Stock only in jurisdictions where
offers and sales are permitted. The distribution of this prospectus
supplement and the offering of the Series A Convertible Preferred
Stock in certain jurisdictions may be restricted by law. Persons
outside the United States who come into possession of this
prospectus supplement must inform themselves about, and observe any
restrictions relating to, the offering of the Series A Convertible
Preferred Stock and the distribution of this prospectus supplement
outside the United States. This prospectus supplement does not
constitute, and may not be used in connection with, an offer to
sell, or a solicitation of an offer to buy, any securities offered
by this prospectus supplement by any person in any jurisdiction in
which it is unlawful for such person to make such an offer or
solicitation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We further note
that the representations, warranties and covenants made by us in
any agreement that is filed as an exhibit to any document that is
incorporated by reference in the accompanying prospectus were made
solely for the benefit of the parties to such agreement, including,
in some cases, for the purpose of allocating risk among the parties
to such agreements, and should not be deemed to be a
representation, warranty or covenant to you. Moreover, such
representations, warranties or covenants were accurate only as of
the date when made. Accordingly, such representations, warranties
and covenants should not be relied on as accurately representing
the current state of our affairs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">When used herein,
&#x201C;cbdMD&#x201D;, &#x201C;we&#x201D;, &#x201C;us&#x201D; or
&#x201C;our&#x201D; refers to cbdMD, Inc., a North Carolina
corporation formerly known as Level Brands, Inc., and our
subsidiaries, CBD Industries, LLC, a North Carolina limited
liability company formerly known as cbdMD, LLC, which we refer to
as &#x201C;CBDI,&#x201D; <font style="color: #000000">Beauty and
Pinups, LLC, a North Carolina limited liability company which we
refer to as &#x201C;Beauty &amp; Pin-Ups&#x201D;, I | M 1, LLC, a
California limited liability company, which we refer to as
&#x201C;I&#x2019;M1&#x201D;, Encore Endeavor 1 LLC, a California
limited liability company which we refer to as &#x201C;EE1,&#x201D;
and Level H&amp;W, LLC, a North Carolina limited liability company
which we refer to as &#x201C;Level H&amp;W.&#x201D; In addition,
&#x201C;fiscal 2017&#x201D; refers to the year ended September 30,
2017, &#x201C;fiscal 2018&#x201D; refers to the year ended September
30, 2018, and &#x201C;fiscal 2019&#x201D; refers to the year ending
September 30, 2019.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-ii</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING
INFORMATION</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The information
included or incorporated by reference into this prospectus
supplement and the accompanying prospectus contains forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933, as amended, or Securities Act, and Section 21E of the
Securities Exchange Act of 1934, as amended, or Exchange Act. These
<font style="color: #000000">forward-looking statements that relate
to future events or our future financial performance and involve
known and unknown risks, uncertainties and other factors that may
cause our actual results, levels of activity, performance or
achievements to differ materially from any future results, levels
of activity, performance or achievements expressed or implied by
these forward-looking statements. Words such as, but not limited
to, &#x201C;believe,&#x201D; &#x201C;expect,&#x201D;
&#x201C;anticipate,&#x201D; &#x201C;estimate,&#x201D;
&#x201C;intend,&#x201D; &#x201C;plan,&#x201D; &#x201C;targets,&#x201D;
&#x201C;likely,&#x201D; &#x201C;aim,&#x201D; &#x201C;will,&#x201D;
&#x201C;would,&#x201D; &#x201C;could,&#x201D; and similar expressions
or phrases identify forward-looking statements. We have based these
forward-looking statements largely on our current expectations and
future events and financial trends that we believe may affect our
financial condition, results of operation, business strategy and
financial needs. Actual results may differ materially from those
expressed or implied in such forward-looking statements as a result
of various factors. We do not undertake, and we disclaim, any
obligation to update any forward-looking statements or to announce
any revisions to any of the forward-looking statements, except as
required by law. Certain factors that could cause results to be
materially different from those projected in the forward-looking
statements include, but are not limited to, statements
about:</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">terms and
provisions of the designations, rights and preferences of the
Series A Convertible Preferred Stock;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
obtain a listing of the Series A Convertible Preferred Stock on the
NYSE American and, if such listing is obtained, risks associated
with a new issue of securities with no established trading
market;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">management&#x2019;s
broad discretion as to the use of proceeds from this
offering;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the impact of fair
value accounting on our results of operations in future
periods;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">possible continuing
material weaknesses in our internal control over financial
reporting;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the dilution to our
shareholders upon the possible future issuance of the Earnout
Shares;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with control by our executive officers, directors and
affiliates;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our history of
losses and possible charges related to the carrying value of
assets;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">laws and
regulations impacting our company; and</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our possible need to raise additional capital.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We urge you to
consider these factors before investing in our Series A Convertible
Preferred Stock. The forward-looking statements included in this
prospectus supplement, the accompanying prospectus and any other
offering material, or in the documents incorporated by reference
into this prospectus supplement, the accompanying prospectus and
any other offering material, are made only as of the date of the
prospectus supplement, the accompanying prospectus, any other
offering material or the incorporated document. For more detail on
these and other risks, please see &#x201C;Risk Factors&#x201D; in
this prospectus supplement, the accompanying prospectus, our Annual
Report on Form 10-K for our fiscal year ended September 30, 2018
filed with the Securities and Exchange Commission, or SEC, on
December 12, 2018, our Quarterly Report on Form 10-Q/A for the
period ended December 31, 2018 as filed with the SEC on April 26,
2019, our Quarterly Report on Form 10-Q for the period ended March
31, 2019 as filed with the SEC on May 15, 2019, our Quarterly
Report on Form 10-Q for the period ended June 30, 2019 filed with
the SEC on August 14, 2019 and our subsequent filings with the
SEC.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-iii</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT SUMMARY</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
The following information below is only a summary of more detailed
information included elsewhere in, or incorporated by reference in,
this prospectus supplement and the accompanying prospectus, and
should be read together with the information contained or
incorporated by reference in other parts of this prospectus
supplement and the accompanying prospectus. This summary highlights
selected information about us and this offering. This summary may
not contain all of the information that may be important to you.
Before making a decision to invest in our Series A Convertible
Preferred Stock, you should read carefully all of the information
contained in or incorporated by reference into this prospectus
supplement and the accompanying prospectus, including the
information set forth under the caption &#x201C;Risk Factors&#x201D;
in this prospectus supplement and the accompanying prospectus as
well as the documents incorporated herein by reference, which are
described under &#x201C;Where You Can Find More Information&#x201D;
and &#x201C;Information Incorporated by Reference&#x201D; in this
prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Our Company</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5004.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">cbdMD was
originally founded in 2015 as an <font style="color: #000000">innovative branding and marketing company with a
focus on lifestyle-based brands. In December 2018 we acquired Cure
Based Development LLC following the</font> approval of the United
States of the Agricultural Improvement Act of 2018, commonly known
as the Farm Bill, which contained a permanent declassification of
cannabidiol (CBD) as a controlled substance under Federal
law<font style="color: #000000">. As a result of that transaction,
we</font> own and operate the nationally recognized CBD brand cbdMD
which now represents substantially all of our revenues. We also
continue to own legacy licensing and corporate brand management
businesses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Through our CBDI
subsidiary which succeeded to the business of Cure Based
Development LLC, we produce <font style="color: #222222; background-color: #ffffff">and distribute</font>
various high-grade, premium CBD products, including tinctures,
capsules, gummies, bath bombs and topical creams. We recently
launched a 36 SKU line of pet related CBD products under our Paw
CBD brand including tinctures, treats, and balms, with additional
products under development. We manufacture our premium line of
products at our Charlotte, NC facility using 100%, all-natural CBD
extracted from organic, non-GMO, vegan, and gluten-free industrial
hemp grown in the USA. We utilize a CO2 extraction process for
broad-spectrum concentrations retaining other cannabinoids,
terpenes, vitamins, and various other compounds for enhanced
benefits while eliminating <font style="color: #545454; background-color: #ffffff">tetrahydrocannabinol
(</font>THC) content.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-1</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5005.jpg"></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Since December
2018, we have <font style="color: #000000">increased the number of
locations cbdMD products are available in by 500%, and with the
building momentum of retailer acceptance subsequent to the passage
of the Farm Bill, we are pursuing multiple opportunities to expand
our product distribution as we continue to work to build cbdMD into
a top recognized brand in the industry. We are also utilizing
partnerships and sponsorships with professional athletes as a way
to gain brand recognition. During the third quarter of fiscal 2019
we signed several significant sponsorships, including professional
golfer and 12-time PGA Tour winner Bubba Watson, Ice Cube&#x2019;s
Big 3 basketball league, Bellator MMA, and Nitro
Circus.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5006.jpg"></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Risk
Factors</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">An investment in
our Series A Convertible Preferred Stock involves risk. Before
deciding whether to participate in this offering, you should
carefully consider the risk factors beginning on page S-9 of this
prospectus supplement and the risk factors contained in the
documents incorporated by reference in this prospectus supplement
and the accompanying prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-2</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Corporate
Information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
company was formed under the laws of the state of North Carolina in
March 2015 under the name Level Beauty Group, Inc. In November 2016
we changed the name of our company to Level Brands, Inc. Effective
May 1, 2019, we changed our name to cbdMD, Inc. in connection with
the mergers with Cure Based Development.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Our principal executive offices are located at
8845 Red Oak Boulevard, Charlotte, NC 28217. Our telephone number
at this location is (704) 445-3060. Our website address is</font>
<font style="color: #0000ff; text-decoration: underline">www.cbdmd.com</font><font style="color: #000000">.
We make our periodic and current reports that are filed with the
SEC available, free of charge, on our website as soon as reasonably
practicable after such material is electronically filed with, or
furnished to, the SEC. The information contained in, and that can
be accessed through, our website is not incorporated into and is
not a part of this prospectus supplement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Please see our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018 and subsequently filed Quarterly Report on Form 10-Q for the
quarters ended December 31, 2018, March 31, 2019 and June 30, 2019
for additional information about our business, operations and
financial condition. See &#x201C;Where You Can Find More
Information.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold">Implications of Being an Emerging Growth
Company</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We qualify as an
&#x201C;emerging growth company&#x201D; as defined in the JOBS Act.
As an emerging growth company, we intend to take advantage of
specified reduced disclosure and other requirements that are
otherwise applicable generally to public companies. These
provisions include:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">allowance to
provide only two years of audited financial statements in addition
to any required unaudited interim financial statements with
correspondingly reduced Management&#x2019;s Discussion and Analysis
of Financial Condition and Results of Operations
disclosures;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">reduced disclosure
about our executive compensation arrangements;&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font><font style="font-size: 13px; font-family: Times New Roman">no non-binding
advisory votes on executive compensation or golden parachute
arrangements; and &#xA0;</font> &#xA0;&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">exemption from
auditor attestation requirements in the assessment of our internal
control over financial reporting.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We may take
advantage of these provisions for up to five years or such earlier
time that we are no longer an emerging growth company. We would
cease to be an emerging growth company on the date that is the
earliest of: (i) the last day of the fiscal year in which we have
total annual gross revenues of $1.07 billion or more; (ii) the last
day of our fiscal year following the fifth anniversary of the date
of the completion of our initial public offering; (iii) the date on
which we have issued more than $1.0 billion in nonconvertible debt
during the previous three years; or (iv) the date on which we are
deemed to be a large accelerated filer under the rules of the SEC.
We have taken advantage of reduced reporting requirements in this
prospectus. Accordingly, the information contained herein may be
different than the information you receive from other public
companies in which you have beneficial ownership.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-3</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
THE OFFERING</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The following
summary contains basic information about this offering. The summary
is not intended to be complete. You should read the full text and
more specific details contained elsewhere in this prospectus
supplement. See &#x201C;Description of Series A Convertible
Preferred Stock&#x201D; and &#x201C;Underwriting.&#x201D;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Issuer</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Securities
Offered</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">500,000
shares of 8.0% Series A Cumulative Convertible Preferred Stock,
liquidation preference $10.00 per share.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Offering
Price</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">$10.00
per share.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
Over-allotment Option</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
have granted to the representative of the underwriters the option,
exercisable for 45 days from the date of this prospectus
supplement, to purchase up to additional 75,000 shares of Series A
Convertible Preferred Stock to cover over-allotments.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Dividends</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Holders of shares
of the Series A Convertible Preferred Stock are entitled to
receive, when, as and if declared by our board of directors, out of
funds legally available for the payment of dividends, cumulative
cash dividends at the rate of 8.0% per annum of the $10.00 per
share liquidation preference (equivalent to $0.80 per annum per
share). All accrued dividends on the Series A Convertible Preferred
Stock shall be paid in cash only when, as and if declared by the
Board out of funds legally available therefor or upon a liquidation
or redemption of the Series A Convertible Preferred
Stock.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Dividends will be payable monthly in arrears on
the 15th day of each month (each, a &#x201C;Dividend Payment
Date&#x201D;)</font>; provided that if any Dividend Payment Date is
not a business day, then the dividend that would otherwise have
been payable on that Dividend Payment Date may be paid on the next
succeeding business day and no interest, additional dividends or
other sums will accrue on the amount so payable for the period from
and after that Dividend Payment Date to that next succeeding
business day. <font style="color: #000000">The record date for the
payment of dividends on the Series A Convertible Preferred Stock is
the close of business on the first day of the calendar month,
whether or not a business day (each, a &#x201C;Dividend Record
Date&#x201D;). The shares of Series A Convertible Preferred Stock
offered hereby will be credited as having accrued dividends since
the first day of the calendar month in which they are
issued.</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As a result,
holders of shares of Series A Convertible Preferred Stock will not
be entitled to receive dividends on a Dividend Payment Date if such
shares were not issued and outstanding on the applicable Dividend
Record Date.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any dividend
payable on the Series A Convertible Preferred Stock, including
dividends payable for any partial dividend period, will be computed
on the basis of a 360-day year consisting of twelve 30-day
months.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-4</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">No
Maturity</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock has no maturity date, and we are not
required to redeem the Series A Convertible Preferred Stock except
in the event of a Change of Control (as defined hereafter).
Accordingly, the Series A Convertible Preferred Stock will remain
outstanding indefinitely unless a Change of Control occurs, we
decide to redeem it, we elect to automatically convert it into
shares of common stock upon a Market Trigger (as defined hereafter)
or the holder elects to voluntarily convert the Series A
Convertible Preferred Stock into shares of our common stock. We are
not required to set aside funds to redeem the Series A Convertible
Preferred Stock.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Conversion</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Optional
Conversion by the Holder</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Each share of
Series A Convertible Preferred Stock, together with accrued but
unpaid dividends, is convertible into shares of our common stock at
any time at the option of the holder at a Conversion Price of $6.00
per share, which equals 1.667 shares of common stock for each share
of Series A Convertible Preferred Stock so converted, subject to
adjustment for: (i) the payment of stock dividends or other
distributions payable in common stock on the outstanding shares of
our common stock, excluding the shares of common stock issuable
upon the conversion of the Series A Convertible Preferred Stock;
and (ii) subdivisions and combinations (including by way of a
reverse stock split) (the &#x201C;Anti-Dilution
Provisions&#x201D;).</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Market
Trigger</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">At our option, we
may cause the Series A Convertible Preferred Stock, plus accrued
and unpaid dividends, to be automatically converted, in whole or in
part, on a pro rata basis into shares of our common stock at the
Conversion Price if the Trading Price (as defined hereafter) of the
common stock equals or exceeds $8.25 (137.5% of the Conversion
Price) for at least 20 trading days in any 30 consecutive trading
day period ending five days prior to the date of notice of
conversion (such event, the &#x201C;Market
Trigger&#x201D;).</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Optional
Redemption by cbdMD</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock may be redeemed in whole or in part at
our option any time on or after, October 16, 2023 upon not less
than 30 days nor more than 60 days&#x2019; written notice by mail to
the holders prior to the date fixed for redemption thereof, for
cash at a redemption price equal to $10.00 per share, plus any
accrued but unpaid dividends to, but not including, the redemption
date. Holders of Series A Convertible Preferred Stock will have the
right to convert such shares after the optional redemption notice
but prior to the redemption date into shares of our common stock at
the Conversion Price.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-5</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Change
of Control</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Mandatory
Redemption by cbdMD</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon the occurrence
of a Change of Control, we are required to redeem all of the then
issued and outstanding shares of Series A Convertible Preferred
Stock for cash at $11.00 per share, plus accrued but unpaid
dividends (whether or not declared) to, but excluding, the
redemption date.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">A &#x201C;Change of
Control&#x201D; is deemed to occur, after the original issuance of
the Series A Convertible Preferred Stock, upon the acquisition by
any person, including any syndicate or group deemed to be a
&#x201C;person&#x201D; under Section 13(d)(3) of the Exchange Act of
beneficial ownership, directly or indirectly, through a purchase,
merger or other acquisition transaction or series of purchases,
mergers or other acquisition transactions <font style="color: #000000">which were pre-approved by our board of
directors</font> of our stock entitling that person to exercise
more than 50% of the total voting power of all of our stock
entitled to vote generally in the election of our board of
directors (except that such person will be deemed to have
beneficial ownership of all securities that such person has the
right to acquire, whether such right is currently exercisable or is
exercisable only upon the occurrence of a subsequent condition);
<font style="font-style: italic; color: #000000">provided,
however</font><font style="color: #000000">, that (i) the vesting
of the aggregate of 8,750,000 shares of our common stock and/or
(ii) the issuance of an aggregate of 15,525,000 shares of our
common stock both pursuant to the terms and conditions of that
certain Agreement and Plan of Merger dated December 3, 2018 by and
among cbdMD, our wholly-owned subsidiaries and Cure Based
Development, LLC will not be deemed to be a Change of
Control.</font></font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 31%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Change
of Control Conversion Right</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon the
holder&#x2019;s receipt of a change of control notice until the
trading day ending three trading days prior to the change of
control redemption date, the holder of shares of Series A
Convertible Preferred Stock will have the right (&#x201C;Change of
Control Conversion Right&#x201D;) to convert some or all of the
shares of Series A Convertible Preferred Stock held by such holder,
together with accrued but unpaid dividends on those shares, into of
shares of Common Stock at the Conversion Price. In the event of a
Change of Control, any shares of Series A Convertible Preferred
Stock not so converted by the holder pursuant to the Change of
Control Conversion Right will be subject to the mandatory
redemption described above.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 35%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 31%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Liquidation
Preference</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we liquidate,
dissolve or wind up, holders of the Series A Convertible Preferred
Stock will have the right to receive $10.00 per share, plus any
accrued but unpaid dividends to, but not including, the date of
payment, before any payment is made to the holders of our common
stock.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Ranking</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock will rank, with respect to rights to
the payment of dividends and the distribution of assets upon our
liquidation, dissolution or winding up, (1) senior to all classes
or series of our common stock and to all other equity securities
issued by us other than equity securities referred to in clauses
(2) and (3); (2) on a parity with all equity securities issued by
us with terms specifically providing that those equity securities
rank on a parity with the Series A Convertible Preferred Stock with
respect to rights to the payment of dividends and the distribution
of assets upon our liquidation, dissolution or winding up; (3)
junior to all equity securities issued by us with terms
specifically providing that those equity securities rank senior to
the Series A Convertible Preferred Stock with respect to rights to
the payment of dividends and the distribution of assets upon our
liquidation, dissolution or winding up; and (4) junior to all of
our existing and future indebtedness.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-6</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: right; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<font style="font-weight: bold">Limited Voting Rights</font></font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Holders of the
Series A Convertible Preferred Stock do not have any voting rights,
except as set forth as follows or as otherwise required by law. In
the event dividends on the Series A Convertible Preferred Stock are
in arrears for each of 12 or more consecutive monthly periods, the
holders of the Series A Convertible Preferred Stock, voting as a
separate class, will be entitled to vote for the election of two
additional directors to serve on our board of directors until all
dividends that are owed have been paid. In addition, we will be
restricted in our ability to modify the terms of the Series A
Convertible Preferred Stock or to issue or create any class or
series of capital stock ranking senior to the Series A Convertible
Preferred Stock with respect to dividends or distributions, unless
holders of at least two-thirds of the then outstanding Series A
Convertible Preferred Stock voting as a separate class consent to
same. The affirmative consent of the holders of a majority of the
outstanding shares of Series A Convertible Preferred Stock, voting
as a separate class, is required, if we want to increase the number
of authorized shares of this series (except in connection with the
Anti-Dilution Provisions) or if we want to create a class or series
of capital stock ranking <font style="font-style: italic">pari
passu</font> to the Series A Convertible Preferred Stock. Except as
expressly stated in the certificate of designations or as may be
required by applicable law, the Series A Convertible Preferred
Stock does not bestow any relative, participating, optional or
other special voting rights or powers, and the consent of the
holders thereof shall not be required for the taking of any
corporate action.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Exchange
Listing</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Currently, no
market exists for the Series A Convertible Preferred Stock. We have
filed an application to list our Series A Convertible Preferred
Stock&#xA0;on the NYSE American under the symbol
&#x201C;YCBDP.&#x201D; We expect trading of the Series A Convertible
Preferred Stock on the NYSE American, if the listing is approved,
to commence within three business days after the date of initial
issuance of the shares of Series A Convertible Preferred
Stock.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
Representative&#x2019;s Warrants</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">The registration statement of which this
prospectus supplement is a part also registers for sale warrants to
purchase 47,923 shares of our common stock to the representative of
the underwriters as a portion of the underwriting compensation
payable to the underwriters in connection with this offering and
the shares of common stock underlying the warrants. The warrants
will be exercisable for a period commencing 180 days following the
effective date of this offering and ending on the fifth anniversary
of the effective date of this offering at an exercise price equal
to $3.9125 per share, or</font> 125% of the last closing price per
share of our common stock on the NYSE American prior to the
execution of the underwriting agreement for this
offering.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Use of Proceeds</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
intend to use the net proceeds from this offering for working
capital. See &#x201C;Use of Proceeds."</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Risk Factors</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
investment involves a high degree of risk. See &#x201C;Risk
Factors&#x201D; and other information included or incorporated by
reference in this prospectus supplement and the accompanying
prospectus for a discussion of certain factors you should carefully
consider before deciding to invest in shares of our Series A
Convertible Preferred Stock.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-7</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Certain U.S. Federal Income</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Tax Considerations</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">For
a discussion of certain U.S. federal income tax consequences of
purchasing, owning and disposing of the Series A Convertible
Preferred Stock, please see the section entitled &#x201C;Certain
U.S. Federal Income Tax Considerations.&#x201D; You should consult
your independent tax advisor with respect to the U.S. federal
income tax consequences of owning the Series A Convertible
Preferred Stock in light of your own particular situation and with
respect to any tax consequences arising under the laws of any other
taxing jurisdiction.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Form</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
Series A Convertible Preferred Stock will be represented by one or
more global certificates in definitive, fully registered form
deposited with a custodian for, and registered in the name of, a
nominee of The Depository Trust Company
(&#x201C;DTC&#x201D;).</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Settlement</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Delivery
of the Series A Convertible Preferred Stock offered hereby will be
made against payment therefor through the book-entry facilities of
the DTC.</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 32%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Transfer Agent</font></div>
</td>
<td style="vertical-align: top; width: 2%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 66%">
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">The registrar, transfer agent and</font> dividend
<font style="color: #000000">and redemption price disbursing agent
in respect of the Series A Convertible Preferred Stock will be
VStock Transfer, LLC.</font></font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-8</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">RISK
FACTORS</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
<font style="color: #000000">Investing in our Series A Convertible
Preferred Stock involves a high degree of risk. You should
carefully consider and evaluate all of the information contained in
this prospectus supplement, the accompanying prospectus and in the
documents we incorporate by reference into this prospectus
supplement and the accompanying prospectus before you decide to
purchase our securities. In particular, you should carefully
consider and evaluate the risks and uncertainties described under
the heading &#x201C;Risk Factors&#x201D; in this prospectus
supplement and the accompanying prospectus.</font> You should also
consider the risks, uncertainties and assumptions discussed under
Item 1A, &#x201C;Risk Factors,&#x201D; in Part I of our Annual Report
on Form 10-K for the year ended September 30, 2018, Item 1A,
&#x201C;Risk Factors,&#x201D; in our Quarterly Report on Form 10-Q/A
for the period ended December 31, 2018, our Quarterly Reports on
Form 10-Q for the periods ended March 31, 2019 and June 30, 2019,
together with any updates or other risks contained in other filings
that we may make with the SEC after the date of this prospectus,
all of which are incorporated herein by reference, and may be
amended, supplemented or superseded from time to time by other
reports we file with the SEC in the future and any additional
prospectus supplement. <font style="color: #000000">Any of the
risks and uncertainties set forth in this prospectus supplement and
the accompanying prospectus, as updated by annual, quarterly and
other reports and documents that we file with the SEC and
incorporate by reference into this prospectus supplement or the
accompanying prospectus could materially and adversely affect our
business, results of operations and financial condition, which in
turn could materially and adversely affect the value of our Series
A Convertible Preferred Stock. As a result, you could lose all or
part of your investment. &#xA0;See &#x201C;Where You Can Find More
Information,&#x201D; &#x201C;Description of Series A Convertible
Preferred Stock,&#x201D; and &#x201C;Certain U.S. Federal Income Tax
Considerations.&#x201D;</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Risks Related to this Offering</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The Series A Convertible Preferred Stock ranks junior to all of our
indebtedness and other liabilities and is effectively junior to all
indebtedness and other liabilities of our
subsidiaries.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the event of our
bankruptcy, liquidation, dissolution or winding-up of our affairs,
our assets will be available to pay obligations on the Series A
Convertible Preferred Stock only after all of our indebtedness and
other liabilities have been paid. The rights of holders of the
Series A Convertible Preferred Stock to participate in the
distribution of our assets will rank junior to the prior claims of
our current and future creditors and any future series or class of
preferred stock we may issue that ranks senior to the Series A
Convertible Preferred Stock. In addition, the Series A Convertible
Preferred Stock effectively ranks junior to all existing and future
indebtedness and other liabilities of our existing subsidiaries and
any future subsidiaries. Our existing subsidiaries are, and any
future subsidiaries would be, separate legal entities and have no
legal obligation to pay any amounts to us in respect of dividends
due on the Series A Convertible Preferred Stock. If we are forced
to liquidate our assets to pay our creditors, we may not have
sufficient assets to pay amounts due on any or all of the Series A
Convertible Preferred Stock then outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Future offerings of debt may adversely affect the market price of
the Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we decide to
issue debt securities in the future, it is possible that these
securities will be governed by an indenture or other instruments
containing covenants restricting our operating flexibility.
Additionally, any convertible or exchangeable securities that we
issue in the future may have rights, preferences and privileges
more favorable than those of the Series A Convertible Preferred
Stock and may result in dilution to owners of the Series A
Convertible Preferred Stock. We and, indirectly, our shareholders,
will bear the cost of issuing and servicing such securities.
Because our decision to issue debt securities in any future
offering will depend on market conditions and other factors beyond
our control, we cannot predict or estimate the amount, timing or
nature of our future offerings. The holders of the Series A
Convertible Preferred Stock may bear the risk of our future
offerings, potentially reducing the market price of the Series A
Convertible Preferred Stock and diluting the value of their
holdings in us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may not be able to pay dividends on the Series A Convertible
Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our ability to pay
cash dividends on the Series A Convertible Preferred Stock requires
us to (i) either be able to pay our debts as they become due in the
usual course of business, &#x2009;or (ii) have total assets that are
greater than the sum of our total liabilities plus the amount that
would be needed if we were to be dissolved at the time of the
distribution to satisfy the preferential rights upon dissolution of
shareholders whose preferential rights are superior to those
receiving the distribution. Further, notwithstanding these factors,
we may not have sufficient cash to pay dividends on the Series A
Convertible Preferred Stock. Our ability to pay dividends may be
impaired if any of the risks described in this prospectus
supplement and the accompanying prospectus, including the documents
incorporated by reference herein and therein, were to occur. Also,
payment of our dividends depends upon our financial condition and
other factors as our board of directors may deem relevant from time
to time. We cannot assure you that our businesses will generate
sufficient cash flow from operations in an amount sufficient to
enable us to make distributions on our common stock, if any, and
preferred stock, including the Series A Convertible Preferred
Stock, or to fund our other liquidity needs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-9</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The Series A Convertible Preferred Stock is a new issue of
securities and does not have an established trading market, which
may negatively affect its value and your ability to transfer and
sell your shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock is a new issue of securities and
currently no market exists for the Series A Convertible Preferred
Stock. We have filed an application to list the Series A
Convertible Preferred Stock on the NYSE American. Even if so
approved, trading of the Series A Convertible Preferred Stock on
the NYSE American is not expected to begin until sometime during
the period ending three business days after the date of initial
issuance of the Series A Convertible Preferred Stock, and, in any
event, a trading market on the NYSE American for the Series A
Preferred Stock may never develop or, even if one develops, may not
be maintained and may not provide you with adequate liquidity. The
liquidity of any market for the Series A Preferred Stock that may
develop will depend on a number of factors, including prevailing
interest rates, our financial condition and operating results, the
number of holders of the Series A Preferred Stock, the market for
similar securities and the interest of securities dealers in making
a market in the Series A Preferred Stock. As a result, the ability
to transfer or sell the Series A Preferred Stock and could be
adversely affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
If our Series A Convertible Preferred Stock is delisted, the
ability to transfer or sell shares of the Series A Convertible
Preferred Stock may be limited and the market value of the Series A
Convertible Preferred Stock will likely be materially adversely
affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock does not contain provisions that are
intended to protect investors if our Series A Convertible Preferred
Stock is delisted from the NYSE American. If our Series A
Convertible Preferred Stock is delisted from the NYSE American,
investors&#x2019; ability to transfer or sell shares of the Series A
Convertible Preferred Stock will be limited and the market value of
the Series A Convertible Preferred Stock will likely be materially
adversely affected. Moreover, since the Series A Convertible
Preferred Stock has no stated maturity date, absent a
holder&#x2019;s voluntary conversion of the Series A Convertible
Preferred Stock investors may be forced to hold shares of the
Series A Convertible Preferred Stock indefinitely while receiving
stated dividends thereon when, as and if authorized by our board of
directors and paid by us with no assurance as to ever receiving the
liquidation value thereof.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Future issuances of preferred stock, including future issuances of
shares of Series A Convertible Preferred Stock, may reduce the
value of the Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon the completion
of the offering described in this prospectus supplement, we may
sell additional shares of preferred stock, including shares of
Series A Convertible Preferred Stock, on terms that may differ from
those described in this prospectus supplement. Such shares could
rank on parity with or, subject to the voting rights referred to
below (with respect to issuances of new series of preferred stock),
senior to the Series A Convertible Preferred Stock offered hereby
as to distribution rights or rights upon liquidation, winding up or
dissolution. The subsequent issuance of additional shares of Series
A Convertible Preferred Stock, or the creation and subsequent
issuance of additional classes of preferred stock on parity with
the Series A Convertible Preferred Stock, could dilute the
interests of the holders of Series A Convertible Preferred Stock
offered hereby. Any issuance of preferred stock that is senior to
the Series A Convertible Preferred Stock would not only dilute the
interests of the holders of Series A Convertible Preferred Stock
offered hereby, but also could affect our ability to pay
distributions on, redeem or pay the liquidation preference on the
Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-10</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Market interest rates may materially and adversely affect the value
of the Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">One of the factors
that influences the price of the Series A Convertible Preferred
Stock is the dividend yield on the Series A Convertible Preferred
Stock (as a percentage of the market price of the Series A
Convertible Preferred Stock) relative to market interest rates.
Continued increase in market interest rates, which are currently at
low levels relative to historical rates, may lead prospective
purchasers of the Series A Convertible Preferred Stock to expect a
higher dividend yield (and higher interest rates would likely
increase our borrowing costs and potentially decrease funds
available for dividend payments). Thus, higher market interest
rates could cause the market price of the Series A Convertible
Preferred Stock to materially decrease, assuming a market is
established of which there are no assurances.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Holders of the Series A Convertible Preferred Stock may be unable
to use the dividends-received deduction and may not be eligible for
the preferential tax rates applicable to &#x201C;qualified dividend
income.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Distributions paid
to corporate U.S. holders of the Series A Convertible Preferred
Stock may be eligible for the dividends-received deduction, and
distributions paid to non-corporate U.S. holders of the Series A
Convertible Preferred Stock may be subject to tax at the
preferential tax rates applicable to &#x201C;qualified dividend
income,&#x201D; if we have current or accumulated earnings and
profits, as determined for U.S. federal income tax purposes. We do
not currently have any accumulated earnings and profits.
Additionally, we may not have sufficient current earnings and
profits during future fiscal years for the distributions on the
Series A Convertible Preferred Stock to qualify as dividends for
U.S. federal income tax purposes. If the distributions fail to
qualify as dividends, U.S. holders would be unable to use the
dividends-received deduction and may not be eligible for the
preferential tax rates applicable to &#x201C;qualified dividend
income.&#x201D; If any distributions on the Series A Convertible
Preferred Stock with respect to any fiscal year are not eligible
for the dividends-received deduction or preferential tax rates
applicable to &#x201C;qualified dividend income&#x201D; because of
insufficient current or accumulated earnings and profits, it is
possible that the market value of the Series A Convertible
Preferred Stock might decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The Series A Convertible Preferred Stock represents perpetual
equity interests in us, and investors should not expect us to
redeem or convert the Series A Convertible Preferred Stock on the
date the Series A Convertible Preferred Stock becomes redeemable or
convertible by us or on any particular date
afterwards.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock represents perpetual equity interests
in us, and it has no maturity or mandatory redemption except upon a
Change of Control, and is not redeemable at the option of investors
under any other circumstances. As a result, the Series A
Convertible Preferred Stock will not give rise to a claim for
payment of any amount at a particular date. As a result, holders of
the Series A Convertible Preferred Stock may be required to bear
the financial risks of an investment in the Series A Convertible
Preferred Stock for an indefinite period of time unless the holder
chooses to voluntarily convert the shares of Series A Convertible
Preferred Stock into shares of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The Series A Convertible Preferred Stock has not been
rated.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have not sought
to obtain a rating for the Series A Convertible Preferred Stock.
However, one or more rating agencies may independently determine to
issue such a rating or such a rating, if issued, may adversely
affect the market price of the Series A Convertible Preferred
Stock. In addition, we may elect in the future to obtain a rating
for the Series A Convertible Preferred Stock, which could adversely
affect the market price of the Series A Convertible Preferred
Stock. Ratings only reflect the views of the rating agency or
agencies issuing the ratings and such ratings could be revised
downward, placed on a watch list or withdrawn entirely at the
discretion of the issuing rating agency if in its judgment
circumstances so warrant. Any such downward revision, placing on a
watch list or withdrawal of a rating could have an adverse effect
on the market price of the Series A Convertible Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Change of Control redemption obligations may make it more difficult
for a party to acquire us or discourage a party from acquiring
us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Change of
Control redemption feature of the Series A Convertible Preferred
Stock may have the effect of discouraging a third party from making
an acquisition proposal for us or of delaying, deferring or
preventing certain of our change of control transactions under
circumstances that otherwise could provide the holders of our
common stock and Series A Convertible Preferred Stock with the
opportunity to realize a premium over the then-current market price
of such stock or that shareholders may otherwise believe is in
their best interests.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-11</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The market price of the Series A Convertible Preferred Stock could
be substantially affected by various factors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Assuming a market
develops for the Series A Convertible Preferred Stock, the market
price of the Series A Convertible Preferred Stock will depend on
many factors, which may change from time to time,
including:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">prevailing interest
rates, increases in which may have an adverse effect on the market
price of the Series A Convertible Preferred Stock;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">government
regulation impacting the manufacture and sale of CBD
products;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">continued consumer
acceptance of our products;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the highly
competitive market in which we operate and our ability to
effectively compete;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our operating
expenses which fluctuate due to growth of our
business;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">variable sales
cycle and implementation periods for our products;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the annual yield
from distributions on the Series A Preferred Stock as compared to
yields on other financial instruments;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">general economic
and financial market conditions;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">significant changes
in the financial condition, performance and prospects of us and our
competitors;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">changes in
financial estimates or recommendations by securities analysts with
respect to us, our competitors in our industry;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our issuance of
additional preferred equity or debt securities; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">actual or
anticipated variations in quarterly operating results of us and our
competitors.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As a result of
these and other factors, investors who purchase the Series A
Convertible Preferred Stock in this offering may experience a
decrease, which could be substantial and rapid, in the market price
of the Series A Convertible Preferred Stock, including decreases
unrelated to our operating performance or prospects.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-12</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
A holder of Series A Convertible Preferred Stock has extremely
limited voting rights.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The voting rights
for a holder of Series A Convertible Preferred Stock are limited.
Our shares of common stock are the only class of our securities
that carry full voting rights. Holders of the shares of Series A
Convertible Preferred Stock do not have any voting right other than
as set forth below in the next two sentences or unless dividends on
the Series A Convertible Preferred Stock are in arrears for each of
12 or more consecutive monthly periods, in which case the holders
of the Series A Convertible Preferred Stock will be entitled to
vote as a separate class for the election of two additional
directors to serve on the board of directors until all dividends
that are owed have been paid. Holders of shares of Series A
Convertible Preferred Stock, voting as a class, are also entitled
to vote if we should seek to issue or create any class or series of
capital stock ranking senior to the Series A Convertible Preferred
Stock with respect to dividends or distributions, in which event
the consent of holders of at least two thirds of the then
outstanding Series A Convertible Preferred Stock is required. The
consent of the holders of a majority of the Series A Convertible
Preferred Stock, voting as a class, is required if we were to seek
to <font style="color: #000000">adopt any amendment to our articles
of incorporation or bylaws that would materially affect existing
terms of the Series A Convertible Preferred Stock, or</font>
increase the number of authorized shares of that series, other than
in connection with the Anti-Dilution Provisions, or if we seek to
create a series or class which ranks pari passu with the Series A
Convertible Preferred Stock. Other than these limited circumstances
and except to the extent required by law, holders of Series A
Convertible Preferred Stock do not have any voting
rights.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We have broad discretion in determining how to use the proceeds
from this offering and we cannot assure you that we will be
successful in spending the proceeds in ways that increase our
profitability or market value, or otherwise yield favorable
returns.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We plan to utilize
net proceeds of this offering for general working capital.
Nevertheless, we will have broad discretion in determining specific
expenditures. You will be entrusting your funds to our management,
upon whose judgment you must depend, with limited information
concerning the purposes to which the funds will ultimately be
applied. We may not be successful in spending the proceeds of this
offering in ways which increase our profitability or market value,
or otherwise yield favorable returns.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may redeem the Series A Convertible Preferred Stock at our
option, we will be required to redeem the Series A Convertible
Preferred Stock upon a Change of Control and we may convert shares
of Series A Convertible Preferred Stock upon a Market Trigger into
shares of our common stock. In the event of any of these
occurrences, you may not receive dividends that you
anticipate.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">On or after October 16, 2023 we may, at our
option, redeem the Series A Convertible Preferred Stock, in whole
or in part, at any time or from time to time.</font> In addition,
upon the occurrence of a Change of Control, we are required to
redeem any or all of the shares of Series A Convertible Preferred
Stock at a redemption price of $11.00 per share, plus any accrued
but unpaid dividends to, but excluding, the redemption date.
Furthermore, <font style="color: #000000">upon a Market Trigger, we
may convert all or any portion of</font> those shares of Series A
Convertible Preferred Stock <font style="color: #000000">into
shares of our common stock. We may have an incentive to redeem or
convert the Series A Convertible Preferred Stock voluntarily if
market conditions allow us to issue other preferred stock or debt
securities at a rate that is lower than the dividend rate on the
Series A Convertible Preferred Stock. If we redeem or convert the
Series A Convertible Preferred Stock, then from and after the
redemption date or conversion date, as applicable, dividends will
cease to accrue on shares of Series A Convertible Preferred Stock,
the shares of Series A Convertible Preferred Stock shall no longer
be deemed outstanding and all rights as a holder of those shares
will terminate, including the rights to receive dividend
payments.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Risks
Related to the Regulatory Environment</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Changes to state laws pertaining to industrial hemp could slow the
use of industrial hemp which would materially impact our revenues
in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As of the date
hereof, approximately 40 states authorized industrial hemp programs
pursuant to the Farm Bill. Continued development of the industrial
hemp industry will be dependent upon new legislative authorization
of industrial hemp at the state level, and further amendment or
supplementation of legislation at the federal level. Any number of
events or occurrences could slow or halt progress all together in
this space. While progress within the industrial hemp industry is
currently encouraging, growth is not assured. While there appears
to be ample public support for favorable legislative action,
numerous factors may impact or negatively affect the legislative
process(es) within the various states where we have business
interests. Any one of these factors could slow or halt use of
industrial hemp, which could negatively impact the business up to
possibly causing us to discontinue operations as a
whole.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Costs associated with compliance with numerous laws and regulations
could impact our financial results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The manufacture,
labeling and distribution by us of the CBD products is regulated by
various federal, state and local agencies. These governmental
authorities may commence regulatory or legal proceedings, which
could restrict the permissible scope of our product claims or the
ability to sell products in the future. The U.S. Food and Drug
Administration, or FDA, may regulate our products to ensure that
the products are not adulterated or misbranded. We are subject to
regulation by the federal government and other state and local
agencies as a result of our CBD products. The shifting compliance
environment and the need to build and maintain robust systems to
comply with different compliance in multiple jurisdictions
increases the possibility that we may violate one or more of the
requirements. If our operations are found to be in violation of any
of such laws or any other governmental regulations that apply to
our company, we may be subject to penalties, including, without
limitation, civil and criminal penalties, damages, fines, the
curtailment or restructuring of our operations, any of which could
adversely affect the ability to operate our business and our
financial results. Failure to comply with FDA requirements may
result in, among other things, injunctions, product withdrawals,
recalls, product seizures, fines and criminal prosecutions. Our
advertising is subject to regulation by the U.S. Federal Trade
Commission, or FTC, under the Federal Trade Commission Act. In
recent years, the FTC has initiated numerous investigations of
dietary and nutrition supplement products and companies.
Additionally, some states also permit advertising and labeling laws
to be enforced by private attorneys general, who may seek relief
for consumers, seek class-action certifications, seek class-wide
damages and product recalls of products sold by us. Any actions
against our company by governmental authorities or private
litigants could have a material adverse effect on our business,
financial condition and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-13</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Uncertainty caused by potential changes to legal regulations could
impact the use of CBD products.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">There is
substantial uncertainty and different interpretations among
federal, state and local regulatory agencies, legislators,
academics and businesses as to the scope of operation of Farm
Bill-compliant hemp programs relative to the emerging regulation of
cannabinoids. These different opinions include, but are not limited
to, the regulation of cannabinoids by the U.S. Drug Enforcement
Administration, or DEA, and/or the FDA and the extent to which
manufacturers of products containing Farm Bill-compliant
cultivators and processors may engage in interstate commerce. The
uncertainties cannot be resolved without further federal, and
perhaps even state-level, legislation, regulation or a definitive
judicial interpretation of existing legislation and rules. If these
uncertainties continue, such may have an adverse effect upon the
introduction of our products in different markets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
If we fail to obtain the required regulatory permits, licenses and
approvals our ability to conduct our business would be in
jeopardy.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We may be required
to obtain and maintain certain permits, licenses and approvals in
the jurisdictions where our products are sold. There can be no
assurance that we will be able to obtain or maintain any necessary
licenses, permits or approvals. Any material delay or inability to
receive these items is likely to delay and/or inhibit our ability
to conduct our business, and could have an adverse effect on our
business, financial condition and results of
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Risks Related to our Company</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We have identified weaknesses in our internal controls, and we
cannot provide assurances that these weaknesses will be effectively
remediated or that additional material weaknesses will not occur in
the future.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Our management is responsible for establishing and
maintaining adequate internal control over our financial reporting,
as defined in Rule 13a-15(f) under the Exchange Act. During the
first quarter of 2019, we determined that a material weakness in
our internal control over financial reporting existed as of
December 31, 2018 in that we did not maintain effective internal
controls related to accounting for the application of new
accounting rules. Specifically, we did not properly assess the
phase-in date of ASU 2016-01 which became material to our company
in the quarter ended December 31, 2018. The foregoing resulted in
the restatement of our unaudited condensed consolidated financial
statements for quarter ended December 31, 2018. While certain
remedial actions have been completed in the second and third
quarters of fiscal 2019, and we intend to continue to remediate
these control deficiencies, there can be no assurance that the
internal control over financial reporting, as modified, will enable
us to identify or avoid material weaknesses in the future.</font>
Any failure to maintain effective disclosure controls and internal
control over financial reporting could have a material and adverse
effect on our business and operating results, and cause a decline
in the market price of our Series A Convertible Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Our executive officers, directors and their affiliates may exert
control over us and may exercise influence over matters subject to
shareholder approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
executive officers and directors, together with their respective
affiliates, beneficially own approximately 55% of our outstanding
common stock as of October 10, 2019. Accordingly, these
shareholders, if they act together, may exercise substantial
influence over matters requiring shareholder approval, including
the election of directors and approval of corporate transactions.
This concentration of ownership could have the effect of delaying
or preventing a change in control or otherwise discourage a
potential acquirer from attempting to obtain control over us, which
in turn could have a material adverse effect on the market value of
our Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">&#xA0;</font>&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-14</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Risks Related to our Overall Business</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
The impact of changes in the fair value of our contingent
liabilities associated with the Earnout Shares may materially
impact our results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">As
consideration for the mergers with Cure Based Development, LLC, we
had a contractual obligation, after approval by our shareholders,
to issue 15,250,000 shares of our common stock (the &#x201C;Initial
Shares&#x201D;) to the members of Cure Based Development, LLC of
which 8,750,000 of the shares will vest over a five year period and
are subject to a voting proxy agreement, as well as to issue
another 15,250,000 shares of our common stock (the &#x201C;Earnout
Shares&#x201D;) in the future upon earnout goals being within the
next five years. Our shareholders approved the issuance of the both
the Initial Shares and the Earnout Shares at our 2019 annual
shareholder meeting and the Initial Shares were issued to members
of Cure Based Development on April 19, 2019. Under GAAP we are
required to record a non-cash contingent liability associated with
both the Initial Shares and the Earnout Shares. As of June 30,
2019, the Initial Shares have been issued and have been
reclassified from contingent liability to additional paid in
capital. At June 30, 2019, the total of this contingent liability
was $70,600,000 and is reflective of the Earnout Shares. We will be
obligated to reassess the obligations associated with the Earnout
Shares and, in the event our estimate of the fair value of the
contingent consideration changes, we will record increases or
decreases in the fair value as an adjustment to earnings, which
could have a material impact on our results of operations, our
shareholders&#x2019; equity and the market price of the Series A
Convertible Preferred Stock. In particular, changes in the market
price of our common stock, which is one of the inputs used in
determining the amount of the non-cash contingent liability, will
result in increases or decreases in this liability and positively
or negatively impact our net loss or profit for the period.
Investors should not place undue reliance on the impact of these
non-cash changes when evaluating our results of operations in
future periods, as they have no impact on the operations of the
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We have a
history of losses and there are no assurances we will report
profitable operations in future periods</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
reported net losses to common shareholders of $61,600,702, $412,075
and $1,738,734 for the nine months ended June 30, 2019, fiscal 2018
and fiscal 2017, respectively. Included in our net loss for the
nine months ended June 30, 2019 was an increase of approximately
$52.5 million in the non-cash contingent liability associated with
the Earnout Shares as a result of the increase in the market price
of our common stock. Until such time, if ever, that we are
successful in generating profits which are sufficient to pay our
operating expenses it is likely we will continue to report losses
in future periods. There are no assurances we will generate
substantial revenues from the new businesses or that we will ever
generate sufficient revenues to report profitable operations or a
net profit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We could incur charges in future periods related to assets
associated with our non-core businesses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have assets on
our consolidated balance sheet from subsidiaries which are no
longer a part of our core business, as our CBD operations have
significantly expanded since the mergers with Cure Based
Development. As we determine future direction in relation to the
subsidiaries, which could include sale or wind down of the non-core
subsidiaries, we could incur a charge on our consolidated income
statement related to the carrying value of those
assets.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may require additional capital to finance the acquisition of
additional brands and if we are unable to raise such capital on
beneficial terms or at all this could restrict our
growth.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may, in the future, require additional capital to help fund all or
part of potential acquisitions. If, at the time required, we do not
have sufficient cash to finance those additional capital needs, we
will need to raise additional funds through equity and/or debt
financing. We cannot guarantee that, if and when needed, additional
financing will be available to us on acceptable terms or at all.
Further, if additional capital is needed and is either unavailable
or cost prohibitive, our growth may be limited as we may need to
change our business strategy to slow the rate of our expansion
plans. In addition, any additional financing we undertake could
impose additional covenants upon us that restrict our operating
flexibility, and, if we issue equity securities to raise capital or
as acquisition consideration, our existing shareholders may
experience dilution or the new securities may have rights senior to
those of our Series A Convertible Preferred Stock, assuming the
holders of the Series A Convertible Preferred Stock approve the
issuance of such senior securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-15</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">USE
OF PROCEEDS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We estimate that
the net proceeds from the issuance and sale of the Series A
Convertible Preferred Stock in this offering will be approximately
$4,253,000, after deducting the underwriting discounts and
commissions and estimated offering expenses payable by us, assuming
no exercise of the over-allotment option and approximately
$4,946,750 if the over-allotment option is exercised in
full.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We will have broad
discretion in the use of the net proceeds from the sale of the
shares of Series A Convertible Preferred Stock offered under this
prospectus supplement. We presently intend to use the net proceeds
from the sale of our shares of Series A Convertible Preferred Stock
for general working capital.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pending our use of
the net proceeds from this offering, we intend to invest the net
proceeds in a variety of capital preservation investments,
including short-term, investment grade, interest bearing
instruments and U.S. government securities.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-16</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
CAPITALIZATION</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
following table sets forth our capitalization as of June 30,
2019:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">on
an actual basis; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">on
an as adjusted basis to give effect to the sale of 500,000 shares
of Series A Convertible Preferred Stock in this offering at the
public offering price of $10.00 per share, after deducting
underwriting discounts and commissions and other estimated offering
expenses payable by us, but giving no effect to the exercise of the
over-allotment option.</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
capitalization table should be read in conjunction with
Management&#x2019;s Discussion and Analysis of Financial Condition
and Results of Operations and our consolidated financial statements
and related notes incorporated by reference in this prospectus
supplement, and other financial information included and
incorporated by reference in this prospectus supplement. See
&#x201C;Where You Can Find More Information.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; margin-left: 0px; margin-right: 0px; width: 100%;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="2" rowspan="1" style="vertical-align: bottom; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 90%; display: inline-block; border-bottom: 2px solid #000; font-size: 11px">
<div><font style="font-weight: bold; font-family: Times New Roman">As of June 30,
2019</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman">(unaudited)</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000; font-size: 11px">
<div><font style="font-weight: bold; font-family: Times New Roman">Actual</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000; font-size: 11px">
<div><font style="font-weight: bold; font-family: Times New Roman">As
Adjusted</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Cash and cash
Equivalents</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">11,633,213</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">15,886,213<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td colspan="1" style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Preferred stock,
authorized 50,000,000 shares, $0.001 par value; no shares issued
and outstanding, actual, 5,000,000 shares designated; 500,000
shares outstanding, as adjusted</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">-</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">500<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Common stock,
authorized 150,000,000 shares, $0.001 par value; 27,720,356 shares
issued and outstanding</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">27,720</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">27,720</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Additional paid-in
capital</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">96,130,158</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">100,382,658<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Accumulated
deficit</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">(70,782,736</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">)</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">(70,782,736</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">)</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Total cbdMD, Inc.
shareholders&#x2019; equity</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">25,375,142</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">29,628,142<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Non-controlling
interest</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">(229,420</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">)</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000; font-size: 13px; font-family: Times New Roman">(229,420</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">)</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Total
shareholders&#x2019; equity</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">25,145,722</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">29,398,722<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 76%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Total
capitalization</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">25,145,722</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block; font-size: 13px; font-family: Times New Roman">$&#xA0;</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block; font-size: 13px; font-family: Times New Roman">29,398,722<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">All
information in this Capitalization section excludes:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">1,219,650 shares
issuable upon the exercise of outstanding options with a weighted
average exercise price of $6.07per share;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">57,500 shares
issuable upon vesting of restricted stock awards;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">423,605 shares
issuable upon the exercise of outstanding warrants with a weighted
average exercise price of $6.64 per share;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">47,923 shares of
our common stock issuable upon the exercise of the
representative&#x2019;s warrants to be issued upon the closing of
this offering at an exercise price equal to $3.9125 per share, or
125% of the last closing price per share our common stock on the
NYSE American prior to the execution of the underwriting agreement
for this offering;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">962,955 shares
reserved for future issuances under our equity compensation
plan;&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the future issuance
of up to 15,250,000 Earnout Shares; and&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the future impact
of changes in the fair value of the contingent liabilities
associated with the Earnout Shares. &#xA0;&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><br>
</font></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-17</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DESCRIPTION OF THE SERIES A CONVERTIBLE PREFERRED
STOCK</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
The description of certain terms of the Series A Convertible
Preferred Stock in this prospectus supplement does not purport to
be complete and is in all respects subject to, and qualified in its
entirety by references to the relevant provisions of our articles
of incorporation, as amended, the certificate of designations
establishing the terms of our Series A Convertible Preferred Stock,
our bylaws and North Carolina corporate law. You are strongly
encouraged to read the certificate of designations because it, and
not this description, defines your rights as a holder of shares of
Series A Convertible Preferred Stock. See &#x201C;Where You Can Find
More Information.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">General</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pursuant to our
articles of incorporation, as amended, we are currently authorized
to designate and issue up to 50,000,000 shares of preferred stock,
par value $0.001 per share, in one or more classes or series and,
subject to the limitations prescribed by our articles of
incorporation and North Carolina corporate law, with such rights,
preferences, privileges and restrictions of each class or series of
preferred stock, including dividend rights, voting rights, terms of
redemption, liquidation preferences and the number of shares
constituting any class or series as our board of directors may
determine, without any vote or action by our shareholders. On
October 10, 2019, we filed articles of amendment to our articles of
incorporation designating 5,000,000 shares of preferred stock as
the Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As of October 10,
2019, we had no shares of preferred stock issued and outstanding.
Assuming all of the shares of Series A Convertible Preferred Stock
offered hereunder (including the underwriters&#x2019; over-allotment
option) are issued, we will have available for issuance 45,000,000
authorized and undesignated and unissued shares of preferred stock,
and 4,425,000 shares of unissued Series A Convertible Preferred
Stock available for future issuance. The Series A Convertible
Preferred Stock offered hereby, when issued, delivered and paid for
in accordance with the terms of the underwriting agreement, will be
fully paid and nonassessable. Our board of directors may, without
the approval of holders of the Series A Convertible Preferred Stock
or our common stock, designate additional series of authorized
preferred stock ranking junior to or on par with the Series A
Convertible Preferred Stock and/or sell additional shares of the
Series A Convertible Preferred Stock. Designation of preferred
stock ranking senior to the Series A Convertible Preferred Stock
will require approval of the holders of Series A Convertible
Preferred Stock, as described below in &#x201C;&#x2014;Voting
Rights.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The registrar,
transfer agent and dividend and redemption price disbursing agent
in respect of the Series A Convertible Preferred Stock is V Stock
Transfer, LLC. Its principal business address is 18 Lafayette
Place, Woodmere, NY 11598.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Listing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Currently, no
market exists for the Series A Convertible Preferred Stock. We have
filed an application to list our Series A Convertible Preferred
Stock on the NYSE American under the symbol &#x201C;YCBDPRA.&#x201D;
We expect trading of the Series A Convertible Preferred Stock on
the NYSE American, if the listing is approved, to commence within
three business days after the date of initial issuance of the
Series A Convertible Preferred Stock. We expect the Series A
Convertible Preferred Stock will be issued and maintained in
book-entry form registered in the name of the nominee, The
Depository Trust Company. See &#x201C;&#x2014;Book-Entry
Procedures&#x201D; described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">No
Maturity</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock has no maturity date, and we are not
required to redeem the Series A Convertible Preferred Stock, except
in the event of a Change of Control. Accordingly, the Series A
Convertible Preferred Stock will remain outstanding indefinitely
unless a Change of Control occurs, we decide to redeem it, we elect
to automatically convert it into shares of common stock upon a
Market Trigger or the holder elects to voluntarily convert the
Series A Preferred into shares of our common stock. We are not
required to set aside funds to redeem the Series A Convertible
Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-18</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Ranking</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock will rank, with respect to rights to
the payment of dividends and the distribution of assets upon our
liquidation, dissolution or winding up:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px; font-family: Times New Roman">(1)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">senior to all
classes or series of our common stock and to all other equity
securities issued by us other than equity securities referred to in
clauses (2) and (3) below;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px; font-family: Times New Roman">(2)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">on a parity with
all equity securities issued by us with terms specifically
providing that those equity securities rank on a parity with the
Series A Convertible Preferred Stock with respect to rights to the
payment of dividends and the distribution of assets upon our
liquidation, dissolution or winding up, which we refer to as
&#x201C;Parity Stock&#x201D;;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px; font-family: Times New Roman">(3)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">subject to the
consent of the Series A Convertible Preferred Stockholders set
forth below in &#x201C;&#x2014;Voting Rights,&#x201D; junior to all
equity securities issued by us with terms specifically providing
that those equity securities rank senior to the Series A
Convertible Preferred Stock with respect to rights to the payment
of dividends and the distribution of assets upon our liquidation,
dissolution or winding up, which we refer to as &#x201C;Senior
Stock&#x201D;; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px; font-family: Times New Roman">(4)</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">junior to all of
our existing and future indebtedness.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Dividends</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Holders of shares
of the Series A Convertible Preferred Stock are entitled to
receive, when, as and if declared by our board of directors, out of
funds legally available for the payment of dividends, cumulative
cash dividends at the rate of 8.0% per annum of the $10.00 per
share liquidation preference (equivalent to $0.80 per annum per
share), which we refer to as the &#x201C;Dividend
Rate.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Dividends on our
Series A Convertible Preferred Stock will accrue daily and will be
cumulative from, and including, the first day of the calendar month
in which they are issued and will be payable monthly in arrears on
the Dividend Payment Date, which is the 15th day of each calendar
month; provided that if any Dividend Payment Date is not a Business
Day then the dividend that would otherwise have been payable on
that Dividend Payment Date may be paid on the next succeeding
Business Day and no interest, additional dividends or other sums
will accrue on the amount so payable for the period from and after
that Dividend Payment Date to that next succeeding Business Day.
&#x201C;Business Day&#x201D; shall mean any day, other than a
Saturday or Sunday, that is neither a legal holiday nor a day on
which banking institutions in New York, New York are authorized or
required by law, regulation or executive order to
close.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any dividend
payable on the Series A Convertible Preferred Stock, including
dividends payable for any partial Dividend Period, will be computed
on the basis of a 360-day year consisting of twelve 30-day months.
Dividends will be payable to holders of record as they appear in
our stock records for the Series A Convertible Preferred Stock at
the close of business on the corresponding Dividend Record Date,
the first day of each calendar month, whether or not a Business
Day.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No dividends on
shares of Series A Convertible Preferred Stock shall be authorized
by our board of directors or paid or set apart for payment by us at
any time when the payment thereof would be unlawful under the laws
of the State of North Carolina or when the terms and provisions of
any agreement of ours, including any agreement relating to our
indebtedness, prohibits the authorization, payment or setting apart
for payment thereof or provide that the authorization, payment or
setting apart for payment thereof would constitute a breach of the
agreement or a default under the agreement, or if the
authorization, payment or setting apart for payment shall be
restricted or prohibited by law.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-19</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Notwithstanding the
foregoing, dividends on the Series A Convertible Preferred Stock
will accrue regardless of whether (i) the terms of any Senior Stock
we may issue or agreements we may enter into, including any
documents governing any indebtedness, at any time prohibit the
current payment of dividends, (ii) if we have earnings, (iii) there
are funds legally available for the payment of those dividends; or
(iv) such dividends are declared by our board of directors. No
interest, or sum in lieu of interest, will be payable in respect of
any dividend payment or payments on the Series A Convertible
Preferred Stock that may be in arrears, and holders of the Series A
Convertible Preferred Stock will not be entitled to any dividends
in excess of full cumulative dividends described above. Any
dividend payment made on the Series A Convertible Preferred Stock
shall first be credited against the earliest accrued but unpaid
dividend due with respect to those shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Unless full
cumulative dividends on all shares of Series A Convertible
Preferred Stock have been or contemporaneously are declared and
paid or declared and a sum sufficient for the payment thereof has
been or contemporaneously is set apart for payment for all past
Dividend Periods, no dividends (other than in shares of our common
stock or in shares of any junior stock we may issue as to dividends
and upon liquidation) shall be declared or paid or set aside for
payment upon shares of any junior stock or Parity Stock that we may
issue.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">When dividends are
not paid in full (or a sum sufficient for such full payment is not
so set apart) upon the Series A Convertible Preferred Stock and the
shares of any other series of preferred stock that we may issue
ranking on a parity as to the payment of dividends with the Series
A Convertible Preferred Stock, all dividends declared upon the
Series A Convertible Preferred Stock and any other series of
preferred stock that we may issue ranking on a parity as to the
payment of dividends with the Series A Convertible Preferred Stock
shall be declared pro rata so that the amount of dividends declared
per share of Series A Convertible Preferred Stock and such other
series of preferred stock that we may issue shall in all cases bear
to each other the same ratio that accrued dividends per share on
the Series A Convertible Preferred Stock and such other series of
preferred stock that we may issue (which shall not include any
accrual in respect of unpaid dividends for prior Dividend Periods
if such preferred stock does not have a cumulative dividend) bear
to each other. No interest, or sum of money in lieu of interest,
shall be payable in respect of any dividend payment or payments on
the Series A Convertible Preferred Stock that may be in
arrears.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Holders of Series A
Convertible Preferred Stock shall not be entitled to any dividend
in excess of all accumulated accrued and unpaid dividends on the
Series A Convertible Preferred Stock as described herein. Any
dividend payment made on the Series A Convertible Preferred Stock
shall first be credited against the earliest accumulated accrued
and unpaid dividend due with respect to such shares which remains
payable at the time of such payment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Liquidation
Preference</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon the voluntary
or involuntary liquidation, dissolution or winding up of our
affairs, then, before any distribution or payment shall be made to
the holders of any common stock or any other class or series of
junior stock, the holders of Series A Convertible Preferred Stock
shall be entitled to receive out of our assets legally available
for distribution to shareholders, liquidating distributions in the
amount of the liquidation preference, or $10.00 per share, plus an
amount equal to all dividends (whether or not declared) accrued and
unpaid thereon to and including the date of payment. After payment
of the full amount of the liquidating distributions to which they
are entitled, the holders of Series A Convertible Preferred Stock
will have no right or claim to any of our remaining assets. In the
event that, upon any such voluntary or involuntary liquidation,
dissolution or winding up, our available assets are insufficient to
pay the amount of the liquidating distributions on all outstanding
shares of Series A Convertible Preferred Stock and the
corresponding amounts payable on all Senior Stock and Parity Stock,
then after payment of the liquidating distribution on all
outstanding Senior Stock, the holders of the Series A Convertible
Preferred Stock and all other such classes or series of Parity
Stock shall share ratably in any such distribution of assets in
proportion to the full liquidating distributions to which they
would otherwise be respectively entitled. For such purposes, any
consolidation or merger of our company with or into any other
entity, or the sale, lease or conveyance of all or substantially
all of the property or business of our company, or a statutory
share exchange shall not be deemed to constitute the voluntary or
involuntary liquidation, dissolution or winding up of our
company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Conversion</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock, together with accrued but unpaid
dividends, is convertible at any time at the option of the holder,
by us upon a Market Trigger and upon a holder&#x2019;s receipt of a
Change of Control Notice. Except as provided below, the Series A
Convertible Preferred Stock is not convertible into or exchangeable
for any other securities or property.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-20</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Conversion at Option of Holder</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Each share of
Series A Convertible Preferred Stock, together with accrued but
unpaid dividends, is convertible into shares of our common stock at
a Conversion Price of $6.00 per common share, which initially
equals 1.667 shares of our common stock, at any time at the option
of the holder, subject to adjustment for the Anti-Dilution
Provisions set forth below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="background-color: #ffffff">Holders shall effect conversions of the
Series A Convertible Preferred Stock (an &#x201C;Optional
Conversion&#x201D;) by providing us a conversion notice (a
&#x201C;Notice of Optional Conversion&#x201D;), duly completed and
executed. Other than a conversion following a Change of Control
Notice (as defined and as set forth below), the Optional Notice of
Conversion must specify the number of shares of Series A
Convertible Preferred Stock then held by the holder and the number
of such shares which the holder is converting (the &#x201C;Optional
Conversion Shares&#x201D;). Provided that our transfer agent is
participating in the DTC Fast Automated Securities Transfer
program, the Notice of Optional Conversion may specify, at the
holder&#x2019;s election, whether the Optional Conversion Shares are
to be credited to the account of the holder&#x2019;s prime broker
with DTC through its Deposit Withdrawal Agent Commission
(&#x201C;DWAC&#x201D;) system (a &#x201C;DWAC Delivery&#x201D;). The
&#x201C;Optional Conversion Date&#x201D;, or the date on which a
conversion will be deemed effective, is the Trading Day that the
Notice of Optional Conversion, completed and executed, is sent by
facsimile or other electronic transmission to, and received during
regular business hours by, us;</font> <font style="font-style: italic; background-color: #ffffff">provided</font>
<font style="background-color: #ffffff">that the original
certificate(s) (if applicable) representing such shares of Series A
Convertible Preferred Stock being converted, duly endorsed, and the
accompanying Notice of Optional Conversion, are received by us
within two Trading Days thereafter. In all other cases, the
Optional Conversion Date shall be defined as the Trading Day on
which the original share certificate(s) (if applicable) of Series A
Convertible Preferred Stock being converted, duly endorsed, and the
accompanying Notice of Optional Conversion, are received by
us.</font> &#x201C;Trading Day&#x201D; shall mean any Business Day on
which the common stock is traded, or able to be traded, on the
&#x201C;Trading Market&#x201D; which means the NYSE American, the
Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global
Select Market or the New York Stock Exchange, or any successor
exchange to the foregoing, or any market on which our common stock
is listed or admitted to trading (including any over-the-counter
market).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If, at any time
while the Series A Convertible Preferred Stock is outstanding: we
(A) pay a stock dividend or otherwise make a distribution or
distributions payable in shares of our common stock (which, for
avoidance of doubt, shall not include any shares of common stock
issued by us upon conversion of the Series A Convertible Preferred
Stock) with respect to the then outstanding shares of common stock;
(B) subdivide outstanding shares of common stock into a larger
number of shares; or (C) combine (including by way of a reverse
stock split) outstanding shares of common stock into a smaller
number of shares, which we refer to collectively as the
&#x201C;Anti-Dilution Provisions&#x201D;, then the Conversion Price
shall be multiplied by a fraction of which the numerator shall be
the number of shares of common stock (excluding any treasury
shares) outstanding immediately before such event and of which the
denominator shall be the number of shares of common stock
outstanding immediately after such event (excluding any treasury
shares). Any adjustment made as a result of the Anti-Dilution
Provisions shall become effective immediately after the record date
for the determination of shareholders entitled to receive such
dividend or distribution and shall become effective immediately
after the effective date in the case of a subdivision or
combination. All calculations will be made to the nearest cent or
the nearest 1/100th of a share, as the case may be. For purposes of
the Anti-Dilution Provisions, the number of shares of common stock
deemed to be issued and outstanding as of a given date shall be the
sum of the number of shares of common stock (excluding any treasury
shares) issued and outstanding. Whenever the Conversion Price is
adjusted pursuant to any Anti-Dilution Provision, we will promptly
deliver to each holder of Series A Convertible Preferred Stock a
notice setting forth the Conversion Price after such adjustment and
setting forth a brief statement of the facts requiring such
adjustment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If (A) we declare a
dividend (or any other distribution in whatever form) on our common
stock, (B) we declare a special nonrecurring cash dividend on or a
redemption of our common stock, (C) we authorize the granting to
all holders of the common stock of rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of any
rights, (D) the approval of any of our shareholders shall be
required in connection with any reclassification of the common
stock, any consolidation or merger to which we are a party, any
sale or transfer of all or substantially all of our assets, or any
compulsory share exchange whereby the common stock is converted
into other securities, cash or property, or (E) we authorize the
voluntary or involuntary dissolution, liquidation or winding up of
our affairs, then, in each case, we shall cause to be filed at each
office or agency maintained for the purpose of conversion of this
Series A Convertible Preferred Stock, and, except if such notice
and the contents thereof shall be deemed to constitute material
non-public information, shall cause to be delivered to each holder
at its last address as it shall appear upon our stock books, at
least 20 calendar days prior to the applicable record or effective
date hereinafter specified, a notice stating (x) the date on which
a record is to be taken for the purpose of such dividend,
distribution, redemption, rights or warrants, or if a record is not
to be taken, the date as of which the holders of our common stock
of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y) the date
on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or
close, and the date as of which it is expected that holders of our
common stock of record shall be entitled to exchange their shares
of the common stock for securities, cash or other property
deliverable upon such reclassification, consolidation, merger,
sale, transfer or share exchange; <font style="font-style: italic">provided</font> that the failure to deliver
such notice or any defect therein or in the delivery thereof shall
not affect the validity of the corporate action required to be
specified in such notice.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-21</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Notwithstanding
anything herein to the contrary, we will not effect any Optional
Conversion of the Series A Convertible Preferred Stock, and a
holder shall not have the right to convert any portion of the
Series A Convertible Preferred Stock, to the extent that, after
giving effect to an attempted conversion set forth on an applicable
Notice of Optional Conversion, such holder (together with such
Holder&#x2019;s Affiliates (as that term is defined in Rule 405 of
the Securities Act), and any other natural person, company,
corporation, partnership, association, trust or organization
(collectively, a &#x201C;Person&#x201D;) whose beneficial ownership
of our common stock would be aggregated with the holder&#x2019;s for
purposes of Section 13(d) or Section 16 of the Exchange Act and the
applicable regulations of the SEC, including any
&#x201C;group&#x201D; of which the holder is a member, which we refer
to as the &#x201C;Attribution Parties,&#x201D; would beneficially own
a number of shares of our common stock in excess of the Beneficial
Ownership Limitation (as defined below). For purposes of the
foregoing sentence, the aggregate number of shares of common stock
beneficially owned by such holder and its Attribution Parties shall
include the number of shares of common stock held by such holder
and its Attribution Parties plus the number of shares of common
stock issuable upon Optional Conversion subject to the Notice of
Optional Conversion with respect to which such determination is
being made, but shall exclude the number of shares of common stock
which are issuable upon (A) conversion of the remaining,
unconverted shares of Series A Convertible Preferred Stock
beneficially owned by such holder or any of its Attribution
Parties, and (B) exercise or conversion of the unexercised or
unconverted portion of any other of our securities beneficially
owned by such holder or any of its Attribution Parties that, in the
case of both (A) and (B), are subject to a limitation on conversion
or exercise similar to the limitation contained herein. For
purposes of this section, beneficial ownership shall be calculated
in accordance with Section 13(d) of the Exchange Act and the
applicable regulations of the SEC. In addition, for purposes
hereof, &#x201C;group&#x201D; has the meaning set forth in Section
13(d) of the Exchange Act and the applicable regulations of the
SEC. For purposes of this section, in determining the number of
outstanding shares of common stock, a holder may rely on the number
of outstanding shares of common stock as stated in the most recent
of the following: (A) our most recent periodic or annual filing
with the SEC, as the case may be, (B) a more recent public
announcement by us that is filed with the SEC, or (C) a more recent
notice by us or our transfer agent to the holder setting forth the
number of shares of common stock then outstanding. Upon the written
request of a holder (which may be by email), we shall, within three
Trading Days thereof, confirm in writing to such holder (which may
be via email) the number of shares of common stock then
outstanding. In any case, the number of outstanding shares of
common stock shall be determined after giving effect to any actual
conversion or exercise of our securities, including shares of
Series A Convertible Preferred Stock, by such holder or its
Attribution Parties since the date as of which such number of
outstanding shares of common stock was last publicly reported or
confirmed to the holder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The
&#x201C;Beneficial Ownership Limitation&#x201D; shall initially be
9.99% of the number of shares of the common stock outstanding
immediately after giving effect to the issuance of shares of common
stock pursuant to such Notice of Optional Conversion (to the extent
permitted pursuant to this section), or 4.99% upon election by the
holder at the time of the purchase of the shares of our Series A
Convertible Preferred Stock in this offering. Notwithstanding the
foregoing, by written notice to us, which will not be effective
until the 61st day after such notice is delivered to us, the holder
may reset the Beneficial Ownership Limitation percentage to a
higher or lower percentage, or if such notice is given upon initial
issuance of the Series A Convertible Preferred Stock to the holder,
then the reset Beneficial Ownership Limitation shall be effective
immediately. Upon such a change by a holder of the Beneficial
Ownership Limitation, the Beneficial Ownership Limitation may not
be further amended by such holder without first providing the
minimum 61-day notice to us. We are entitled to rely on
representations made to us by the holder in any Notice of Optional
Conversion regarding its Beneficial Ownership Limitation, and the
determination as to whether the Series A Convertible Preferred
Stock is convertible and of which portion of the Series A
Convertible Preferred Stock is convertible shall be made in the
sole discretion of the holder and we shall have no obligation to
verify or confirm the accuracy of such determination.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-22</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Market Trigger Conversion</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We, at our option,
may cause the Series A Convertible Preferred Stock, together with
accrued but unpaid dividends, to be converted, which we refer to as
a &#x201C;Market Trigger Conversion,&#x201D; in whole or in part, on
a pro rata basis, into fully paid and nonassessable shares of
common stock at the Conversion Price if the Trading Price (as
defined hereafter) of the common stock shall have equaled or
exceeded 137.5% of the Conversion Price for at least 20 trading
days in any 30 consecutive trading day period ending five days
prior to the Market Trigger Conversion Date which is defined
below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">As used herein,
&#x201C;Trading Price&#x201D; of our common stock on any Trading Day
(excluding any after-hours trading as of such date) shall
mean:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 36px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px; font-family: Times New Roman">(A)&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the last sale
price, regular way, or, in case no such sale takes place on such
day, the average of the closing bid and ask prices, regular way, in
either case as reported by the principal consolidated transaction
reporting system with respect to the common stock listed or
admitted to trading or quoted on the NYSE American, or if the
common stock is not listed or admitted to trading or quoted on the
NYSE American, as reported in the principal consolidated
transaction reporting system with respect to the common stock
listed on the principal national securities exchange or national
securities market on or in which the common stock is listed or
admitted to trading;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: -36px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 36px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px; font-family: Times New Roman">(B)&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">if the common stock
is not listed on, admitted to trading or quoted on the NYSE
American or a national securities exchange or national securities
market on that date, the last price quoted by OTC Market Group Inc.
for the common stock on the date, or if OTC Market Group Inc. is
not quoting such price, a similar quotation service selected by
us;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: -36px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 36px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px; font-family: Times New Roman">(C)&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">if the common stock
is not so quoted, the average mid-point of the last bid and ask
prices for the common stock on that date from at least two dealers
recognized as market-makers for our common stock selected by us for
this purpose; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 72px; margin-right: 0px; text-indent: -36px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 36px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 36px">
<font style="font-size: 13px; font-family: Times New Roman">(D)&#xA0;&#xA0;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">if the common stock
is not so quoted, the average of the last bid and ask prices for
the common stock on that date from a dealer engaged in the trading
of the common stock selected by us for such purpose.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No greater than 60
nor fewer than 20 days prior to the date of any such Market Trigger
Conversion, notice (the &#x201C;Market Trigger Conversion
Notice&#x201D;) shall be given to the holders of record of the
Series A Convertible Preferred Stock to be converted, by first
class mail, postage prepaid and addressed to such holders at their
last addresses as shown on our stock transfer books. The Market
Trigger Conversion Notice shall specify the date fixed for
conversion (the &#x201C;Market Trigger Conversion Date&#x201D;), the
place or places for surrender of shares of Series A Convertible
Preferred Stock and the then effective Conversion
Price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any outstanding
shares of Series A Convertible Preferred Stock, together with
accrued but unpaid dividends, subject to the Market Trigger
Conversion Notice will automatically convert into shares of common
stock on the Market Trigger Conversion Date. The holders entitled
to receive the shares of our common stock issuable upon the Market
Trigger (the &#x201C;Market Trigger Conversion Shares&#x201D;) will
be treated as the record holder(s) of such shares as of 5:00 p.m.,
New York City time, on the Market Trigger Conversion Date. Prior to
5:00 p.m., New York City time, on the Market Trigger Conversion
Date, the Market Trigger Conversion Shares will not be outstanding
for any purpose and you will have no rights with respect to such
Market Trigger Conversion Shares, including voting rights, rights
to respond to tender offers and rights to receive any dividends or
other distributions on the common stock, by virtue of holding the
Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-23</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Holders Change of Control Conversion Rights</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon a
holder&#x2019;s receipt of a Change of Control Notice (as defined
below) until the Trading Day ending three (3) Trading Days prior to
the Change of Control Redemption Date (as defined below) (the
&#x201C;Change of Control Conversion Date&#x201D;, holders of the
Series A Convertible Preferred Stock will have the right to convert
some or all of the shares of Series A Convertible Preferred Stock
held by such holder, together with all accrued but unpaid dividends
(the &#x201C;Change of Control Conversion Right&#x201D;) into shares
of our common stock at the Conversion Price (the &#x201C;Change of
Control Conversion Shares&#x201D;). In the event of a Change of
Control, any shares of Series A Convertible Preferred Stock not
converted pursuant to the Change of Control Conversion Right will
be subject to the Change of Control Redemption described
below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Additional Conversion Terms</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Delivery of Certificate or Electronic Issuance Upon
Conversion</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Not later than the
earlier of (i) two Trading Days and (ii) the number of Trading Days
comprising the Standard Settlement Period after the applicable
conversion date, or if the holder requests the issuance of physical
certificate(s), five Business Days after receipt by us of both the
original certificate(s) representing such shares of Series A
Convertible Preferred Stock being converted, duly endorsed, and the
accompanying notice of conversion (the &#x201C;Share Delivery
Date&#x201D;), we shall (A) deliver, or cause to be delivered, to
the converting holder a physical certificate or certificates
representing the number of either Optional Conversion Shares or
Market Trigger Conversion Shares or the Change of Control
Conversion Shares (collectively, the &#x201C;Conversion
Shares&#x201D;) being acquired upon the conversion of shares of
Series A Convertible Preferred Stock or (B) in the case of a DWAC
Delivery, electronically transfer such Conversion Shares by
crediting the account of the holder&#x2019;s prime broker with DTC
through its DWAC system. As used herein, &#x201C;Standard Settlement
Period&#x201D; means the standard settlement period, expressed in a
number of Trading Days, on the Trading Market. If in the case of
any Notice of Optional Conversion such certificate or certificates
are not delivered to or as directed by or, in the case of a DWAC
Delivery, such shares are not electronically delivered to or as
directed by, the applicable holder by the Share Delivery Date, the
applicable holder shall be entitled to elect to rescind such Notice
of Optional Conversion by written notice to us at any time on or
before its receipt of such certificate or certificates for Optional
Conversion Shares or electronic receipt of such shares, as
applicable, in which event we shall promptly return to such holder
any original Series A Convertible Preferred Stock certificate
delivered to us and such holder shall promptly return to us any
common stock certificates or otherwise direct the return of any
shares of common stock delivered to the holder through the DWAC
system, representing the shares of Series A Convertible Preferred
Stock unsuccessfully tendered for conversion to us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="background-color: #ffffff; font-style: italic; font-size: 13px; font-family: Times New Roman">
Obligation Absolute</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="background-color: #ffffff; font-size: 13px; font-family: Times New Roman">
Subject to holder&#x2019;s right to rescind a Notice of Optional
Conversion set forth above, our obligation to issue and deliver the
Conversion Shares upon conversion of Series A Convertible Preferred
Stock in accordance with its terms are absolute and unconditional,
irrespective of any action or inaction by a holder to enforce the
same, any waiver or consent with respect to any provision hereof,
the recovery of any judgment against any Person or any action to
enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by such
holder or any other Person of any obligation to us or any violation
or alleged violation of law by such holder or any other Person, and
irrespective of any other circumstance which might otherwise limit
our obligation to such holder in connection with the issuance of
such Conversion Shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Buy-In on Failure to Timely Deliver Certificates Upon
Conversion</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we fail to
deliver to a holder the applicable certificate or certificates or
to effect a DWAC Delivery, as applicable, by the Share Delivery
Date (other than a failure caused by incorrect or incomplete
information provided by the holder to us), and if after such Share
Delivery Date the holder is required by its brokerage firm to
purchase (in an open market transaction or otherwise), or the
holder&#x2019;s brokerage firm otherwise purchases, shares of common
stock to deliver in satisfaction of a sale by such holder of the
Conversion Shares which the holder was entitled to receive upon the
conversion relating to such Share Delivery Date (a
&#x201C;Buy-In&#x201D;), then we are obligated to (A) pay in cash to
the holder (in addition to any other remedies available to or
elected by the holder) the amount by which (x) the holder&#x2019;s
total purchase price (including any brokerage commissions) for the
shares of common stock so purchased exceeds (y) the product of (1)
the aggregate number of shares of common stock that such holder was
entitled to receive from the conversion at issue multiplied by (2)
the actual sale price at which the sell order giving rise to such
purchase obligation was executed (including any brokerage
commissions) and (B) at the option of the holder, either reissue
(if surrendered) the shares of Series A Convertible Preferred Stock
equal to the number of shares of Series A Convertible Preferred
Stock submitted for conversion or deliver to the holder the number
of shares of common stock that would have been issued if we had
timely complied with our delivery requirements. For example, if a
holder purchases shares of common stock having a total purchase
price of $11,000 to cover a Buy-In with respect to an attempted
conversion of shares of Series A Convertible Preferred Stock with
respect to which the actual sale price (including any brokerage
commissions) giving rise to such purchase obligation was a total of
$10,000 under clause (A) of the immediately preceding sentence, we
would be required to pay such holder $1,000. The holder shall
provide us written notice, within three Trading Days after the
occurrence of a Buy-In, indicating the amounts payable to such
holder in respect of such Buy-In together with applicable
confirmations and other evidence reasonably requested by us.
Nothing herein shall limit a holder&#x2019;s right to pursue any
other remedies available to it hereunder, at law or in equity
including, without limitation, a decree of specific performance
and/or injunctive relief with respect our failure to timely deliver
certificates representing shares of common stock upon conversion of
the shares of Series A Convertible Preferred Stock as required
pursuant to the terms hereof; <font style="font-style: italic">provided, however</font>, that the holder
shall not be entitled to both (i) require the reissuance of the
shares of Series A Convertible Preferred Stock submitted for
conversion for which such conversion was not timely honored and
(ii) receive the number of shares of common stock that would have
been issued if we had timely complied with its delivery
requirements under the section entitled &#x201C;Delivery of
Certificate or Electronic Issuance Upon
Conversion.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-24</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Reservation of Shares Issuable Upon Conversion</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have agreed that
we will at all times reserve and keep available out of our
authorized and unissued shares of common stock for the sole purpose
of issuance upon conversion of the Series A Convertible Preferred
Stock, free from preemptive rights or any other actual contingent
purchase rights of Persons other than the holders of the Series A
Convertible Preferred Stock, not less than such aggregate number of
shares of the common stock as shall be issuable upon the conversion
of all outstanding shares of Series A Convertible Preferred Stock.
We have further agreed that all shares of common stock that shall
be so issuable shall, upon issue, be duly authorized, validly
issued, fully paid, nonassessable and free and clear of all liens
and other encumbrances.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Fractional Shares</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No fractional
shares or scrip representing fractional shares of common stock will
be issued upon the conversion of the Series A Convertible Preferred
Stock. As to any fraction of a share which a holder would otherwise
be entitled to receive upon such conversion, we will pay a cash
adjustment in respect of such final fraction in an amount equal to
such fraction multiplied by the Conversion Price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Transfer Taxes</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The issuance of
certificates for shares of the common stock upon conversion of the
Series A Convertible Preferred Stock shall be made without charge
to any holder for any documentary stamp or similar taxes that may
be payable in respect of the issue or delivery of such
certificates, provided that we will not be required to pay any tax
that may be payable in respect of any transfer involved in the
issuance and delivery of any such certificate upon conversion in a
name other than that of the registered holder(s) of such shares of
Series A Convertible Preferred Stock and we will not be required to
issue or deliver such certificates unless or until the Person or
Persons requesting the issuance thereof shall have paid to us the
amount of such tax or shall have established to our satisfaction
that such tax has been paid.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Status as Shareholder</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon each
Conversion Date, (a) the shares of Series A Convertible Preferred
Stock being converted shall be deemed converted into shares of
common stock and (b) the holder&#x2019;s rights as a holder of such
converted shares of Series A Convertible Preferred Stock shall
cease and terminate, excepting only the right to receive
certificates for such shares of common stock and to any remedies
provided herein or otherwise available at law or in equity to such
holder because of our failure to comply with the terms of the
Certificate of Designations, Rights and Preferences of the Series A
Convertible Preferred Stock. In all cases, the holder shall retain
all of its rights and remedies for our failure to convert Series A
Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-style: italic; font-size: 13px; font-family: Times New Roman">
Dividends</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If a holder
converts any shares of Series A Convertible Preferred Stock and if
the Conversion Date occurs after a Dividend Record Date and on or
prior to the related Dividend Payment Date, the dividend payable on
such Dividend Payment Date with respect to such shares so converted
shall be payable on such Dividend Payment Date to the holders of
record at the close of business on such Dividend Record Date, and
shall not be converted into shares of common stock as part of the
Conversion Price for such shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Redemption</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock is redeemable by us at our option
commencing, October 16, 2023 or on a mandatory basis at any time
upon a Change of Control.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-25</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Optional Redemption</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock is not redeemable by us prior to
October 16, 2023. On or after October 16, 2023, at our option, upon
not less than 30 days nor more than 60 days&#x2019; written notice,
redeem (the &#x201C;Optional Redemption&#x201D;) the then issued and
outstanding shares of Series A Convertible Preferred Stock, in
whole or in part, for cash at a redemption price of $10.00 per
share, plus any accrued but unpaid dividends to, but not including,
the date fixed for redemption (the &#x201C;Optional Redemption
Date&#x201D;). If we elect to redeem any shares of Series A
Convertible Preferred Stock as described in this paragraph, we may
use any available cash to pay the redemption price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Notice of an
Optional Redemption (the &#x201C;Optional Redemption Notice&#x201D;)
will be mailed upon not less than 30 days nor more than 60 days
before the date fixed by us for the Optional Redemption (the
&#x201C;Optional Redemption Date&#x201D;) to each holder of record of
Series A Convertible Preferred Stock at the address shown on our
share transfer books. The Optional Redemption Notice shall state:
(i) the Optional Redemption Date; (ii) the number of shares of
Series A Convertible Preferred Stock to be redeemed; (iii) the
Optional Redemption Price; (iv) the place or places where any
certificates issued for Series A Convertible Preferred Stock other
than through DTC book entry described below, are to be surrendered
for payment of the Optional Redemption Price; (v) that dividends on
the Series A Convertible Preferred Stock will cease to accrue on
such Optional Redemption Date; and (vi) any other information
required by law or by the applicable rules of any exchange upon
which the Series A Convertible Preferred Stock may be listed or
admitted for trading. If fewer than all outstanding shares of
Series A Convertible Preferred Stock are to be redeemed, the
Optional Redemption Notice mailed to each such holder thereof shall
also specify the number of shares of Series A Convertible Preferred
Stock to be redeemed from each such holder. For the avoidance of
doubt, holders of shares of Series A Convertible Preferred Stock
shall have the right to convert all or a portion of the Series A
Convertible Preferred Stock at any time following the Optional
Redemption Notice but prior to the Optional Redemption
Date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Mandatory Redemption Upon the Occurrence of a Change of
Control</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the event of a
transaction resulting in a Change of Control, we are required to
redeem (the &#x201C;Change of Control Redemption&#x201D;), by
irrevocable written notice to the holders, all of the then issued
and outstanding shares of the Series A Convertible Preferred Stock
held by the holders. Upon such Change of Control Redemption, we
will pay or deliver, as applicable, to each holder in respect to
each share of Series A Convertible Preferred Stock held by the
holder, an amount equal to $11.00 per share of Series A Convertible
Preferred Stock held by such holder plus the aggregate amount of
accrued but unpaid dividends from the Dividend Payment Date
immediately preceding the redemption date through, but excluding,
the redemption date (the &#x201C;Change of Control Redemption
Price&#x201D;). We will issue a press release for publication on the
Dow Jones &amp; Company, Inc., Business Wire, PR Newswire or
Bloomberg Business News (or, if these organizations are not in
existence at the time of issuance of the press release, such other
news or press organization as is reasonably calculated to broadly
disseminate the relevant information to the public), in any event
prior to the opening of business on the first Business Day
following any date on which we provide the Change of Control Notice
described below to the holders of shares of Series A Convertible
Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">A &#x201C;Change of
Control&#x201D; is deemed to occur upon the acquisition by any
person, including any syndicate or group deemed to be a
&#x201C;person&#x201D; under Section 13(d)(3) of the Exchange Act, of
beneficial ownership, directly or indirectly, through a purchase,
merger or other acquisition transaction or series of purchases,
mergers or other acquisition transactions <font style="color: #000000">which were pre-approved by our board of
directors</font> of our stock entitling that person to exercise
more than 50% of the total voting power of all our stock entitled
to vote generally in the election of our directors (except that
such person will be deemed to have beneficial ownership of all
securities that such person has the right to acquire, whether such
right is currently exercisable or is exercisable only upon the
occurrence of a subsequent condition); <font style="font-style: italic; color: #000000">provided,
however</font><font style="color: #000000">, that (i) the vesting
of the aggregate of 8,750,000 shares of our common stock and/or
(ii) the issuance of an aggregate of 15,525,000 shares of our
common stock both pursuant to the terms and conditions of that
certain Agreement and Plan of Merger dated December 3, 2018 by and
among cbdMD, our wholly-owned subsidiaries and Cure Based
Development, LLC will not be deemed to be a Change of
Control.&#xA0;</font>If, in connection with a transaction resulting
in a Change of Control, we or our successor shall not have
sufficient funds legally available under applicable North Carolina
law to redeem all outstanding shares of Series A Convertible
Preferred Stock, then we shall (a) redeem, pro rata among the
holders, a number of shares of Series A Convertible Preferred Stock
equal to the number of shares of Series A Convertible Preferred
Stock that can be redeemed with the maximum amount legally
available for the redemption of such shares of Series A Convertible
Preferred Stock under applicable North Carolina law, and (b) redeem
all remaining shares of Series A Convertible Preferred Stock not
redeemed because of the foregoing limitations at the applicable
Change of Control Redemption Price as soon as practicable after we
(or our successor) is able to make such redemption out of assets
legally available for the purchase of such share of Series A
Convertible Preferred Stock. Our inability (or that of our
successor) to make a redemption payment for any reason shall not
relieve us (or our successor) from our obligation to effect any
required redemption when, as and if permitted by applicable
law.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-26</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">On or prior to the
10th Business Day prior to the date on which we anticipate
consummating a transaction which would result in a Change of
Control, we shall send written notice (a &#x201C;Change of Control
Notice&#x201D;) to each holder of record of Series A Convertible
Preferred Stock at the address shown on our share transfer books.
The Change of Control Notice shall state (i) the date on which the
transaction that would result in a Change of Control is anticipated
to be effected, (ii) a description of the material terms and
conditions of such Change of Control transaction, (iii) a statement
that all shares of Series A Convertible Preferred Stock shall be
redeemed by us (or our successor) on the date specified in such
Change of Control Notice (the &#x201C;Change of Control Redemption
Date&#x201D;), which such date must be a Business Day of our
choosing that is no later than the date of the consummation of the
transaction resulting in such Change of Control, (iv) the Change of
Control Redemption Price with respect to each share of Series A
Convertible Preferred Stock, and (v) the procedures that holders of
shares of Series A Convertible Preferred Stock must follow in order
for their shares of Series A Convertible Preferred Stock to be
redeemed. Any Change of Control Notice mailed or delivered will be
conclusively presumed to have been duly given, whether or not any
applicable holder receives such notice, but failure to duly give
such notice by mail or delivery, or any defect in such notice or in
the mailing or delivery thereof, to any holder of shares of Series
A Convertible Preferred Stock to be redeemed pursuant to a Change
of Control will not affect the validity of the proceedings for the
redemption of any other share(s) of Series A Convertible Preferred
Stock to the extent that such failure to duly give notice or any
defect in such notice or the mailing or delivery thereof (in each
case, to the extent such failure or defect is not promptly cured or
corrected) does not materially prejudice any such holder. For
avoidance of doubt, <font style="background-color: #ffffff">u</font>pon a holder&#x2019;s receipt of
a Change of Control Notice until the Trading Day ending three (3)
Trading Days prior to the Change of Control Redemption Date,
h<font style="background-color: #ffffff">olders of shares of Series
A Convertible Preferred Stock shall have the right to convert all
or a portion of the Series A Convertible Preferred Stock at the
Conversion Price.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Additional
Redemption Procedures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">At our election, on
or prior to the Optional Redemption Date or the Change of Control
Redemption Date (collectively, the &#x201C;Redemption Date&#x201D;),
as applicable, we may irrevocably deposit the Optional Redemption
Price or the Change of Control Redemption Price, as applicable
(collectively, the &#x201C;Redemption Price&#x201D;) (including
accrued and unpaid dividends) of the Series A Convertible Preferred
Stock so called for redemption in trust for the holders thereof
with a bank or trust company of its choice, in which case the
notice to holders of redemption of shares of Series A Convertible
Preferred Stock will (i) state the date of such deposit, and (ii)
specify the office of such bank or trust company as the place of
payment of the Redemption Price. Any interest or other earnings
earned on the Redemption Price (including all accrued and unpaid
dividends) deposited with a bank or trust company will be paid to
us. Any monies so deposited that remain unclaimed by the holders of
shares of Series A Convertible Preferred Stock at the end of six
months after the Redemption Date will be returned to us by such
bank or trust company. If we make such a deposit, shares of Series
A Convertible Preferred Stock shall not be considered outstanding
for purposes of voting or determining shares entitled to vote on
any matter on or after the date of such deposit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">On or after the
date fixed for redemption, each holder of shares of Series A
Convertible Preferred Stock that holds a certificate other than
through the DTC book entry must present and surrender each
certificate representing his or her Series A Convertible Preferred
Stock to us at the place designated in the applicable notice and
thereupon the Redemption Price of such shares will be paid to or on
the order of the person whose name appears on such certificate
representing the Series A Convertible Preferred Stock as the owner
thereof.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we redeem any
shares of Series A Convertible Preferred Stock and if the
Redemption Date occurs after a Dividend Record Date and on or prior
to the related Dividend Payment Date, the dividend payable on such
Dividend Payment Date with respect to such shares called for
redemption shall be payable on such Dividend Payment Date to the
holders of record at the close of business on such Dividend Record
Date, and shall not be payable as part of the Redemption Price for
such shares.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Voting
Rights</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Holders of shares
of Series A convertible Preferred Stock will not have any voting
rights other than those set forth below, except as specifically
required by North Carolina law or by our articles of incorporation
from time to time.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-27</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Right to Elect Two Directors Upon Nonpayment</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Whenever dividends
on any shares of Series A Convertible Preferred Stock have not been
declared and paid for the equivalent of 12 or more Dividend
Periods, whether or not for consecutive Dividend Periods (a
&#x201C;Nonpayment&#x201D;), the authorized number of directors on
our board of directors shall, at the next annual meeting of
shareholders or at a special meeting of shareholders as provided
below, automatically be increased by two and holders of shares of
Series A Convertible Preferred Stock, voting together as a single
class, shall be entitled, at our next annual meeting of
shareholders or at a special meeting of shareholders as provided
below, to vote for the election of a total of two additional
members of the board of directors (the &#x201C;Preferred Stock
Directors&#x201D;); <font style="font-style: italic">provided</font>
that the election of any such Preferred Stock Directors will not
cause our company to violate the corporate governance requirements
of NYSE American (or any other exchange or automated quotation
system on which our securities may be listed or quoted) that
requires listed or quoted companies to have a majority of
independent directors; <font style="font-style: italic">provided
further</font> that such Preferred Stock Director shall not be
subject to any &#x201C;Bad Actor&#x201D; disqualifications described
in Rule 506(d)(1)(i) to (viii) under the Securities Act (a
&#x201C;Disqualifying Event&#x201D;), except for a Disqualifying
Event covered by Rule 506(d)(2) or (d)(3); <font style="font-style: italic">provided further</font> that the board of
directors shall, at no time, include more than two Preferred Stock
Directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the event of a
Nonpayment, the holders of at least 25% of the shares of Series A
Convertible Preferred Stock may request that a special meeting of
shareholders be called to elect such Preferred Stock Directors;
<font style="font-style: italic">provided, however</font>, to the
extent permitted by our bylaws, if the next annual or a special
meeting of shareholders is scheduled to be held within 90 days of
the receipt of such request, the election of such Preferred Stock
Directors shall be included in the agenda for, and shall be held
at, such scheduled annual or special meeting of shareholders. The
Preferred Stock Directors shall stand for reelection annually, at
each subsequent annual meeting of the shareholders, so long as the
holders continue to have such voting rights. At any meeting at
which the holders are entitled to elect Preferred Stock Directors,
the holders of record of at least 33 1/3% of the then outstanding
shares of Series A Convertible Preferred Stock, present in person
or represented by proxy, shall constitute a quorum and the vote of
the holders of record of a majority of such shares of Series A
Convertible Preferred Stock so present or represented by proxy at
any such meeting at which there shall be a quorum shall be
sufficient to elect the Preferred Stock Directors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If and when all
accumulated and unpaid dividends on Series A Convertible Preferred
Stock have been paid in full (a &#x201C;Nonpayment Remedy&#x201D;),
the holders shall immediately and, without any further action by
us, be divested of the voting rights described in this section,
subject to the revesting of such rights in the event of each
subsequent Nonpayment. If such voting rights for the holders shall
have terminated, the term of office of each Preferred Stock
Director so elected shall terminate at such time and the authorized
number of directors on the board of directors shall automatically
decrease by two.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any Preferred Stock
Director may be removed at any time, with or without cause, by the
holders of a majority in voting power of the outstanding shares of
Series A Convertible Preferred Stock then outstanding when they
have the voting rights described in this section. In the event that
a Nonpayment shall have occurred and there shall not have been a
Nonpayment Remedy, any vacancy in the office of a Preferred Stock
Director (other than prior to the initial election of Preferred
Stock Directors after a Nonpayment) may be filled by the written
consent of the Preferred Stock Director remaining in office, except
in the event that such vacancy is created as a result of such
Preferred Stock Director being removed or if no Preferred Stock
Director remains in office, such vacancy may be filled by a vote of
the holders of a majority in voting power of the outstanding shares
of Series A Convertible Preferred Stock then outstanding when they
have the voting rights described above; provided that the election
of any such Preferred Stock Directors to fill such vacancy will not
cause our company to violate the corporate governance requirements
of NYSE American (or any other exchange or automated quotation
system on which our securities may be listed or quoted) that
requires listed or quoted companies to have a majority of
independent directors. The Preferred Stock Directors shall each be
entitled to one vote per director on any matter that shall come
before the Board of Directors for a vote.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Other Voting Rights</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">So long as any
shares of Series A Convertible Preferred Stock are outstanding, in
addition to any other vote or consent of shareholders required by
law or by our articles of incorporation, we shall not, without the
affirmative vote or consent of the holders of at least two-third
(2/3) in voting power of the outstanding shares of Series A
Convertible Preferred Stock, voting as a separate class, given in
person or by proxy, either by vote at an annual or special meeting
of such shareholders or, if and to the extent permitted by
applicable North Carolina law and our articles of incorporation, in
writing:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px"><font style="font-size: 13px; font-family: Times New Roman">(i)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;adopt
any amendment to our articles of incorporation or bylaws that would
materially affect the special rights, preferences, privileges or
voting powers of the Series A Convertible Preferred Stock, and if
all series of a class of preferred stock are not equally affected
by a proposed change to the existing terms of the Series A
Convertible Preferred Stock, the approval of the holders and the
approval of the holders of at least two-third (2/3) in voting power
of the series that will have a diminished status will be required
to authorize such change; or</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-28</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 96px"><font style="font-size: 13px; font-family: Times New Roman">(ii)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;create
a Senior Stock, although consent by the holders of the Series A
Convertible Preferred Stock will not be required for the creation
of a Senior Stock if the Series A Convertible Preferred
Stockholders received adequate notice of redemption to occur within
90 days; <font style="font-style: italic">provided, however</font>,
a vote of the holders of the Series A Convertible Preferred Stock
will be required if all or part of shares of Series A Convertible
Preferred Stock is being retired with proceeds from the sale of the
new issue;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">provided, however</font>, that so long as any
shares of Series A Convertible Preferred Stock are outstanding, in
addition to any other vote or consent of shareholders required by
law or by our articles of incorporation, we shall not, without the
affirmative vote or consent of the holders of at least a majority
in voting power of the outstanding shares of Series A Convertible
Preferred Stock, voting as a separate class, given in person or by
proxy, either by vote at an annual or special meeting of such
shareholders or, if and to the extent permitted by applicable North
Carolina law and our articles of incorporation, increase in the
number of authorized shares of Series A Convertible Preferred
Stock, except in connection with the Anti-Dilution Provisions or
create an issue of Parity Stock as to dividend rights and
distribution rights upon our liquidation, winding up or
dissolution;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">provided, further, however,</font>
that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(A)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;any
increase in the amount of our authorized but unissued shares of
preferred stock,</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(B)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;any
increase in the amount of our authorized or issued shares of Series
A Convertible Preferred Stock as a result of the Anti-Dilution
Provisions, and</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(C)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;the
creation or issuance, or an increase in the authorized or issued
amount, of any other series of junior stock as to dividend rights
and distribution rights upon our liquidation, winding-up or
dissolution,</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">shall be deemed not
to adversely affect the special rights, preferences, privileges or
voting powers of the Series A Convertible Preferred Stock and shall
not require the affirmative vote or consent of
holders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Amendments without Holder Consent</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Without the consent
of the holders, so long as such action does not adversely affect
the special rights, preferences, privileges or voting powers of the
Series A Convertible Preferred Stock and limitations and
restrictions thereof, we may amend, alter, supplement or repeal any
terms of the Series A Convertible Preferred Stock to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(A)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;to
cure any ambiguity or mistake, or to correct or supplement any
provision contained in the Certificate of Designations, Rights and
Preferences of the Series A Convertible Preferred Stock that may be
defective or inconsistent with any other provision contained in the
Certificate of Designations, Rights and Preferences;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(B)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;to
make any provision with respect to matters or questions relating to
the Series A Convertible Preferred Stock that is not inconsistent
with the provisions of our articles of Incorporation or the
Certificate of Designations, Rights and Preferences;
or</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 144px"><font style="font-size: 13px; font-family: Times New Roman">(C)&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;&#xA0;to
waive any of our rights with respect to the Series A Convertible
Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Information
Rights</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">During any period
in which we are not subject to Section 13 or 15(d) of the Exchange
Act and any shares of Series A Convertible Preferred Stock are
outstanding, we shall use our best efforts to (a) transmit by mail
to all holders of Series A Convertible Preferred Stock, as their
names and addresses appear in our record books and without cost to
such holders, copies of the annual reports and quarterly reports
that we would have been required to file with the SEC pursuant to
Section 13 or 15(d) of the Exchange Act if we were subject to such
sections (other than any exhibits that would have been required)
and (b) promptly upon written request, supply copies of such
reports to any prospective holder of Series A Convertible Preferred
Stock. We will mail the reports to the holders of Series A
Convertible Preferred Stock within 30 days after the respective
dates by which we would have been required to file the reports with
the SEC if we were then subject to Section 13 or 15(d) of the
Exchange Act, assuming we are a &#x201C;non-accelerated filer&#x201D;
in accordance with the Exchange Act.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-29</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Record
Holders</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We and our transfer
agent shall deem and treat the record holder of any shares of
Series A Convertible Preferred Stock as the true and lawful owner
thereof for all purposes, and neither our company nor our transfer
agent shall be affected by any notice to the contrary.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Sinking
Fund</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock shall not be entitled to the benefits
of any retirement or sinking fund.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Status
of Acquired Shares</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">All shares of
Series A Convertible Preferred Stock redeemed or converted, or
otherwise acquired by us, will be cancelled and restored to the
status of authorized but unissued shares of undesignated preferred
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Preemptive
Rights</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No holders of the
Series A Convertible Preferred Stock will, as holders of Series A
Convertible Preferred Stock, have any preemptive rights to purchase
or subscribe for our common stock or any other
security.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Book-Entry
Procedures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred DTC will act as securities depository for our
outstanding Series A Convertible Preferred Stock. With respect to
the Series A Convertible Preferred Stock offered hereunder, we will
issue one or more fully registered global securities certificates
in the name of DTC&#x2019;s nominee, Cede &amp; Co. These
certificates will represent the total aggregate number of shares of
Series A Convertible Preferred Stock. We will deposit these
certificates with DTC or a custodian appointed by DTC. We will not
issue certificates to you for the shares of Series A Convertible
Preferred Stock that you purchase, unless DTC&#x2019;s services are
discontinued as described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Title to book-entry
interests in the Series A Convertible Preferred Stock will pass by
book-entry registration of the transfer within the records of DTC
in accordance with its procedures. Book-entry interests in the
securities may be transferred within DTC in accordance with
procedures established for these purposes by DTC. Each person
owning a beneficial interest in shares of the Series A Convertible
Preferred Stock must rely on the procedures of DTC and the
participant through which such person owns its interest to exercise
its rights as a holder of the Series A Convertible Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DTC has advised us
that it is a limited-purpose trust company organized under the New
York Banking Law, a member of the Federal Reserve System, a
&#x201C;clearing corporation&#x201D; within the meaning of the New
York Uniform Commercial Code and a &#x201C;clearing agency&#x201D;
registered under the provisions of Section 17A of the Exchange Act.
DTC holds securities that its participants (&#x201C;Direct
Participants&#x201D;) deposit with DTC. DTC also facilitates the
settlement among Direct Participants of securities transactions,
such as transfers and pledges in deposited securities through
electronic computerized book-entry changes in Direct
Participants&#x2019; accounts, thereby eliminating the need for
physical movement of securities certificates. Direct Participants
include securities brokers and dealers, banks, trust companies,
clearing corporations, and certain other organizations. Access to
the DTC system is also available to others such as securities
brokers and dealers, including the placement agent, banks and trust
companies that clear through or maintain a custodial relationship
with a Direct Participant, either directly or indirectly
(&#x201C;Indirect Participants&#x201D;). The rules applicable to DTC
and its Direct and Indirect Participants are on file with the
SEC.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">When you purchase
shares of Series A Convertible Preferred Stock within the DTC
system, the purchase must be by or through a Direct Participant.
The Direct Participant will receive a credit for the Series A
Convertible Preferred Stock on DTC&#x2019;s records. You will be
considered to be the &#x201C;beneficial owner&#x201D; of the Series A
Convertible Preferred Stock. Your beneficial ownership interest
will be recorded on the Direct and Indirect Participants&#x2019;
records, but DTC will have no knowledge of your individual
ownership. DTC&#x2019;s records reflect only the identity of the
Direct Participants to whose accounts shares of Series A
Convertible Preferred Stock are credited.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">You will not
receive written confirmation from DTC of your purchase. The Direct
or Indirect Participants through whom you purchased the Series A
Convertible Preferred Stock should send you written confirmations
providing details of your transactions, as well as periodic
statements of your holdings. The Direct and Indirect Participants
are responsible for keeping an accurate account of the holdings of
their customers like you.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-30</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Transfers of
ownership interests held through Direct and Indirect Participants
will be accomplished by entries on the books of Direct and Indirect
Participants acting on behalf of the beneficial
owners.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The laws of some
states may require that specified purchasers of securities take
physical delivery of shares of Series A Convertible Preferred Stock
in definitive form. These laws may impair the ability to transfer
beneficial interests in the global certificates representing the
Series A Convertible Preferred Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Conveyance of
notices and other communications by DTC to Direct Participants, by
Direct Participants to Indirect Participants, and by Direct
Participants and Indirect Participants to beneficial owners will be
governed by arrangements among them, subject to any statutory or
regulatory requirements as may be in effect from time to
time.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We understand that,
under DTC&#x2019;s existing practices, in the event that we request
any action of the holders, or an owner of a beneficial interest in
a global security, such as you, desires to take any action that a
holder is entitled to take under our amended and restated
certificate of incorporation (including the certificate of
designations designating the Series A Convertible Preferred Stock),
DTC would authorize the Direct Participants holding the relevant
shares to take such action, and those Direct Participants and any
Indirect Participants would authorize beneficial owners owning
through those Direct and Indirect Participants to take such action
or would otherwise act upon the instructions of beneficial owners
owning through them.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any optional
conversion, Market Trigger or redemption notices with respect to
the Series A Convertible Preferred Stock will be sent to Cede &amp;
Co. If less than all of the outstanding shares of Series A
Convertible Preferred Stock are being converted or redeemed, DTC
will reduce each Direct Participant&#x2019;s holdings of shares of
Series A Convertible Preferred Stock in accordance with its
procedures.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In those instances
where a vote is required, neither DTC nor Cede &amp; Co. itself
will consent or vote with respect to the shares of Series A
Convertible Preferred Stock. Under its usual procedures, DTC would
mail an omnibus proxy to us as soon as possible after the record
date. The omnibus proxy assigns Cede &amp; Co.&#x2019;s consenting
or voting rights to those Direct Participants whose accounts the
shares of Series A Convertible Preferred Stock are credited to on
the record date, which are identified in a listing attached to the
omnibus proxy.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Dividends on the
Series A Convertible Preferred Stock are made directly to DTC (or
its successor, if applicable). DTC&#x2019;s practice is to credit
participants&#x2019; accounts on the relevant payment date in
accordance with their respective holdings shown on DTC&#x2019;s
records unless DTC has reason to believe that it will not receive
payment on that payment date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Payments by Direct
and Indirect Participants to beneficial owners will be governed by
standing instructions and customary practices, as is the case with
securities held for the accounts of customers in bearer form or
registered in &#x201C;street name.&#x201D; These payments will be the
responsibility of the participant and not of DTC, us or any agent
of ours.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">DTC may discontinue
providing its services as securities depositary with respect to the
Series A Convertible Preferred Stock at any time by giving
reasonable notice to us. Additionally, we may decide to discontinue
the book-entry only system of transfers with respect to the Series
A Convertible Preferred Stock. In that event, we will print and
deliver certificates in fully registered form for the Series A
Convertible Preferred Stock. If DTC notifies us that it is
unwilling to continue as securities depositary, or it is unable to
continue or ceases to be a clearing agency registered under the
Exchange Act and a successor depositary is not appointed by us
within 90 days after receiving such notice or becoming aware that
DTC is no longer so registered, we will issue the Series A
Convertible Preferred Stock in definitive form, at our expense,
upon registration of transfer of, or in exchange for, such global
security.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">According to DTC,
the foregoing information with respect to DTC has been provided to
the financial community for informational purposes only and is not
intended to serve as a representation, warranty or contract
modification of any kind.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Global
Clearance and Settlement Procedures</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Initial settlement
for the Series A Convertible Preferred Stock will be made in
immediately available funds. Secondary market trading among
DTC&#x2019;s participants occurs in the ordinary way in accordance
with DTC&#x2019;s rules and will be settled in immediately available
funds using DTC&#x2019;s Same-Day Funds Settlement
System.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Direct
Registration System</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Series A
Convertible Preferred Stock will be registered in book-entry form
through the Direct Registration System (the &#x201C;DRS&#x201D;). The
DRS is a system administered by DTC pursuant to which the
depositary may register the ownership of uncertificated shares,
which ownership shall be evidenced by periodic statements issued by
the depositary to the holders of shares of Series A Convertible
Preferred Stock entitled thereto. This direct registration form of
ownership allows investors to have securities registered in their
names without requiring the issuance of a physical stock
certificate, eliminates the need for you to safeguard and store
certificates and permits the electronic transfer of securities to
effect transactions without transferring physical
certificates.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-31</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">CERTAIN
U.S. FEDERAL INCOME TAX CONSIDERATIONS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The following is a
summary of certain U.S. federal income tax considerations relevant
to the purchase, ownership, disposition and conversion of the
Series A Convertible Preferred Stock and the ownership and
disposition of our common stock received upon conversion of the
Series A Convertible Preferred Stock. The following summary is
based upon the provisions of the Internal Revenue Code of 1986, as
amended (the "Code"), Treasury Regulations and judicial and
administrative authority, all of which are subject to change,
possibly with retroactive effect, or to different interpretations.
We have not sought any ruling from the Internal Revenue Service
(the "IRS") or opinion of counsel with respect to the statements
made and conclusions reached in this summary, and there can be no
assurance that the IRS or a court will agree with these summary
statements and conclusions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">This summary does
not address all aspects of U.S. federal income taxation that may be
relevant to an investor's decision to purchase shares of Series A
Convertible Preferred Stock, nor any tax consequences arising under
U.S. federal estate or gift tax laws or under the laws of any
state, locality or foreign jurisdiction. This summary also does not
address the Medicare tax on certain investment income or the tax
consequences that may be applicable to special classes of investors
including, but not limited to, tax-exempt organizations, qualified
foreign pension funds, insurance companies, banks or other
financial institutions, partnerships or other pass-through entities
or holders of interests therein, dealers in securities or currency,
persons liable for the alternative minimum tax, U.S. expatriates
and former long-term U.S. residents, traders in securities that
elect to use a mark-to-market method of accounting for their
securities holdings, regulated investment companies, real estate
investment trusts, "controlled foreign corporations," "passive
foreign investment companies," common trust funds, certain trusts,
hybrid entities, U.S. holders whose "functional currency" is not
the U.S. dollar, foreign governments or international organizations
and persons that will hold our Series A Convertible Preferred Stock
or common stock as a position in a "straddle", "conversion
transaction" or other risk reduction transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">This summary is
limited to taxpayers who will hold our Series A Convertible
Preferred Stock and our common stock received upon conversion of
our Series A Convertible Preferred Stock as "capital assets"
(generally, property held for investment). We cannot assure you
that a change in the law will not significantly alter the tax
consequences that we describe in this discussion.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If a partnership
(including an entity or arrangement treated as a partnership for
U.S. federal income tax purposes) holds our Series A Convertible
Preferred Stock or common stock, the tax treatment of a partner in
the partnership will generally depend upon the status of the
partner and upon the activities of the partnership. Accordingly, we
urge partnerships (including entities and arrangements treated as
partnerships for U.S. federal income tax purposes) that hold our
Series A Convertible Preferred Stock and partners in such
partnerships to consult their tax advisors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Tax reform
legislation informally known as the Tax Cuts and Jobs Act (the
&#x201C;Tax Act&#x201D;) was enacted in the United States on December
22, 2017. The Tax Act makes major changes to the Code, including a
number of provisions that may affect the taxation of holders. The
individual and collective impact of these changes is uncertain, and
may not become evidence for some period of time. Legislative,
regulatory, or administrative changes could be enacted or
promulgated at any time, either prospectively or with retroactive
effect, and may adversely affect the Fund the Company and/or its
shareholders<font style="font-weight: bold">.&#xA0;We urge each
prospective investor to consult with its own tax adviser as to the
U.S. federal, state, local, foreign and any other tax consequences,
including the implications of the Tax Act, of the purchase,
ownership, conversion and disposition of our Series A Convertible
Preferred Stock and of the ownership and disposition of our common
stock.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Consequences to U.S. holders of Series A Convertible Preferred
Stock or common stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The discussion in
this section is addressed to a holder of our Series A Convertible
Preferred Stock and common stock received in respect thereof that
is a U.S. holder for U.S. federal income tax purposes. You are a
"U.S. holder" if you are a beneficial owner of Series A Convertible
Preferred Stock or common stock and you are, for U.S. federal
income tax purposes:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">An individual
citizen or resident of the United States, including an alien
individual who is a lawful permanent resident of the United States
or who meets the "substantial presence" test under Section 7701(b)
of the Code;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">a corporation, or
other entity taxable as a corporation for U.S. federal income tax
purposes, that was created or organized in or under the laws of the
United States, any state thereof or the District of
Columbia;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">an estate whose
income is subject to U.S. federal income tax regardless of its
source; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">a trust (i) whose
administration is subject to the primary supervision of a U.S.
court and which has one or more U.S. persons who have the authority
to control all substantial decisions of the trust or (ii) which has
made a valid election to be treated as a U.S. person.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-32</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Distributions in General</font>. Distributions
with respect to our Series A Convertible Preferred Stock and our
common stock (other than certain stock distributions with respect
to our common stock) will be treated as dividends to the extent of
our current or accumulated earnings and profits, as determined
under the Code. To the extent that the amount of distributions with
respect to our Series A Convertible Preferred Stock or common stock
exceeds our current and accumulated earnings and profits, such
excess will be treated first as a tax-free return of capital to the
extent of the U.S. holder's adjusted tax basis in such Series A
Convertible Preferred Stock or common stock, as the case may be, on
a share-by-share basis, and thereafter as capital gain. Such gain
will be long-term capital gain provided that the U.S. holder has
held such Series A Convertible Preferred Stock or common stock, as
the case may be, for more than one year as of the time of the
distribution. For a discussion of a U.S. holder's tax basis and
holding period in respect of our common stock received with respect
to our Series A Convertible Preferred Stock, see below under
"Common Stock Distributions on the Series A Convertible Preferred
Stock" and "Conversion of Series A Convertible Preferred Stock into
Common Stock."</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Subject to certain
exceptions for short-term and hedged positions and dividends that a
holder elects to treat as "investment income," distributions
constituting dividend income received by non-corporate U.S. holders
in respect of our Series A Convertible Preferred Stock or common
stock will be subject to a reduced U.S. federal income tax rate if
such dividends are treated as "qualified dividend income" for U.S.
federal income tax purposes. If a dividend received by a
non-corporate U.S. holder that qualifies for the rate reduction is
an "extraordinary dividend" within the meaning of Section 1059 of
the Code, such non-corporate U.S. holder would be required to treat
any losses on the sale of Series A Convertible Preferred Stock as
long-term capital loss to the extent of such "extraordinary
dividend," irrespective of such holder's holding period for the
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Subject to similar
exceptions for short-term and hedged positions, distributions on
our Series A Convertible Preferred Stock and common stock
constituting dividend income paid to U.S. holders that are U.S.
corporations are subject to tax at ordinary corporate rates, but
will qualify for the dividends received deduction. However, any
distribution (or the portion of any distribution) that exceeds our
current and accumulated earnings and profits will not be eligible
for the dividends received deduction. A U.S. holder should consult
its own tax adviser regarding the availability of the reduced U.S.
federal income tax rate applicable to "qualified dividend income"
or the dividends received deduction, as applicable, in the light of
its particular circumstances.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Investors that are
U.S. corporations that receive an "extraordinary dividend" within
the meaning of Section 1059 of the Code in respect of our Series A
Convertible Preferred Stock or common stock generally would be
required to reduce their basis in our Series A Convertible
Preferred Stock or common stock (but not below zero) by the portion
of the dividend that is not taxed because of the dividends received
deduction. To the extent the non-taxed portion of such dividend
exceeds the corporate investor's stock basis, such investor must
treat such excess as gain from the sale or exchange of our Series A
Convertible Preferred Stock or common stock for the taxable year in
which such dividend is received.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Common Stock Distributions on the Series A
Convertible Preferred Stock</font>. If the Company pays a
distribution on the Series A Convertible Preferred Stock in the
form of common stock, such distribution will be taxable for U.S.
federal income tax purposes in the same manner as distributions
described above under "Distributions in General." The amount of
such distribution will equal the fair market value on the
distribution date of the common stock distributed to a U.S. holder
on that date. A U.S. holder's tax basis in such common stock will
equal the fair market value of such common stock on the
distribution date, and such U.S. holder's holding period for such
common stock will begin on the day following the distribution
date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Sale or Other Disposition</font>. A U.S.
holder will generally recognize capital gain or loss on a sale or
exchange of our Series A Convertible Preferred Stock (other than
pursuant to a conversion into common stock or pursuant to a
redemption) or common stock equal to the difference between the
amount realized upon the sale or exchange (not including any
proceeds attributable to any dividends in arrears, which generally
will be taxable as described above under "Distributions in
General") and the U.S. holder's adjusted tax basis in the shares
sold or exchanged. Such capital gain or loss will be long-term
capital gain or loss if the U.S. holder's holding period for the
shares sold or exchanged is more than one year. Long-term capital
gains of non-corporate taxpayers generally are subject to a reduced
rate of taxation. The deductibility of capital losses is subject to
limitations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Conversion of Series A Convertible Preferred
Stock into Common Stock</font>. As a general rule, a U.S. holder
will not recognize any gain or loss in respect of the receipt of
common stock upon the conversion of our Series A Convertible
Preferred Stock into common stock. Cash received in lieu of a
fractional share of common stock will generally be treated as a
payment in a taxable exchange for such fractional share, and gain
or loss will be recognized on the receipt of cash in an amount
equal to the difference between the amount of cash received and the
amount of adjusted tax basis in the stock that is allocable to the
fractional share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-33</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The adjusted tax
basis of common stock received on conversion will equal the
adjusted tax basis of the Series A Convertible Preferred Stock
converted (reduced by the portion of adjusted tax basis allocated
to any fractional shares of common stock exchanged for cash, as
described above), and the holding period of such common stock
received on conversion will generally include the period during
which the Series A Convertible Preferred Stock was held by the U.S.
holder prior to conversion. A U.S. holder's tax basis in a
fractional share will be determined by allocating such holder's tax
basis in the Series A Convertible Preferred Stock between the
common stock such U.S. holder receives upon conversion and the
fractional share in accordance with their respective fair market
values.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If a U.S. holder
exercises its right to convert the Series A Convertible Preferred
Stock into shares of common stock after a regular record date but
before the Dividend Payment Date, then upon conversion, the U.S.
holder generally will be required to pay to us in cash an amount
equal to the portion of such dividend attributable to the current
monthly dividend period. In this case, the U.S. holder will be
entitled to receive the dividend payment on the corresponding
Dividend Payment Date. A U.S. holder should consult its own tax
adviser with respect to the treatment of such cash payment and the
subsequent receipt of such dividend payment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Adjustment of Conversion Price</font>. The
conversion price of the Series A Convertible Preferred Stock is
subject to adjustment under certain circumstances pursuant to the
Anti-Dilution Provisions. Treasury Regulations promulgated under
Section 305 of the Code would treat a U.S. holder of our Series A
Convertible Preferred Stock as having received a constructive
distribution includable in such U.S. holder's income in the manner
described under "Distributions in General," above, if and to the
extent that certain adjustments (or failures to make adjustments)
in the conversion price increase the proportionate interest of the
U.S. holder in our assets or earnings and profits. For example, a
decrease in the conversion price to reflect a taxable dividend to
holders of common stock will generally give rise to a deemed
taxable dividend to the holders of Series A Convertible Preferred
Stock to the extent of an allocable portion of our current and
accumulated earnings and profits. Thus, under certain
circumstances, U.S. holders may recognize income in the event of a
constructive distribution even though they may not receive any cash
or property. Adjustments to the conversion price made pursuant to a
bona fide reasonable adjustment formula that has the effect of
preventing dilution in the interest of the U.S. holders of the
Series A Convertible Preferred Stock (other than an adjustment in
respect of a taxable dividend on the common stock), however,
generally will not be considered to result in a constructive
dividend distribution.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Redemption of Series A Convertible Preferred
Stock</font>. If we redeem our Series A Convertible Preferred Stock
solely in exchange for common stock, the tax consequences to a U.S.
holder would be as described above under "&#x2014;Conversion of
Series A Convertible Preferred Stock into common stock" (except
that any common stock received in respect of dividends in arrears
generally will be taxable as described above under "Distributions
in General").</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we redeem our
Series A Convertible Preferred Stock solely in exchange for cash,
the redemption would be treated as a sale or exchange if the
redemption (i) results in a meaningful reduction in the U.S.
holder's interest in us or (ii) results in a complete termination
of the U.S. holder's entire equity interest in us (in either case,
within the meaning of Section 302(b) of the Code). If the
redemption qualifies as a sale under one of these rules, the tax
consequences to a U.S. holder would be as described above under
"Sale or other disposition." If the redemption does not qualify as
a sale for tax purposes under the rules described above, the amount
of cash received by a U.S. holder would be treated as described
above under "Distributions in General."</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we redeem our
Series A Convertible Preferred Stock in exchange for a combination
of cash and common stock, a U.S. holder could not recognize a loss
but would recognize gain equal to the lesser of (i) the excess of
the sum of the fair market value of the common stock and the amount
of cash received (not including any proceeds attributable to any
dividends in arrears, which generally will be taxable as described
above under "Distributions in General") over the U.S. holder's
adjusted tax basis in the Series A Convertible Preferred Stock
redeemed, and (ii) the amount of cash received by the U.S. holder
(not including any proceeds attributable to any dividends in
arrears, which generally will be taxable as described above under
"Distributions in General"). The character of such gain is
uncertain. If the redemption results in a meaningful reduction in
the U.S. holder's interest in us (within the meaning of Section
302(b) of the Code), then the gain would be capital gain that is
taxed as described above under "&#x2014;Sale or other disposition."
If the redemption does not qualify as a sale for tax purposes under
one of these rules, the gain recognized by you would be treated as
described above under "Distributions in General." The initial
adjusted tax basis of common stock received by a U.S. holder upon
redemption will be equal to the U.S. holder's aggregate adjusted
tax basis in the Series A Convertible Preferred Stock redeemed,
reduced by the amount of any cash received (other than cash
attributable to accrued but unpaid dividends), and increased by the
amount of gain, if any, recognized. The holding period for the
shares of common stock received by the U.S. holder upon redemption
of the Series A Convertible Preferred Stock generally will include
the U.S. holder's holding period in the Series A Convertible
Preferred Stock redeemed, except that the holding period of any
common stock received with respect to dividends in arrears will
commence on the day after the date of receipt.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Information Reporting and Backup
Withholding</font>. Certain U.S. holders will be subject to
information reporting with respect to distributions on our Series A
Convertible Preferred Stock or common stock and the payment of
proceeds on the sale or other disposition of our Series A
Convertible Preferred Stock or common stock, and backup withholding
may apply unless the U.S. holder provides proof of an applicable
exemption or a correct taxpayer identification number, and
otherwise complies with applicable requirements of the backup
withholding rules.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-34</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any amount withheld
under the backup withholding rules from a payment to a U.S. holder
is allowable as a credit against such holder's U.S. federal income
tax liability, which may entitle the U.S. holder to a refund if the
amount of taxes withheld exceed the U.S. holder's actual tax
liability, provided that the U.S. holder timely provides the
required information to the IRS. U.S. holders are urged to consult
their own tax advisers regarding the application of backup
withholding in their particular circumstances and the availability
of and procedure for obtaining an exemption from backup withholding
under current Treasury Regulations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Consequences
to non-U.S. holders of Series A Convertible Preferred Stock or
common stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The discussion in
this section is addressed to a holder of our Series A Convertible
Preferred Stock and common stock received in respect thereof that
is a non-U.S. holder. You are a "non-U.S. holder" if you are a
beneficial owner of Series A Convertible Preferred Stock or common
stock received in respect thereof and you are not a U.S.
holder.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Distributions</font>. Generally, distributions
(including any constructive distributions taxable as dividends as
described below and any cash paid upon a conversion that is treated
as a dividend) treated as dividend income and paid to a non-U.S.
holder with respect to our Series A Convertible Preferred Stock or
our common stock will be subject to a 30% U.S. withholding tax, or
such lower rate as may be specified by an applicable tax treaty.
Any dividends paid on our Series A Convertible Preferred Stock in
shares of our common stock and taxed as dividend income as
described above under "Consequences to U.S. holders of Series A
Convertible Preferred Stock or common stock&#x2014;common stock
distributions on the Series A Convertible Preferred Stock" will be
subject to withholding tax in the same manner as described in the
previous sentence. Any required withholding tax might be satisfied
by the withholding agent through a sale of a portion of the shares
you receive as a dividend or might be withheld from cash dividends
or sales proceeds subsequently paid or credited to you. To receive
the benefit of a reduced treaty rate, a non-U.S. holder must
provide the applicable withholding agent with an IRS Form W-8BEN,
IRS Form W-8BEN-E, or other appropriate version of IRS Form W-8
certifying qualification for the reduced rate. Special
certification and other requirements apply to certain non-U.S.
holders that are pass-through entities rather than corporations or
individuals.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Dividends that are
effectively connected with a trade or business carried on by a
non-U.S. holder within the United States, and, to the extent an
applicable tax treaty provides, attributable to a permanent
establishment maintained by the non-U.S. holder in the United
States, will generally be subject to U.S. federal income tax on a
net basis at the individual or corporate rates generally applicable
to U.S. holders, but will not be subject to U.S. withholding tax if
certain certification requirements are satisfied. You can generally
meet the certification requirements by providing a properly
executed IRS Form W-8ECI or appropriate substitute form to the
applicable withholding agent. A non-U.S. holder that is a
corporation may also be subject to a "branch profits tax" at a 30%
rate (or such lower rate as may be specified by an applicable tax
treaty) on its "effectively connected earnings and profits,"
subject to certain adjustments, which will include effectively
connected dividends.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">A non-U.S. holder
of our common stock may obtain a refund of any excess amounts
withheld under these rules if the non-U.S. holder is eligible for a
reduced rate of United States withholding tax and an appropriate
claim for refund is timely filed with the IRS.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Sale or Other Disposition</font>. Subject to
the discussion under "Information reporting and backup withholding"
and "FATCA," a non-U.S. holder generally will not be subject to
U.S. federal income or withholding tax on any gain realized on the
sale, exchange or other taxable disposition (other than a
redemption) of our Series A Convertible Preferred Stock or our
common stock unless:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the gain is
effectively connected with a trade or business conducted by the
non-U.S. holder in the United States and, if required by an
applicable tax treaty, is attributable to a permanent establishment
or fixed base maintained by such non-U.S. holder in the United
States);</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the non-U.S. holder
is an individual who is present in the United States for a period
or periods aggregating 183 days or more during the calendar year in
which the sale or disposition occurs and certain other conditions
are met; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our common stock
constitutes a "United States real property interest" by reason of
our status as a "United States real property holding corporation"
("USRPHC") for U.S. federal income tax purposes at any time during
the five-year period ending on the date of such disposition or, if
shorter, the non-U.S. holder's holding period for its shares of
common stock or Series A Convertible Preferred Stock, as
applicable, and one of the circumstances below applies to
you.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">A non-U.S. holder
whose gain is described in the first bullet point above will be
subject to U.S. federal income tax on the gain derived from the
sale in the same manner as a U.S. person, unless an applicable tax
treaty provides otherwise. If such non-U.S. holder is a foreign
corporation, it may also be subject to a branch profits tax (at a
30% rate or such lower rate as specified by an applicable tax
treaty) on its effectively connected earnings and profits
attributable to such gain, as adjusted for certain items. A
non-U.S. holder described in the second bullet point above will be
subject to a 30% U.S. federal income tax (or such lower rate as may
be specified by an applicable tax treaty) on the gain derived from
the sale, which may be offset by certain U.S.-source capital
losses.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-35</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">With respect to the
third bullet point above, we are, and expect to continue to be for
the foreseeable future, a USRPHC (and the remainder of this
discussion assumes we are and will be a USRPHC). Our common stock
is currently listed on the NYSE American and we believe that, for
as long as we continue to be so listed, our common stock will be
treated as regularly traded on an established securities market. If
we are a USRPHC, and if our common stock continues to be regularly
traded on an established securities market:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">with respect to a
disposition of our common stock, if you have owned, or are deemed
to have owned, at any time within the shorter of the five-year
period preceding the disposition of our common stock or your
holding period for your common stock, more than 5% of our common
stock, you generally would be subject to U.S. federal income tax on
any gain from the disposition;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">with respect to a
disposition of Series A Convertible Preferred Stock, if (as
expected) the Series A Convertible Preferred Stock is not regularly
traded on an established securities market at the time of the
disposition and, on the date you acquired the Series A Convertible
Preferred Stock, it had a fair market value greater than 5% of the
fair market value of our common stock outstanding, you generally
would be subject to U.S. federal income tax on the gain from the
disposition and the transferee of the Series A Convertible
Preferred Stock generally would be required to withhold 15% of the
gross proceeds payable to you. For this purpose, if you
subsequently acquire additional Series A Convertible Preferred
Stock, then such Series A Convertible Preferred Stock would be
aggregated and valued as of the date of the subsequent acquisition
in order to apply the 5% limitation.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If the gain from
any disposition is subject to tax as described above, it will be
taxed as if you were a U.S. holder and you would be required to
file a U.S. tax return with respect to such gain.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If, during the
calendar year in which the relevant sale, exchange or other taxable
disposition occurs, we are a USRPHC and our common stock were not
considered to be regularly traded on an established securities
market, all non-U.S. holders generally would be subject to U.S.
federal income tax on any gain from the disposition of the Series A
Convertible Preferred Stock or our common stock (regardless of the
amount of Series A Convertible Preferred Stock or our common stock
owned), and transferees of the Series A Convertible Preferred Stock
or our common stock would generally be required to withhold 15% of
the gross proceeds payable to the non-U.S. holder. The gain from
the disposition would be subject to regular U.S. income tax as if
the non-U.S. holder were a U.S. holder, and the non-U.S. holder
would be required to file a U.S. tax return with respect to such
gain.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Non-U.S. holders
that may be treated as actually or constructively owning more than
5% of our Series A Convertible Preferred Stock or common stock
should consult their own tax advisers with respect to the U.S.
federal income tax consequences of the ownership and disposition of
Series A Convertible Preferred Stock or common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Conversion of Series A Convertible Preferred
Stock into Common Stock</font>. You generally will not recognize
any gain or loss by reason of receiving common stock upon
conversion of the Series A Convertible Preferred Stock, except gain
or loss will be recognized with respect to any cash received in
lieu of fractional shares, which may be subject to U.S. federal
income tax, as discussed above in "Sale or other
disposition."</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Notwithstanding
these general rules, if a non-U.S. holder is subject to tax under
the special rules governing USRPHCs as described above under "Sale
or other disposition" with respect to its Series A Convertible
Preferred Stock but not the common stock into which the Series A
Convertible Preferred Stock is convertible, then the conversion of
the Series A Convertible Preferred Stock into common stock would be
a taxable event and such non-U.S. holder would be subject to U.S.
tax in the same manner as described in "Sale or other disposition."
This situation could arise, for example, if the Series A
Convertible Preferred Stock were "regularly traded" and a non-U.S.
holder owned more than 5% of Series A Convertible Preferred Stock
that was convertible into less than 5% of the common stock. If, as
to a non-U.S. holder, both the Series A Convertible Preferred Stock
and the common stock into which the Series A Convertible Preferred
Stock is convertible are subject to the special rules governing
USRPHCs described above, then, although the conversion of the
Series A Convertible Preferred Stock solely into the common stock
generally would not be taxable, the non-U.S. holder may be required
to file a U.S. federal income tax return for the taxable year of
the conversion and satisfy certain procedural requirements in
accordance with the applicable Treasury Regulations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Non-U.S. holders
that may be subject to the special rules governing USRPHCs should
consult their own tax advisers with respect to the U.S. federal
income tax consequences of the conversion of their Series A
Convertible Preferred Stock into common stock, including any filing
requirements that may be applicable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Adjustment of Conversion Price</font>. As
described above under "Consequences to U.S. Holders of Series A
Convertible Preferred Stock or common stock&#x2014;Adjustment of
Conversion Price," adjustments in the conversion price (or failures
to adjust the conversion price) that result in an increase in the
proportionate interest of a non-U.S. holder in our assets or
earnings and profits could result in deemed distributions to the
non-U.S. holder that are taxed as described under "Distributions."
It is possible that any withholding tax on such a deemed
distribution might be satisfied by the withholding agent through a
sale of a portion of the shares you receive as a dividend or might
be withheld from cash dividends, shares of our common stock or sale
proceeds subsequently paid or credited to you.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-36</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Redemption of Series A Convertible Preferred
Stock</font>. If we redeem our Series A Convertible Preferred Stock
solely in exchange for common stock, the tax consequences to a
non-U.S. holder would be as described above under "Conversion of
Series A Convertible Preferred Stock into common stock" (except
that any common stock received in respect of dividends in arrears
generally will be taxable as described above under
"Distributions").</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we redeem our
Series A Convertible Preferred Stock solely in exchange for cash,
the redemption would be treated as a sale or exchange if the
redemption results in a meaningful reduction in the non-U.S.
holder's interest in us, or results in a complete termination of
the non-U.S. holder's entire equity interest in us (in each case,
within the meaning of Section 302(b) of the Code). If the
redemption qualifies as a sale under one of these rules, the tax
consequences to a non-U.S. holder would be as described above under
"Sale or other disposition." If the redemption does not qualify as
a sale for tax purposes under the rules described above, the amount
of cash received by a non-U.S. holder would be treated as described
above under "Distributions."</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">If we redeem our
Series A Convertible Preferred Stock in exchange for a combination
of cash and common stock, a non-U.S. holder would recognize gain
(but not loss) equal to the lesser of (i) the excess of the sum of
the fair market value of the common stock and the amount of cash
received (not including any proceeds attributable to any dividends
in arrears, which generally will be taxable as described above
under "Distributions") over the non-U.S. holder's adjusted tax
basis in the Series A Convertible Preferred Stock redeemed, and
(ii) the amount of cash received by the non-U.S. holder (not
including any proceeds attributable to any dividends in arrears,
which generally will be taxable as described above under
"Distributions"), provided, however, that the amount of gain
required to be recognized by a non-U.S. holder that is subject to
tax under the special rules governing USRPHCs may be greater than
described above.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The tax treatment
of any such gain to non-U.S. holders is uncertain. If the
redemption results in a meaningful reduction in the non-U.S.
holder's interest in us (in either case, within the meaning of
Section 302(b) of the Code), then the gain generally would be taxed
only as described above under "Sale or other disposition." If the
redemption does not qualify as a sale for tax purposes under one of
these rules, the gain generally would be treated as described above
under "Distributions." Because the characterization of a redemption
of the Series A Convertible Preferred Stock in exchange for common
stock is uncertain and is determined on a holder-by-holder basis,
it is possible that a withholding agent would withhold on the cash
proceeds received.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Non-U.S. holders
that are subject to tax under the special rules governing USRPHCs
should consult their own tax advisers with respect to the U.S.
federal income tax consequences of a redemption of their Series A
Convertible Preferred Stock, including any filing requirements that
may be applicable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">Information Reporting and Backup
Withholding</font>. Payment of dividends (including constructive
dividends), and the tax withheld with respect thereto, is subject
to information reporting requirements. These information reporting
requirements apply regardless of whether withholding was reduced or
eliminated by an applicable tax treaty or withholding was not
required because the dividends were effectively connected with a
trade or business in the United States conducted by the non-U.S.
holder. Copies of the information returns reporting such dividends
and withholding may also be made available under the provisions of
an applicable tax treaty or agreement with the tax authorities in
the country in which the non-U.S. holder resides. U.S. backup
withholding will generally apply to the payment of dividends to
non-U.S. holders unless such non-U.S. holders furnish to the payor
a Form W-8BEN or Form W-8BEN-E (or other applicable form) or
otherwise establish an exemption.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Payment by a U.S.
office of a broker of the proceeds of a sale of our Series A
Convertible Preferred Stock or common stock is subject to both
backup withholding and information reporting unless the non-U.S.
holder, or beneficial owner thereof, as applicable, certifies that
it is a non-U.S. holder on Form W-8BEN or Form W-8BEN-E (or other
suitable substitute or successor form), or otherwise establishes an
exemption. Subject to certain exceptions, backup withholding and
information reporting generally will not apply to a payment of
proceeds from the sale of our Series A Convertible Preferred Stock
or common stock if such sale is effected through a foreign office
of a broker, provided that the broker does not have certain U.S.
connections.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any amount withheld
under the backup withholding rules from a payment to a non-U.S.
holder is allowable as a credit against such holder's U.S. federal
income tax liability (if any), which may entitle the holder to a
refund if in excess of such liability, provided that the holder
timely provides the required information to the IRS. Non-U.S.
holders are urged to consult their own tax advisers regarding the
application of backup withholding in their particular circumstances
and the availability of and procedure for obtaining an exemption
from backup withholding under current Treasury
Regulations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic">FATCA</font>. Sections 1471 to 1474 of the
Code (such sections, and the Treasury Regulations and
administrative guidance issued thereunder, commonly referred to as
&#x201C;FATCA&#x201D;) impose a 30% U.S. withholding tax on certain
"withholdable payments" made to a "foreign financial institution"
or a "non-financial foreign entity." "Withholdable payments"
include payments of dividends and the gross proceeds from a
disposition of certain property (such as the Series A Convertible
Preferred Stock or our common stock), if such disposition occurs
after December 31, 2018. In general, if a holder is a "foreign
financial institution" (which includes investment entities such as
hedge funds and private equity funds), the 30% withholding tax will
apply to withholdable payments made to such holder, unless such
holder enter into an agreement with the U.S. Department of Treasury
to collect and provide substantial information regarding its U.S.
account holders, including certain account holders that are foreign
entities with U.S. owners, and to withhold 30% on certain "passthru
payments." If such holder is a "non-financial foreign entity,"
FATCA also generally will impose a withholding tax of 30% on
withholdable payments made to such holder unless the holder provide
the withholding agent with a certification that it does not have
any "substantial United States owners" or a certification
identifying its direct and indirect substantial United States
owners. Intergovernmental agreements between the United States and
a holder's resident country may modify some of the foregoing
requirements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Non-U.S. holders
should consult their own tax advisers with respect to the U.S.
federal income tax consequences of FATCA on their ownership and
disposition of Series A Convertible Preferred Stock and common
stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-37</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">UNDERWRITING</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ThinkEquity, a
division of Fordham Financial Management, Inc., is acting as the
representative of the underwriters of this offering, which we refer
to as the Representative or ThinkEquity. We have entered into an
underwriting agreement dated October 10, 2019 with the
Representative. Subject to the terms and conditions of the
underwriting agreement, we have agreed to sell to each underwriter
named below and each underwriter named below has severally and not
jointly agreed to purchase from us, at the public offering price
per share less the underwriting discounts set forth on the cover
page of this prospectus supplement, the number of shares of Series
A Convertible Preferred Stock listed next to its name in the
following table:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; margin-left: 0px; margin-right: 0px; width: 100%;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 88%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; border-bottom: 2px solid #000000"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Underwriters</font></div>
</td>
<td rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000">
<div><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Number
of Shares</font></div>
</font><font style="text-align: left; width: 10%; vertical-align: bottom; display: inline-block; padding-bottom: 2px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 88%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">ThinkEquity, a
division of Fordham Financial Management, Inc.</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">332,500<br></font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 88%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The Benchmark
Company, LLC</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">142,500<br></font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 88%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">WestPark Capital,
Inc.<br></font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 2px solid #000000; font-size: 13px; font-family: Times New Roman">25,000<br></font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 2px; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 88%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Total</font></div>
</td>
<td style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 4px; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 5%; border-bottom: 4px double #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font><font style="text-align: right; vertical-align: bottom; display: inline-block; width: 75%; border-bottom: 4px double #000000; font-size: 13px; font-family: Times New Roman">500,000<br></font><font style="text-align: left; vertical-align: bottom; display: inline-block; width: 10%; padding-bottom: 4px; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">All of the shares
of Series A Convertible Preferred Stock to be purchased by the
underwriters will be purchased from us.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriting
agreement provides that the obligations of the underwriters to pay
for and accept delivery of the shares of Series A Convertible
Preferred Stock offered by this prospectus supplement are subject
to various conditions and representations and warranties, including
the approval of certain legal matters by their counsel and other
conditions specified in the underwriting agreement. The shares of
Series A Convertible Preferred Stock are offered by the
underwriters, subject to prior sale, when, as and if issued to and
accepted by them. The underwriters reserve the right to withdraw,
cancel or modify the offer to the public and to reject orders in
whole or in part. The underwriters are obligated to take and pay
for all of the shares of Series A Preferred Stock offered by this
prospectus supplement if any such shares of Series A Convertible
Preferred Stock are taken, other than those shares of Series A
Convertible Preferred Stock covered by the over-allotment option
described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We expect that
delivery of the Series A Convertible Preferred Stock will be made
against payment therefor on or about October 16, 2019. Under Rule
15c6-1 under the Exchange Act, trades in the secondary market
generally are required to settle in two business days, unless the
parties to any such trade expressly agree otherwise.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Over-Allotment
Option</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have granted to
the underwriters an option, exercisable no later than 45 calendar
days after the closing of this offering, to purchase up to an
additional 75,000 shares of Series A Convertible Preferred Stock
(15% of the shares of Series A Convertible Preferred Stock sold in
this offering) from us to cover over-allotments, if any, at a price
per share of Series A Convertible Preferred Stock equal to the
public offering price, less the underwriting discounts and
commissions. The underwriters may exercise this option only to
cover over-allotments made in connection with this offering. If the
underwriters exercise this option in whole or in part, then the
underwriters will be severally committed, subject to the conditions
described in the underwriting agreement, to purchase these
additional shares of Series A Convertible Preferred Stock. If any
additional shares of Series A Preferred Stock are purchased, the
underwriters will offer the additional shares of Series A
Convertible Preferred Stock on the same terms as those on which the
shares of Series A Convertible Preferred Stock are being offered
hereby.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Discounts
and Commissions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="background-color: #ffffff; font-size: 13px; font-family: Times New Roman">
The Representative has advised us that the underwriters propose to
offer the shares of Series A Convertible Preferred Stock to the
public at the public offering price per share set forth on the
cover page of this prospectus supplement. The underwriters may
offer shares to securities dealers at that price less a concession
of not more than $0.50 per share. After the initial offering to the
public, the public offering price and other selling terms may be
changed by the Representative.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The following table
summarizes the public offering price, underwriting discounts and
commissions and proceeds before expenses to us assuming both no
exercise and full exercise by the underwriters of their
over-allotment option:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; margin-left: 0px; margin-right: 0px; width: 100%;">
<tr>
<td rowspan="1" style="vertical-align: bottom; width: 64%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000; font-size: 11px">
<div><font style="font-family: Times New Roman">&#xA0;</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman">Per
Share</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000; font-size: 11px">
<div><font style="font-family: Times New Roman">&#xA0;</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman">Total Without
Over-allotment Option</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
<td colspan="1" rowspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font><font style="text-align: center; vertical-align: bottom; width: 80%; display: inline-block; border-bottom: 2px solid #000000; font-size: 11px">
<div><font style="font-family: Times New Roman">&#xA0;</font></div>
<div><font style="font-weight: bold; font-family: Times New Roman">Total With
Over-allotment Option</font></div>
</font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block; padding-bottom: 2px; font-size: 11px">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 64%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Public offering
price</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">10.00<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">5,000,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">5,750,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #ffffff">
<td style="vertical-align: bottom; width: 64%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Underwriting
discounts and commissions (7.5%)</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">0.75<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">375,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">431,250<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr><tr style="background-color: #cceeff">
<td style="vertical-align: bottom; width: 64%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Proceeds, before
expenses, to us</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">9.25<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">4,625,000<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
<td colspan="1" style="vertical-align: bottom; width: 12%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font><font style="text-align: left; vertical-align: bottom; width: 5%; display: inline-block">$</font><font style="text-align: right; vertical-align: bottom; width: 75%; display: inline-block">5,318,750<br></font><font style="text-align: left; vertical-align: bottom; width: 10%; display: inline-block">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="background-color: #ffffff">We</font> have agreed to reimburse the
Representative for all reasonable and actual out-of-pocket
accountable fees and costs incurred by the Representative in
connection with this offering up to a maximum of $125,000 in the
aggregate, including the fees and expenses of the
underwriters&#x2019; legal counsel.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We estimate the
expenses of this offering payable by us, not including underwriting
discounts and commissions, will be approximately
$372,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-38</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Representative&#x2019;s
Warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon closing of
this offering, we have agreed to issue to the Representative as
compensation warrants to purchase a number of shares of common
stock (47,923 shares) equal to 3.0% of the quotient of the gross
proceeds from this offering divided by $3.13 (the last closing
price per share of our common stock on the NYSE American prior to
the execution of the underwriting agreement for this offering),
which we refer to as the Representative&#x2019;s Warrants. The
Representative&#x2019;s Warrants will be exercisable at a per share
exercise price equal to $3.9125, which is 125% of the last closing
price per share of our common stock on the NYSE American prior to
the execution of the underwriting agreement for this offering
(excluding the over-allotment option). The Representative&#x2019;s
Warrants are exercisable at any time and from time to time, in
whole or in part, during the four and one-half year period
commencing 180 days from the effective date of <font style="color: #000000">the registration statement of which this
prospectus supplement is a part, which we refer to as the effective
date of</font> this offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The
Representative&#x2019;s Warrants have been deemed compensation by
FINRA and are therefore subject to a 180-day lock-up pursuant to
Rule 5110(g)(1) of FINRA. The Representative (or permitted
assignees under Rule 5110(g)(1)) will not sell, transfer, assign,
pledge, or hypothecate these warrants or the securities underlying
these warrants, nor will they engage in any hedging, short sale,
derivative, put, or call transaction that would result in the
effective economic disposition of the warrants or the underlying
securities for a period of 180 days from the effective date of this
offering. In addition, the warrants provide for registration rights
upon request, in certain cases. The demand registration right
provided will not be greater than five years from the effective
date of this offering in compliance with FINRA Rule
5110(f)(2)(G)(iv). The piggyback registration right provided will
not be greater than seven years from the effective date of this
offering in compliance with FINRA Rule 5110(f)(2)(G)(v). We will
bear all fees and expenses attendant to registering the securities,
including only one demand registration right granted by us to the
Representative, issuable on exercise of the warrants other than
underwriting commissions incurred and payable by the holders. The
exercise price and number of shares issuable upon exercise of the
warrants may be adjusted in certain circumstances including in the
event of a stock dividend or our recapitalization, reorganization,
merger or consolidation. However, the warrant exercise price or
underlying shares will not be adjusted for issuances of shares of
common stock at a price below the warrant exercise
price.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Right
of First Refusal</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">From the date of
the executed underwriting agreement until March 31, 2020, the
Representative will have, subject to certain exceptions, an
irrevocable right of first refusal to act as sole investment
banker, sole book-runner and/or sole placement agent, at the
Representative&#x2019;s sole discretion, for each and every future
public and private equity financing, including equity-linked
financings, during such period, for us, or any successor to or any
subsidiary of us, on terms customary for the Representative. The
Representative will have the sole right to determine whether or not
any other broker-dealer shall have the right to participate in any
such offering and the economic terms of any such
participation.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Discretionary
Accounts</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriters do
not intend to confirm sales of the securities offered hereby to any
accounts over which they have discretionary authority.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Other</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">From time to time, certain of the underwriters
and/or their affiliates have provided, and may in the future
provide, various investment banking and other financial services
for us for which</font> services <font style="color: #000000">they
have received and, may in the future receive, customary fees.
&#xA0;In the course of their businesses, the underwriters and their
affiliates may actively trade our securities or loans for their own
account or for the accounts of customers, and, accordingly, the
underwriters and their affiliates may at any time hold long or
short positions in such securities or loans.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Except
for services provided in connection with this offering and our
public offering in May 2019 in which ThinkEquity acted as the lead
underwriter, no underwriter has provided any investment banking or
other financial services to us during the 180-day period preceding
the date of this prospectus supplement and we do not expect to
retain any underwriter to perform any investment banking or other
financial services for at least 90 days after the date of this
prospectus supplement.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-39</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Lock-Up
Agreements</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pursuant to
&#x201C;lock-up&#x201D; agreements, we and our executive officers,
directors and 5% or greater shareholders have agreed, subject to
limited exceptions, without the prior written consent of the
Representative not to directly or indirectly, offer to sell, sell,
pledge or otherwise transfer or dispose of any of our shares of
common stock or securities convertible into or exercisable or
exchangeable for our common stock or any of our other securities
(or enter into any transaction or device that is designed to, or
could be expected to, result in the transfer or disposition by any
person at any time in the future of our securities), enter into any
swap or other derivatives transaction that transfers to another, in
whole or in part, any of the economic benefits or risks of
ownership of our of our shares of common stock or securities
convertible into or exercisable or exchangeable for our common
stock or any of our other securities, make any demand for or
exercise any right or cause to be filed a registration statement,
including any amendments thereto, with respect to the registration
of any of our securities, shares of common stock or securities
convertible into or exercisable or exchangeable for common stock or
any of our other securities or publicly disclose the intention to
do any of the foregoing, subject to customary exceptions, for a
period of 90 days from the date of the pricing of this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">NYSE
American Listing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have applied to
list our Series A Convertible Preferred Stock on the NYSE American
under the symbol &#x201C;YCBDPRA.&#x201D; If the application is
approved, trading of the Series A Convertible Preferred Stock is
expected to begin on October 21, 2019, three business days after
the initial issuance of the Series A Convertible Preferred
Stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Transfer
Agent</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our transfer agent
for our Series A Convertible Preferred Stock is <font style="color: #000000">VStock Transfer, LLC, 18 Lafayette Place,
Woodmere, New York 11598.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Price
Stabilization, Short Positions and Penalty Bids</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In connection with
this offering, the underwriters may engage in transactions that
stabilize, maintain or otherwise affect the price of our Series A
Convertible Preferred Stock. Specifically, the underwriters may
over-allot in connection with this offering by selling more shares
of our Series A Convertible Preferred Stock than are set forth on
the cover page of this prospectus supplement. This creates a short
position in our Series A Convertible Preferred Stock for its own
account. The short position may be either a covered short position
or a naked short position. In a covered short position, the number
of shares of Series A Convertible Preferred Stock over-allotted by
the underwriters is not greater than the number of shares of Series
A Convertible Preferred Stock that they may purchase in the
over-allotment option. In a naked short position, the number of
shares of Series A Convertible Preferred Stock involved is greater
than the number of shares Series A Convertible Preferred Stock in
the over-allotment option. To close out a short position, the
underwriters may elect to exercise all or part of the
over-allotment option. The underwriters may also elect to stabilize
the price of our Series A Convertible Preferred Stock or reduce any
short position by bidding for, and purchasing, Series A Convertible
Preferred Stock in the open market.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The underwriters
may also impose a penalty bid. This occurs when a particular
underwriter or dealer repays selling concessions allowed to it for
distributing shares of Series A Convertible Preferred Stock in this
offering because the underwriter repurchases the shares of Series A
Convertible Preferred Stock in stabilizing or short covering
transactions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Finally, the
underwriters may bid for, and purchase, shares of our Series A
Convertible Preferred Stock in market making transactions,
including &#x201C;passive&#x201D; market making transactions as
described below.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">These activities
may stabilize or maintain the market price of our Series A
Convertible Preferred Stock at a price that is higher than the
price that might otherwise exist in the absence of these
activities. The underwriters are not required to engage in these
activities, and may discontinue any of these activities at any time
without notice. These transactions may be effected on the national
securities exchange on which our shares of Series A Convertible
Preferred Stock are traded, in the over-the-counter market, or
otherwise.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-40</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Passive Market Making</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
connection with the offering, the underwriters may engage in
passive market making transactions in shares of Series&#xA0;A
Convertible Preferred Stock on the NYSE American in accordance with
Rule&#xA0;103 of Regulation&#xA0;M under the Exchange Act during
the period before the commencement of offers or sales of shares of
Series&#xA0;A Convertible Preferred Stock and extending through the
completion of distribution. A passive market maker must display its
bids at a price not in excess of the highest independent bid of the
security. However, if all independent bids are lowered below the
passive market maker&#x2019;s bid, that bid must be lowered when
specified purchase limits are exceeded.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Indemnification</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We have agreed to
indemnify the underwriters against liabilities relating to this
offering arising under the Securities Act and the Exchange Act,
liabilities arising from breaches of some or all of the
representations and warranties contained in the underwriting
agreement, and to contribute to payments that the underwriters may
be required to make for these liabilities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Electronic
Distribution</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">This prospectus supplement in electronic format
may be made availa</font>b<font style="color: #000000">le on
websites or through other online services maintained by one or more
of the underwriters, or by their affiliates. &#xA0;Other than this
prospectus supplement in electronic format, the information on any
underwriters&#x2019; website and any information contained in any
other website maintained by an underwriter is not part of this
prospectus supplement or the registration statement of which this
prospectus supplement is a part, has not been approved and/or
endorsed by us or any underwriter in its capacity as underwriter,
and should not be relied upon by investors.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Selling
Restrictions</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">No action has been
taken in any jurisdiction (except in the United States) that would
permit a public offering of our Series A Convertible Preferred
Stock, or the possession, circulation or distribution of this
prospectus supplement, the accompanying prospectus or any other
material relating to us or our Series A Convertible Preferred Stock
in any jurisdiction where action for that purpose is required.
Accordingly, our Series A Convertible Preferred Stock may not be
offered or sold, directly or indirectly, and none of this
prospectus supplement, the accompanying prospectus or any other
offering material or advertisements in connection with our Series A
Convertible Preferred Stock may be distributed or published, in or
from any country or jurisdiction, except in compliance with any
applicable rules and regulations of any such country or
jurisdiction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
European Economic Area</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In relation to each
Member State of the European Economic Area which has implemented
the Prospectus Directive, each a &#x201C;Relevant Member
State&#x201D;, with effect from and including the date on which the
Prospectus Directive is implemented in that Relevant Member State,
or the &#x201C;Relevant Implementation Date&#x201D;, our securities
will not be offered to the public in that Relevant Member State
prior to the publication of a prospectus in relation to our
securities that has been approved by the competent authority in
that Relevant Member State or, where appropriate, approved in
another Relevant Member State and notified to the competent
authority in that Relevant Member State, all in accordance with the
Prospectus Directive, except that, with effect from and including
the Relevant Implementation Date, an offer of our securities may be
made to the public in that Relevant Member State at any
time:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 24px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">to any legal entity
that is a qualified investor as defined in the Prospectus
Directive; &#xA0; &#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">to fewer than 100
or, if the Relevant Member State has implemented the relevant
provision of the 2010 PD Amending Directive, 150 natural or legal
persons (other than qualified investors as defined in the
Prospectus Directive), as permitted under the Prospectus Directive,
subject to obtaining the prior consent of the manager for any such
offer; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">in any other
circumstances which do not require the publication by the issuer of
a prospectus pursuant to Article 3(2) of the Prospectus Directive,
provided that no such offer of the securities shall require the
issuer or any underwriter to publish a prospectus pursuant to
Article 3 of the Prospectus Directive.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0; <font style="font-size: 13px; font-family: Times New Roman"><br>
</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">For the purposes of
this provision, the expression an &#x201C;offer of securities to the
public&#x201D; in relation to any securities in any Relevant Member
State means the communication in any form and by any means of
sufficient information on the terms of the offer and securities to
be offered so as to enable an investor to decide to purchase or
subscribe securities, as the same may be varied in that Relevant
Member State by any measure implementing the Prospectus Directive
in that Relevant Member State and the expression &#x201C;Prospectus
Directive&#x201D; means Directive 2003/71/EC (and amendments
thereto, including the 2010 PD Amending Directive, to the extent
implemented in the Relevant Member State), and includes any
relevant implementing measure in each Relevant Member State and the
expression &#x201C;2010 PD Amending Directive&#x201D; means Directive
2010/73/EU.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-41</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
United Kingdom</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">In the United
Kingdom, this document is being distributed only to, and is
directed only at, and any offer subsequently made may only be
directed at persons who are &#x201C;qualified investors&#x201D; (as
defined in the Prospectus Directive) (i) who have professional
experience in matters relating to investments falling within
Article 19 (5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005, as amended (the Order), and/or
(ii) who are high net worth companies (or persons to whom it may
otherwise be lawfully communicated) falling within Article 49(2)(a)
to (d) of the Order (all such persons together, the relevant
persons). This document must not be acted on or relied on in the
United Kingdom by persons who are not relevant persons. In the
United Kingdom, any investment or investment activity to which this
document relates is only available to, and will be engaged in with,
relevant persons.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Canada</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The offering of our
Series A Convertible Preferred Stock in Canada is being made on a
private placement basis in reliance on exemptions from the
prospectus requirements under the securities laws of each
applicable Canadian province and territory where our Series A
Convertible Preferred Stock may be offered and sold, and therein
may only be made with investors that are purchasing, or deemed to
be purchasing, as principal and that qualify as both an
&#x201C;accredited investor&#x201D; as such term is defined in
National Instrument 45-106 <font style="font-style: italic">Prospectus Exemptions</font> or subsection
73.3(1) of the <font style="font-style: italic">Securities
Act</font> (Ontario) and as a &#x201C;permitted client&#x201D; as
such term is defined in National Instrument 31-103 <font style="font-style: italic">Registration Requirements, Exemptions and
Ongoing Registrant Obligations.</font> Any offer and sale of our
Series A Convertible Preferred Stock in any province or territory
of Canada may only be made through a dealer that is properly
registered under the securities legislation of the applicable
province or territory wherein our Series A Convertible Preferred
Stock is offered and/or sold or, alternatively, where such
registration is not required.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Any resale of our
Series A Convertible Preferred Stock by an investor resident in
Canada must be made in accordance with applicable Canadian
securities laws, which require resales to be made in accordance
with an exemption from, or in a transaction not subject to,
prospectus requirements under applicable Canadian securities laws.
These resale restrictions may under certain circumstances apply to
resales of the Series A Convertible Preferred Stock outside of
Canada.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Securities
legislation in certain provinces or territories of Canada may
provide a purchaser with remedies for rescission or damages if this
prospectus (including any amendment thereto) contains a
misrepresentation, provided that the remedies for rescission or
damages are exercised by the purchaser within the time limit
prescribed by the securities legislation of the purchaser&#x2019;s
province or territory. The purchaser should refer to any applicable
provisions of the securities legislation of the purchaser&#x2019;s
province or territory for particulars of these rights or consult
with a legal advisor.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pursuant to section
3A.3 (or, in the case of securities issued or guaranteed by the
government of a non-Canadian jurisdiction, section 3A.4) of
National Instrument 33-105 <font style="font-style: italic">Underwriting Conflicts</font> (&#x201C;NI
33-105&#x201D;), the underwriters are not required to comply with
the disclosure requirements of NI 33-105 regarding underwriter
conflicts of interest in connection with this
offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Upon receipt of
this prospectus supplement, each Qu&#xE9;bec investor hereby
confirms that it has expressly requested that all documents
evidencing or relating in any way to the sale of the securities
described herein (including for greater certainty any purchase
confirmation or any notice) be drawn up in the English language
only. <font style="font-style: italic">Par la r&#xE9;ception de ce
document, chaque investisseur qu&#xE9;becois confirme par les
pr&#xE9;sentes qu&#x2019;il a express&#xE9;ment exig&#xE9; que tous
les documents faisant foi ou se rapportant de quelque mani&#xE8;re
que ce soit &#xE0; la vente des valeurs mobili&#xE8;res
d&#xE9;crites aux pr&#xE9;sentes (incluant, pour plus de certitude,
toute confirmation d&#x2019;achat ou tout avis) soient
r&#xE9;dig&#xE9;s en anglais seulement</font>.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-42</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
LEGAL MATTERS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Pearlman Law Group
LLP, Fort Lauderdale, Florida will provide us with an opinion as to
certain legal matters in connection with the securities offered
hereby. <font style="color: #000000">Certain matters under North
Carolina law will be passed upon for us by the Timothy B. Gavigan,
PLLC. Gracin &amp; Marlow, LLP, New York, New York</font> is
representing the underwriters in this offering.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
EXPERTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
consolidated balance sheets as of September 30, 2018 and 2017 and
the related consolidated statements of operations, comprehensive
income (loss), shareholders&#x2019; equity and cash flows for the
fiscal years ended September 30, 2018 and 2017 incorporated by
reference in the registration statement of which this prospectus
supplement is a part have been audited by Cherry Bekaert LLP,
independent registered public accounting firm, as indicated in
their report with respect thereto, and have been so included in
reliance upon the report of such firm given on their authority as
experts in accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Cherry Bekaert LLP, independent registered public
accounting firm, as indicated in their report with respect
thereto,</font> has audited the consolidated financial statements
of Cure Based Development, LLC as of August 31, 2018 and for the
periods from January 1, 2018 to August 31, 2018 and from August 3,
2017 (inception) to December 31, 2017, included in our Current
Report on Form 8-K filed with the SEC on December 20, 2018, as
stated in their report thereon, dated November 27, 2018, included
therein, which is incorporated by reference herein. Such
consolidated financial statements are incorporated by reference in
reliance upon the report of such firm given upon their authority as
experts in accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">WHERE
YOU CAN FIND MORE INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">We file annual,
quarterly and other reports, proxy statements and other information
with the SEC. The SEC maintains a website at <font style="color: #0000ff; text-decoration: underline">www.sec.gov</font>
that contains reports, proxy and information statements, and other
information regarding issuers such as our company that file
electronically with the SEC.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our website address
is <font style="color: #0000ff; text-decoration: underline">www.cbdmd.com</font>.
We make available free of charge, through the Investor section of
our website, annual reports on Form 10-K, quarterly reports on Form
10-Q and current reports on Form 8-K and amendments to those
reports filed or furnished pursuant to Section 13(a) or 15(d) of
the Exchange Act as soon as reasonably practicable after we
electronically file such material with, or furnish it to, the
SEC.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-43</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
INFORMATION INCORPORATED BY REFERENCE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
SEC allows us to incorporate by reference the information we file
with them, which means that we can disclose important information
to you by referring you to those documents. The information
incorporated by reference is considered to be part of this
prospectus supplement, and later information filed with the
Securities and Exchange Commission will update and supersede this
information. We incorporate by reference the documents listed below
that we have previously filed with the SEC, except that information
furnished under Item 2.02 or Item 7.01 of our Current Reports on
Form 8-K or any other filing where we indicate that such
information is being furnished and not filed under the Exchange
Act, is not deemed to be filed and not incorporated by reference
herein:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018 as filed on December 12, 2018;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Quarterly Report on Form 10-Q/A for the period ended December 31,
2018 as filed on April 26, 2019;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Quarterly Report on Form 10-Q for the period ended March 31, 2019
as filed on May 15, 2019;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Quarterly Report on Form 10-Q for the period ended June 30, 2019 as
filed on August 14, 2019;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Current Reports on Forms 8-K and 8-K/A as filed on October 3, 2018,
December 4, 2018, December 20, 2018, December 28, 2018, January 11,
2019, February 22, 2019, March 21, 2019, April 18, 2019, April 19,
2019, April 29, 2019, May 1, 2019, May 10, 2019, May 14, 2019, May
15, 2019, July 1, 2019, September 20, 2019 and September 27,
2019;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
definitive proxy statement on Schedule 14A as filed on March 21,
2019; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
description of our common stock contained in our Registration
Statement on Form 8-A as filed with the SEC on November 15, 2017
and any further amendment or report filed hereafter for the purpose
of updating such description.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
also incorporate by reference into this prospectus supplement
additional documents that we may file with the SEC under Sections
13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
completion or termination of the offering, including all such
documents we may file with the SEC after the date of this
prospectus supplement and before the completion of this offering of
the Series A Convertible Preferred Stock included in this
prospectus supplement, the initial registration statement and prior
to the effectiveness of the registration statement, but excluding
any information deemed furnished and not filed with the SEC. Any
statements contained in a previously filed document incorporated by
reference into this prospectus supplement is deemed to be modified
or superseded for purposes of this prospectus supplement to the
extent that a statement contained in this prospectus supplement, or
in a subsequently filed document also incorporated by reference
herein, modifies or supersedes that statement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus supplement may contain information that updates,
modifies or is contrary to information in one or more of the
documents incorporated by reference in this prospectus supplement.
You should rely only on the information incorporated by reference
or provided in this prospectus supplement. We have not authorized
anyone else to provide you with different information. You should
not assume that the information in this prospectus supplement is
accurate as of any date other than the date of this prospectus
supplement or the date of the documents incorporated by reference
in this prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
will provide to each person, including any beneficial owner, to
whom this prospectus supplement is delivered, upon written or oral
request, at no cost to the requester, a copy of any and all of the
information that is incorporated by reference in this prospectus
supplement. You may request a copy of these filings, at no cost to
you, by telephoning us at (704) 445-3060 or by writing us at the
following address:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">cbdMD,
Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">8845
Red Oak Boulevard</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Charlotte,
NC 28217</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Attention:
Investor Relations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may also access the documents incorporated by reference in this
prospectus supplement through our website at www.cbdmd.com. The
reference to our website is an inactive textual reference only and,
except for the specific incorporated documents listed above, no
information available on or through our website shall be deemed to
be incorporated in this prospectus supplement, the accompanying
prospectus or the registration statement of which it forms a
part.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">S-44</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #ff0000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The information in this prospectus is not complete and may be
changed. We may not sell these securities until the registration
statement filed with the Securities and Exchange Commission is
effective. This prospectus is not an offer to sell these securities
and we are not soliciting offers to buy these securities in any
state where the offer or sale is not permitted.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PROSPECTUS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5007.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
$100,000,000</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Level Brands, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
COMMON STOCK</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PREFERRED STOCK</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
WARRANTS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
UNITS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">We may offer and
sell, from time to time in one or more offerings, any combination
of common stock, preferred stock, warrants or units having a
maximum aggregate offering price of $100,000,000. When we decide to
sell a particular class or series of securities, we will provide
specific terms of the offered securities in a prospectus
supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">The prospectus
supplement may also add, update or change information contained in
or incorporated by reference into this prospectus. However, no
prospectus supplement shall offer a security that is not registered
and described in this prospectus at the time of its effectiveness.
You should read this prospectus and any prospectus supplement, as
well as the documents incorporated by reference or deemed to be
incorporated by reference into this prospectus, carefully before
you invest.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">This prospectus may
not be used to offer or sell our securities unless accompanied by a
prospectus supplement relating to the offered
securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our common stock is
listed on the NYSE American under the symbol &#x201C;LEVB.&#x201D;
The last reported sale price of our common stock on April 3, 2019
was $4.63 per share.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">The aggregate
market value of our outstanding common stock held by non-affiliates
is $51,390,150 based on 10,170,356 shares of common stock
outstanding, of which 7,732,983 shares are held by non-affiliates,
and a per share value of $5.23 based on the closing price of our
common stock on the NYSE American on February 19, 2019. We have not
offered any securities pursuant to General Instruction I.B.6 of
Form S-3 during the prior 12 calendar month period that ends on and
includes the date of this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">These securities
may be sold directly by us, through dealers or agents designated
from time to time, to or through underwriters or through a
combination of these methods. See &#x201C;Plan of
Distribution&#x201D; beginning on page 18. We may also describe the
plan of distribution for any particular offering of our securities
in a prospectus supplement. If any agents, underwriters or dealers
are involved in the sale of any securities in respect of which this
prospectus is being delivered, we will disclose their names and the
nature of our arrangements with them in a prospectus supplement.
The net proceeds we expect to receive from any such sale will also
be included in a prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Investing
in our securities involves various risks. See &#x201C;Risk
Factors&#x201D; on page 5 for more information on these risks.
Additional risks, if any, will be described in the prospectus
supplement related to a potential offering under the heading
&#x201C;Risk Factors&#x201D;. You should review that section of the
related prospectus supplement for a discussion of matters that
investors in such securities should consider.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Neither
the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities, or
passed upon the adequacy or accuracy of this prospectus or any
accompanying prospectus supplement. Any representation to the
contrary is a criminal offense.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">The date of this
prospectus is April 9, 2019</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">1</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
ABOUT THIS PROSPECTUS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus is part of a registration statement on Form S-3 that we
filed with the Securities and Exchange Commission utilizing a
&#x201C;shelf&#x201D; registration, or continuous offering, process.
Under the shelf registration process, we may issue and sell any
combination of the securities described in this prospectus in one
or more offerings with a maximum offering price of up to
$100,000,000.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus provides you with a general description of the
securities we may offer. Each time we sell securities under this
shelf registration, we will provide a prospectus supplement that
will contain certain specific information about the terms of that
offering, including a description of any risks related to the
offering, if those terms and risks are not described in this
prospectus. A prospectus supplement may also add, update or change
information contained in this prospectus. If there is any
inconsistency between the information in this prospectus and the
applicable prospectus supplement, you should rely on the
information in the prospectus supplement. The registration
statement we filed with the Securities and Exchange Commission
includes exhibits that provide more details on the matters
discussed in this prospectus. You should read this prospectus and
the related exhibits filed with the Securities and Exchange
Commission and the accompanying prospectus supplement together with
additional information described under the headings
&#x201C;Available Information&#x201D; and &#x201C;Information
Incorporated by Reference&#x201D; before investing in any of the
securities offered.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may sell securities to or through underwriters or dealers, and also
may sell securities directly to other purchasers or through agents.
To the extent not described in this prospectus, the names of any
underwriters, dealers or agents employed by us in the sale of the
securities covered by this prospectus, the principal amounts or
number of shares or other securities, if any, to be purchased by
such underwriters or dealers and the compensation, if any, of such
underwriters, dealers or agents will be set forth in the
accompanying prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
information in this prospectus is accurate as of the date on the
front cover. Information incorporated by reference into this
prospectus is accurate as of the date of the document from which
the information is incorporated. You should not assume that the
information contained in this prospectus is accurate as of any
other date.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Unless the context otherwise indicates, when used
herein, the terms &#x201C;Level Brands,&#x201D; &#x201C;we,&#x201D;
&#x201C;us&#x201D;, &#x201C;our&#x201D; and similar terms refer to
Level Brands, Inc., a North Carolina corporation formerly known as
Level Beauty Group, Inc., and our subsidiaries</font> <font style="color: #000000">cbdMD, LLC, a North Carolina limited liability
company which we refer to as &#x201C;cbdMD&#x201D;,</font> Beauty and
Pinups, LLC, a North Carolina limited liability company which we
refer to as &#x201C;Beauty &amp; Pin-Ups&#x201D;, I | M 1, LLC, a
California limited liability company, which we refer to as
&#x201C;I&#x2019;M1&#x201D;, Encore Endeavor 1 LLC, a California
limited liability company which we refer to as &#x201C;EE1,&#x201D;
Level H&amp;W, LLC, a North Carolina limited liability company
which we refer to as &#x201C;Level Health &amp; Wellness&#x201D;,
AcqCo, LLC, a newly organized North Carolina limited liability
company and cbdMD LLC, a newly organized North Carolina limited
liability company. In addition, &#x201C;fiscal 2017&#x201D; refers to
the year ended September 30, 2017, "fiscal 2018" refers to the year
ended September 30, 2018, "fiscal 2019" refers to the year ending
September 30, 2019.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
AVAILABLE INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
file annual, quarterly and other reports, proxy statements and
other information with the Securities and Exchange Commission. You
may read and copy any materials that we file at the Securities and
Exchange Commission&#x2019;s Public Reference Room, 100 F Street,
N.E., Washington, D.C. 20549. You may obtain information on the
operation of the Public Reference Room by calling the Securities
and Exchange Commission at 1-800-SEC-0330. The Securities and
Exchange Commission also maintains a website at www.sec.gov that
contains reports, proxy and information statements, and other
information regarding issuers such as our company that file
electronically with the Securities and Exchange
Commission.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
have filed a registration statement under the Securities Act of
1933 with the Securities and Exchange Commission with respect to
the securities to be sold by pursuant to this prospectus. This
prospectus has been filed as part of the registration statement.
This prospectus does not contain all of the information set forth
in the registration statement because certain parts of the
registration statement are omitted in accordance with the rules and
regulations of the Securities and Exchange Commission. You should
refer to the registration statement, including the exhibits, for
further information about us and the securities being offered
pursuant to this prospectus. Statements in this prospectus
regarding the provisions of certain documents filed with, or
incorporated by reference in, the registration statement are not
necessarily complete and each statement is qualified in all
respects by that reference.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
Internet address is www.levelbrands.com. We make available free of
charge, through the investor section of our website, annual reports
on Form 10-K, quarterly reports on Form 10-Q and current reports on
Form 8-K and amendments to those reports filed or furnished
pursuant to Section 13(a) or 15(d) of the Securities Exchange Act
of 1934 as soon as reasonably practicable after we electronically
file such material with, or furnish it to, the Securities and
Exchange Commission.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">2</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
OUR COMPANY</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Level Brands
strives to be an innovative licensing, marketing and brand
management company with a focus on lifestyle-based products. We
champion a bold, unconventional image, and social consciousness for
our company and our brands. Working closely with our Chairman
Emeritus and Chief Brand Strategist, Kathy Ireland, the Chairman,
CEO and Chief Designer of <font style="font-style: italic">kathy
ireland</font>&#xAE; Worldwide, we seek to secure strategic
licenses and joint venture partnerships for our brands, as well as
to grow the portfolio of brands through strategic
acquisitions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">We operate our
business in four business units, including:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px;">
<table cellpadding="0" cellspacing="0" style="text-align: left; font-family: inherit; font-size: inherit;text-align: left; width: 100%;">
<tr>
<td rowspan="3" style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5008.jpg"></div>
</td>
<td rowspan="3" style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td rowspan="3" style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Level H&amp;W was established in September
2017</font> and has an exclusive license to the <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness&#x2122; brand. Its goal is to create a brand which will
include a wide variety of licensed products and services, targeted
to both Baby Boomers as well as millennials. This unit began
operating in fiscal 2018.</font></font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5009.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Founded in early
2017 <font style="color: #000000">and first conceptualized
by</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide</font>,
I'M1 is a men&#x2019;s lifestyle brand established to capitalize on
potentially lucrative licensing and co-branding opportunities with
products focused on millennials.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5010.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Also founded in
2017, EE1 was established to serve as a producer and marketer of
experiential entertainment including recordings, film, TV, web and
live events, and entertainment experiences. EE1 also provides brand
management services including creative development and marketing,
brand strategy, and distribution support.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td colspan="2" style="vertical-align: top; width: 24%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5011.jpg"></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">"<font style="font-style: italic">Beauty belongs to
everyone</font>"</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Beauty &amp;
Pin-Ups, our first business unit is a professional hair care line
with a social conscience and launched its products in 2015. We
offer quality hair care products, including shampoos, conditioners,
styling aides and a patented styling tool, through retailers and
online outlets and are expanding into licensing
opportunities.</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-style: italic">&#xA0;</font> &#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr><tr>
<td style="vertical-align: top; width: 24%">
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5012.jpg"></div>
</td>
<td style="vertical-align: top; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
<td style="vertical-align: top; width: 75%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">Our newest business
unit was established in December 2018 in connection with the
mergers with Cure Based Development LLC. In conjunction with the
mergers, we acquired the cbdMD brand. cbdMD produces <font style="color: #222222; background-color: #ffffff">and distributes</font>
various high-grade, premium cannabidiol ("CBD") products under the
cbdMD brand, including: tinctures, capsules, gummies, bath bombs,
vape oils, topical creams and animal treats and
oils.&#xA0;</font></div>
</td>
<td style="vertical-align: middle; width: 1%">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</td>
</tr></table>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our business model
is designed with the goal of maximizing the value of our brands
through entry into license agreements with partners that are
responsible for the design, manufacturing and distribution of our
licensed products. We promote our brands across multiple channels,
including print, television and social media. We believe that this
&#x201C;omnichannel&#x201D; (or multi-channel) approach, which we
expect will allow our customers to interact with each of our
brands, in addition to the products themselves, will be critical to
our success.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">3</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">Corporate
information</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
company was formed under the laws of the state of North Carolina in
March 2015 under the name Level Beauty Group, Inc. In November 2016
we changed the name of our company to Level Brands,
Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Our principal executive offices are located at
4521 Sharon Road, Suite 450, Charlotte, NC 28211. Our telephone
number at this location is (704</font>) 362-6286. T<font style="color: #000000">he information which appears on our website at
www.levelbrands.com is not part of this
prospectus.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING
INFORMATION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">This prospectus
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. These
forward-looking statements are subject to known and unknown risks,
uncertainties and other factors which may cause actual results,
performance or achievements to be materially different from any
future results, performance or achievements expressed or implied by
such forward-looking statements. These forward-looking statements
were based on various factors and were derived utilizing numerous
assumptions and other factors that could cause our actual results
to differ materially from those in the forward-looking statements.
These factors include, but are not limited to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
successfully integrate the operations of Cure Based Development
following the mergers;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our material
dependence on our relationships with <font style="font-style: italic">kathy ireland&#xAE;</font> Worldwide and
certain of its affiliates;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the significant
dilution to our shareholders of the issuance of the shares of our
common stock as the consideration for the mergers;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our limited
operating history;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the limited
operating histories of our subsidiaries;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our history of
losses;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the evolving and
highly competitive market in which cbdMD operates;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">laws and
regulations impacting cbdMD</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with any failure by us to maintain an effective system of internal
control over financial reporting;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the terms of
various agreements with <font style="font-style: italic">kathy
ireland&#xAE;</font> Worldwide and possible impacts on our
management's abilities to make certain decisions regarding the
operations of our company;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our dependence on
consumer spending patterns;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our history on
reliance on sales from a limited number of customers, including
related parties;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our failure to effectively promote our brands;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
identify and successfully acquire additional brands and
trademarks;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the operating
agreements of our I'M1 and EE1 subsidiaries;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the accounting
treatment of securities we accept as partial compensation for
services;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
liquidate securities we accept as partial compensation for services
and the possible impact of the Investment Company Act of
1940;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the possible need
to raise additional capital in the future;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">terms of the
contracts with third parties in each of our divisions;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">possible conflicts
of interest with <font style="font-style: italic">kathy
ireland&#xAE;</font> Worldwide;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">possible litigation
involving our licensed products;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
effectively compete and our dependence on market acceptance of our
brands;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the lack of
long-term contracts for the purchase of products from our
professional products division;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">our ability to
protect our intellectual property;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">additional
operational risks associated with our professional products
division;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with developing a liquid market for our common stock and possible
future volatility in its trading price;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with any future failure to satisfy the NYSE American LLC continued
listing standards;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">dilution to our
shareholders from the exercise of outstanding options and warrants
and the vesting of restricted stock awards;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our status as an emerging growth company;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with control by our executive officers, directors and
affiliates;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with unfavorable research reports;</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with our status as a public company; and</font></div>
</div>
</div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">risks associated
with articles of incorporation, bylaws and North Carolina
law.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Most of these
factors are difficult to predict accurately and are generally
beyond our control. You should consider the areas of risk described
in connection with any forward-looking statements that may be made
herein. Readers are cautioned not to place undue reliance on these
forward-looking statements and readers should carefully review our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018 as filed with the Securities and Exchange Commission on
December 12, 2018, including the risk factors described therein,
our Quarterly Report on Form 10-Q for the period ended December 31,
2018 as filed with the Securities and Exchange Commission on
February 14, 2019, as well as our other filings with the Securities
and Exchange Commission. Except for our ongoing obligations to
disclose material information under the Federal securities laws, we
undertake no obligation to release publicly any revisions to any
forward-looking statements, to report events or to report the
occurrence of unanticipated events. These forward-looking
statements speak only as of the date of this prospectus, and you
should not rely on these statements without also considering the
risks and uncertainties associated with these statements and our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">4</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISK FACTORS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">An
investment in our securities involves a significant degree of risk.
You should not invest in our securities unless you can afford to
lose your entire investment. You should consider carefully the
following risk factors and other information in this prospectus
before deciding to invest in our securities. If any of the
following risks and uncertainties develops into actual events, our
business, financial condition or results of operations could be
materially adversely affected and you could lose your entire
investment in our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR OVERALL BUSINESS</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THERE ARE NO ASSURANCES WE WILL SUCCESSFULLY INTEGRATE THE CURE
BASED DEVELOPMENT BUSINESSES INTO OUR BUSINESS, WHICH WOULD
ADVERSELY AFFECT THE COMBINED COMPANY&#x2019;S FUTURE
RESULTS.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In December 2018 we
closed the mergers with Cure Based Development. The success of this
transaction will depend, in large part, on the ability of the
combined company to realize anticipated benefits from combining the
businesses of the companies. The failure to successfully integrate
and to successfully manage the challenges presented by the
integration process may result in the failure to achieve some or
all the anticipated benefits of the transaction, which may have a
material adverse effect on our operations and financial condition.
Potential difficulties that may be encountered in the integration
process include the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">the potential
disruption of, or the loss of momentum in, each company&#x2019;s
ongoing business;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">using the combined
company&#x2019;s assets efficiently to develop the business of the
combined company;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">potential unknown
or currently unquantifiable liabilities associated with the mergers
and the operations of the combined company;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">potential unknown
and unforeseen expenses and delays associated with the mergers and
the possibility that integration costs may be
material;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">performance
shortfalls at one or both companies as a result of the diversion of
management&#x2019;s attention caused by integrating the
companies&#x2019; operations;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">necessary changes
in the operations and culture of the acquired company post-closing
in order to accommodate the changes from a privately-held company
with a limited operating history to a subsidiary of a public
company;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">complexities
associated with managing the combined businesses, including
difficulty addressing possible differences in corporate cultures
and management philosophies;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">significant
increases in our operating expenses; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">additional
business, financial and operating risks we have yet to
identify.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">There are no
assurances that the mergers will ultimately result in the
realization of the anticipated economic benefits and other expected
synergies, or that such anticipated economic benefits and other
expected synergies will take longer than excepted to be realized.
If we are unable to fully realize the perceived benefits from the
mergers on a timely basis, we may be required to in the future
impair some or all of the goodwill associated with this transaction
which would materially adversely impact our results of operations
in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">5</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
CBDMD LLC HAS A LIMITED OPERATING HISTORY THAT IMPEDES OUR ABILITY
TO EVALUATE ITS POTENTIAL FUTURE PERFORMANCE AND
STRATEGY.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our wholly-owned
subsidiary, cbdMD, succeeded to the operations of Cure Based
Development following the closing of the mergers in December 2018.
We formed cbdMD in connection with the mergers and it had no
operating history prior to the mergers. Cure Based Development was
formed in 2017 and did not begin reporting any meaningful revenues
until mid-2018. Its limited operating history makes it difficult
for us to evaluate cbdMD&#x2019;s future business prospects and make
decisions based on estimates of its future performance. To address
these risks and uncertainties, we must do the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">successfully
execute our business strategy to offer the highest quality CBD in
the industry;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">introduce new,
differentiated botanical products;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">respond to
competitive business developments;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">effectively and
efficiently market and sell our line of CBD products;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">improve the
distribution of our CBD products; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="font-size: 13px; font-family: Times New Roman">attract, integrate,
retain and motivate qualified personnel.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Our business
strategy may not be successful and we may not successfully address
these risks. In the event that we do not successfully address these
risks, our business, prospects, financial condition and results of
operations may be materially and adversely affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THE MARKET FOR CBD PRODUCTS IS HIGHLY COMPETITIVE, AND IF WE ARE
UNABLE TO COMPETE EFFECTIVELY AGAINST OUR COMPETITORS, OUR BUSINESS
AND OPERATING RESULTS COULD BE ADVERSELY AFFECTED.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">cbdMD operates in a
competitive and rapidly evolving market. While we believe that the
industry is fragmented at the present time, there are numerous
competitors, including Green Roads, PlusCBD, and Select CBD in the
retail of CBD-based products, and in the digital selling space
Diamond CBD, CBDistillery, and Lazarus Naturals, some of whom are
larger and have a longer operating history and may have greater
financial resources than cbdMD does. Moreover, we expect
competition in the CBD industry to intensify following the passage
of the Farm Bill in December 2018. In the future we may also face
competition with larger, better capitalized companies who elect to
enter the market given the relatively low barriers to entry. cbdMD
believes that it competes effectively with its competitors because
of the quality of its products and customer service. However, no
assurance can be given that cbdMD will effectively compete with its
existing or future competitors. In addition, competition may drive
the prices of our products down, which may have a materially
adverse effect on our results of operations in future
periods.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
LAWS AND REGULATIONS AFFECTING OUR INDUSTRY ARE EVOLVING UNDER THE
FARM BILL, FDA AND OTHER REGULATORY AUTHORITIES AND CHANGES TO ANY
REGULATION MAY MATERIALLY EFFECT OUR CBD OPERATIONS.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In conjunction with
the enactment of the Farm Bill, the United States Food and Drug
Administration (&#x201C;FDA&#x201D;) released a statement about the
status of CBD as a nutritional supplement, and the agency&#x2019;s
actions in the short term with regards to CBD will guide the
industry. The statement noted that the Farm Bill explicitly
preserved the FDA&#x2019;s authority to regulate products containing
cannabis or cannabis-derived compounds under the Federal Food,
Drug, and Cosmetic Act (FD&amp;C Act) and Section 351 of the Public
Health Service Act. As a nutritional supplement manufacturer, cbdMD
LLC is also striving to meet or exceed the FDAs Good Manufacturing
Practice (GMP) guidelines. Any difficulties in compliance with
existing government regulation could increase our operating costs
and adversely impact our results of operations in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">In addition, as a
result of the Farm Bill&#x2019;s recent passage, we expect that
there will be a constant evolution of laws and regulations
affecting the CBD industry which could affect cbdMD&#x2019;s
operations. Local, state and federal hemp laws and regulations may
be broad in scope and subject to changing interpretations. These
changes may require us to incur substantial costs associated with
legal and compliance fees and ultimately require us to alter our
business plan. Furthermore, violations of these laws, or alleged
violations, could disrupt our business and result in a material
adverse effect on our operations. In addition, we cannot predict
the nature of any future laws, regulations, interpretations or
applications, and it is possible that regulations may be enacted in
the future that will be directly applicable to our
business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">6</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
THE ISSUANCES OF THE SHARES OF OUR COMMON STOCK TO THE CURE BASED
DEVELOMENT MEMBERS WILL SIGNIFICATLY DILUTE OUR EXISTING
SHAREHOLDERS. WE ARE REQUIRED TO MEET THE INITIAL LISTING STANDARDS
OF THE NYSE AMERICAN IN CONNECTION WITH SUCH
ISSUANCES.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">Upon the terms set
forth in the merger agreement, on the closing date the members of
Cure Based Development received contractual rights to receive
15,250,000 shares of our common stock, representing approximately
60% of our outstanding common stock following such issuance, as the
consideration for the mergers. The merger agreement also provides
that we may issue up to an additional 15,250,000 shares of our
common stock as part of the merger consideration upon the
satisfaction of certain aggregate net revenue criteria by cbdMD
within 60 months following the closing date. As of the closing
date, there were 10,095,396 shares of our common stock issued and
outstanding. Our ability to issue these shares must be approved by
our shareholders at our upcoming 2019 annual meeting of
shareholders in accordance with the rules and regulations of NYSE
American. Assuming the approval of such issuances at the
shareholder meeting, the issuance of the first 15,250,000 shares,
but giving effect to no other change to the number of shares of our
common stock issued and outstanding or the possible issuance of
additional 15,250,000 shares in future periods, the members of Cure
Based Development would own 60.2% of our then outstanding shares of
common stock. Therefore, the ownership and voting rights of our
existing shareholders will be proportionally reduced.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Kathy
Ireland is not an officer or director of our company. We are
materially dependent upon our relationships with kathy
ireland&#xAE; Worldwide and certain of its affiliates. If these
advisory agreements or license rights should be terminated or
expire, we would be deprived of the services and our business could
be materially adversely impacted</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">While affiliates of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide are
minority owners of both I&#x2019;M1 and EE1, the terms of the
operating agreements for those subsidiaries do not require them to
provide any services to us. We have entered into a non-exclusive
advisory agreement with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide, as
amended, which expires in February 2025 under which we engaged it
to provide various consulting and advisory services to us. Ms.
Ireland serves in the non-executive role of Chairman Emeritus and
Chief Brand Strategist to us under this agreement. Ms. Ireland is
not a member of our management or board of directors, the title
Chairman Emeritus is an honorary title and she is not a founder or
co-founder of our company. Ms. Ireland provides services to us
solely under the terms of the non exclusive advisory agreement. We
have also entered into advisory agreements with additional
affiliates of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide,
including Messrs. Roseberry, Carrasco, Meharey and Mendoza,
pursuant to which they provide various management and advisory
services to us, including key operational roles at I&#x2019;M1 and
EE1. These agreements will expire in February 2019 and at that
point extend on a month to month basis unless cancelled by either
party. None of these services are provided on an exclusive basis,
each of these individuals may have a conflict of interest in that
they have a long term relationship with Kathy Ireland and have
derived substantial income from</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide and
there is no minimum number of hours which are required to be
devoted to us. In addition we have obtained a royalty free right to
license the intellectual property related to</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness. Our business model is materially dependent upon our
continued relationship with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide, Ms.
Ireland and her affiliates, including Messrs. Roseberry, Carrasco,
Meharey and Mendoza. If we should lose access to those
relationships or if the reputation of Ms. Ireland and/or</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide were to
be damaged, our results would suffer and there are no assurances we
would be able to continue to operate our company and develop our
brands as presently planned.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Our limited operating history does not afford investors a
sufficient history on which to base an investment
decision.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Level Brands was formed in March 2015. Until
fiscal 2017, our net sales were solely from our products division.
We began reporting revenues from our licensing division and our
entertainment division during the second quarter of fiscal 2017. In
September 2017, we entered into wholesale license agreements for
three new brands, including</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness, a newly created brand. There are no assurances we will be
successful in generating any significant net sales in future
periods based upon these new agreements. Our operations are subject
to all the risks inherent in the establishment of a new business
enterprise. The likelihood of success must be considered in light
of the problems, expenses, difficulties, complications and delays
that are frequently encountered in a newly-formed company. There
can be no assurance that at this time that we will successfully
implement our business plan, operate profitably or will have
adequate working capital to meet our obligations as they become
due. Prospective investors must consider the risks and difficulties
frequently encountered by early stage companies, particularly in
rapidly evolving markets. We cannot be certain that our business
strategy will be successful or that we will successfully address
these risks. In the event that we do not successfully address these
risks, our business, prospects, financial condition, and results of
operations could be materially and adversely affected and we may
not have the resources to continue or expand our business
operations.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Our subsidiaries I&#x2019;M1, EE1 and Level H&amp;W are new entities
with a limited operating history and we recently entered into a
license agreement licensing the rights to certain intellectual
property related to kathy ireland &#xAE; Health &amp; Wellness, a
newly created brand with no previous operating history, which does
not afford investors a sufficient history on our company which to
base an investment decision.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">I&#x2019;M1, EE1, and Level H&amp;W are entities
formed in September 2016, March 2016, and September 2017
respectively. We acquired membership interests in I&#x2019;M1 and
EE1 in January 2017. In September 2017 we entered into an exclusive
license agreement to license the trademark and intellectual
property rights for</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness, a newly created brand with no previous operations. All of
these entities are in the early stages of their businesses and we
began reporting revenues from I&#x2019;M1 and EE1 operations in the
second quarter of fiscal 2017 and reported revenues from Level
H&amp;W in the second quarter of fiscal 2018. Our operations are
subject to all the risks inherent in the establishment of a new
business enterprise. The likelihood of success must be considered
in light of the problems, expenses, difficulties, complications and
delays that are frequently encountered in a newly-formed company.
There can be no assurance that at this time that we will operate
profitably or will have adequate working capital to meet our
obligations as they become due. Prospective investors must consider
the risks and difficulties frequently encountered by early stage
companies, particularly in rapidly evolving markets. We cannot be
certain that our business strategy will be successful or that we
will successfully address these risks. In the event that we do not
successfully address these risks, our business, prospects,
financial condition, and results of operations could be materially
and adversely affected and we may not have the resources to
continue or expand our business operations.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">7</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">&#xA0;</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We have a
history of losses and there are no assurances we will report
profitable operations in future periods</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
reported net losses to common shareholders of $584,385, $412,075
and $1,738,734 for the first quarter of fiscal 2019, fiscal 2018
and fiscal 2017, respectively. Until such time, if ever, that we
are successful in generating profits which are sufficient to pay
our operating expenses it is likely we will continue to report
losses in future periods. Further, historically our revenues have
been attributable to sales from our products division and we did
not begin reporting revenues from either our licensing division or
our entertainment division until the second quarter of fiscal 2017.
There are no assurances we will generate substantial revenues from
the new businesses or that we will ever generate sufficient
revenues to report profitable operations or a net
profit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">The terms
of the various agreements between our company and kathy
ireland&#xAE; Worldwide contain termination provisions which may
impact management's ability to make certain decisions regarding the
operation of our company</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">The master advisory and consulting agreement
with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide on
which we are materially dependent provides that the agreement is
immediately terminable by</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide if any
officers are terminated or resign, including Mr. Roseberry in his
role as President and co-Managing Director of I'M1 and EE1, or if
additional officers are appointed for each I'M1 and EE1 without the
consent of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. The
wholesale license agreement for</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Health &amp;
Wellness&#x2122; contains the right of</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide to
immediately terminate it if any officers are terminated or removed
or additional officers are appointed with respect to either I'M1 or
EE1, or if we compete with or invest in business that compete
with</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. It is
possible, however, that our management's ability to make certain
operational decisions which it believes are otherwise in the best
interests of our company could be restricted in future periods if
these decisions could result in triggering the rights of</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide to
terminate any agreement.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Our
business depends on consumer spending patterns</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
business is sensitive to a number of factors that influence the
levels of consumer spending, including political and economic
conditions such as recessionary environments, the levels of
disposable consumer income, consumer debt, interest rates and
consumer confidence. Reduced consumer spending on beauty products
could have an adverse effect on our operating results in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Substantially
all of our net sales historically have been to a limited number of
customers, the loss of any of which would be materially adverse to
our company</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Prior
to the close of the mergers in December 2018, substantially all of
our net sales in fiscal 2018 and 2017 were attributable to sales to
a limited number of customers. There are no assurances sales to
these customers will continue. While we expect to add additional
customers to our distribution network in the future for our
products division, and expand our licensing and consulting clients
in our other divisions, until such time as we are successful in
these efforts, of which there is no assurance, any significant
decrease in sales to any of our customers would have a material
adverse financial effect on our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
A significant amount of our net sales were from customers who are
identified as related parties, the loss of any of which would be
materially adverse to our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
significant amount of our net sales in fiscal 2018 and 2017,
totaling $1,992,046 and $1,731,238 respectively, were from
customers who are identified as related parties. There are no
assurances sales to these customers will continue. While we expect
to add additional customers in all of our businesses as we expand
our licensing and consulting clients, until such time as we are
successful in these efforts, of which there is no assurance, any
significant decrease in sales to any of our customers would have a
material adverse financial effect on our company.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
If we fail to promote and maintain our brands in the market, our
businesses, operating results, financial condition, and our ability
to attract customers will be materially adversely
affected.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
success depends on our ability to create and maintain brand
awareness for our product offerings. This may require a significant
amount of capital to allow us to market our products and establish
brand recognition and customer loyalty. Additionally, many of the
companies offering similar products have already established their
brand identity within the marketplace. We can offer no assurances
that we will be successful in establishing awareness of our brands
allowing us to compete in this market. The importance of brand
recognition will continue to increase because low barriers of entry
to the industries in which we operate may result in an increased
number of direct competitors. To promote our brands, we may be
required to continue to increase our financial commitment to
creating and maintaining brand awareness. We may not generate a
corresponding increase in revenue to justify these
costs.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">8</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
If we are unable to identify and successfully acquire additional
brands and trademarks, our growth may be limited, and, even if
additional trademarks are acquired, we may not realize anticipated
benefits due to integration or licensing difficulties.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
component of our growth strategy is the acquisition of additional
brands and trademarks. We generally compete with traditional
apparel and consumer brand companies, other brand management
companies and private equity groups for brand acquisitions.
However, as more of our competitors continue to pursue our brand
management model, competition for specific acquisition targets may
become more acute, acquisitions may become more expensive and
suitable acquisition candidates could become more difficult to
find. In addition, even if we successfully acquire additional
trademarks or the rights to use additional trademarks, we may not
be able to achieve or maintain profitability levels that justify
our investment in, or realize planned benefits with respect to,
those additional brands.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Although we seek to temper our acquisition risks by following
acquisition guidelines relating to the existing strength of the
brand, its diversification benefits to us, its potential licensing
scale and credit worthiness of the licensee base, acquisitions,
whether they be of additional intellectual property, or
&#x201C;IP,&#x201D; assets or of the companies that own them, entail
numerous risks, any of which could detrimentally affect our results
of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Acquisition
of brands or trademarks transactions involve a number of risks and
present financial, managerial and operational challenges,
including: diversion of management&#x2019;s attention from running
our existing business; unanticipated costs associated with the
target acquisition, appropriately valuing the target acquisition
and analyzing its marketability, increased expenses, including
legal and administrative expenses; integration costs related to the
customer base and business practices of the acquired company with
our own; and adverse effects on our reported operating results due
to possible write-down of goodwill and/or identifiable intangibles
associated with acquisitions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">When
we acquire IP assets or the companies that own them, our due
diligence reviews are subject to inherent uncertainties and may not
reveal all potential risks. Although we generally attempt to seek
contractual protections through representations, warranties and
indemnities, we cannot be sure that we will obtain such provisions
in our acquisitions or that such provisions will fully protect us
from all unknown, contingent or other liabilities or costs.
Finally, claims against us relating to any acquisition may
necessitate our seeking claims against the seller for which the
seller may not, or may not be able to, indemnify us or that may
exceed the scope, duration or amount of the seller&#x2019;s
indemnification obligations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
No assurance can be given with respect to the timing, likelihood or
financial or business effect of any possible transaction. As a
result, there is no guarantee that our shareholders will achieve
greater returns as a result of any future acquisitions we
complete.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Each
of our I'M1 and EE1 subsidiaries are governed by operating
agreements that require us to distribute amounts to minority
members in certain circumstances. These distributions could reduce
the amount of operating capital we have in future periods. Under
the terms of the operating agreements for each of I&#x2019;M1 and
EE1, Level Brands as the manager of these entities is responsible
for the operations, including the payment of the operating costs.
These costs are then deducted from the &#x201C;profits&#x201D; of the
entity and a portion of those amounts, as determined by the
particular operating agreement, will then be distributed to the
members. We own all of the voting interests in I'M1 and EE1. During
fiscal 2017 EE1 made a distribution to its members, no additional
distributions have been made or are currently planned.
Distributions to the members of I'M1 and EE1 will reduce the amount
of working capital available to us and could adversely impact our
liquidity in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The value of the equity securities we may accept as compensation
under consulting agreements will be subject to adjustment which
could result in losses to us in future periods. By accepting equity
securities as partial compensation for our services, we may be
adversely impacting our working capital in future
periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">From time to time we have entered into several
agreements with third parties under which we accepted shares of its
common stock as partial compensation for the services to be
provided. For fiscal 2018 and fiscal 2017, the value of these
securities represented 60.6% and 43.2%, respectively, of our total
net revenues, and for the first quarter of fiscal 2019 was 37.6% of
total net revenues. By accepting equity securities as partial
compensation for our services in lieu of cash, we incur expenses to
deliver the services without the corresponding cash payments from
our clients. As such, we utilize a greater portion of our working
capital to provide services with the hope that we may benefit from
an increase in the market value of the equity securities we have
received in future periods. In addition, these securities will be
reflected on our balance sheets in future periods as
&#x201C;marketable securities&#x201D; or &#x201C;investment other
securities&#x201D;. At the end of each quarter, we will evaluate the
carrying value of the marketable securities or investment other
securities for a decrease in value. We will evaluate the company
underlying these marketable securities or investment other
securities to determine whether a decline in fair value below the
amortized cost basis is other than temporary. If the decline in
fair value is judged to be &#x201C;other- than- temporary&#x201D;,
the cost basis of the individual security will be written down to
fair value as a new cost basis and the amount of the write-down is
charged to earnings. During fiscal 2018 we recognized another
comprehensive loss of $2,512,539 for loss on these securities, net
of taxes.</font> Subsequent to our most recently Form 10Q being
filed, we have liquidated certain positions in accordance with our
intention to avoid being classified as an Investment Company under
the 1940 Act. As a result of this liquidation, we recognized a
significant other than temporary impairment expense. As we continue
to divest ourselves of such positions in future quarters, such
continued losses are probable. <font style="color: #000000">It is
possible that we may continue to recognize impairments on the
carrying value of these securities in future periods. Any future
impairments would adversely affect our operating results for the
corresponding periods in that we would be required to reduce the
carrying value of these investments.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">9</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may be unable to liquidate securities we accept as partial
compensation under consulting agreements which could adversely
impact our liquidity in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
ability to sell any securities we accept as partial compensation
under consulting agreements is dependent upon a number of factors,
including the existence of a liquid market for the securities and
our compliance with the resale provisions of Federal securities
laws which require us to hold the shares for at least six months,
among other factors. While we expect to generally accept securities
from issuers who are publicly traded or who are expecting to become
a publicly traded company, there are no assurances a liquid market
will exist in such securities at such time as we are able to resell
the shares, or that the price we may receive will be commensurate
with the value of the services we are providing. In that event, we
would not benefit from the expected rise in the market price of the
securities we own as a result of our efforts on behalf of the
client company. In addition, depending upon the terms of our
business relationship with the issuer of the securities, it is
possible that from time to time we could be in possession of
non-public information regarding the issuer which could prohibit us
from disposing of the shares at a time when it is advantageous to
us to do so. If we are unable to readily liquidate any securities
we accept as compensation, we would be deprived of the cash value
of those services and we would be required to write-off the
carrying value of the securities which could adversely impact our
results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We are
subject to the risk of possibly becoming an investment company
under the Investment Company Act of 1940</font><font style="color: #000000">.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
Investment Company Act of 1940 regulates certain companies that
invest in, hold or trade securities. Although we do not believe we
are engaged in the business of investing, reinvesting or trading in
securities, and we do not currently hold ourselves out to the
public as being engaged in those activities, in the past we have
accepted securities of our client companies as partial
compensation. At December 31, 2018, we do not exceed the exemptive
asset and revenue thresholds under Section 3(a)(1)(C) of Investment
Company Act of 1940. So that we do not become an inadvertent
investment company, we will continue to limit the amount of equity
we accept as compensation for services provided so as to stay under
the income threshold as indicated in the Investment Company Act of
1940 going forward. As a result, we may structure transactions in a
less advantageous manner than if we did not have Investment Company
Act of 1940 concerns, or we may avoid otherwise economically
desirable transactions due to those concerns.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We may require additional capital to finance the acquisition of
additional brands and if we are unable to raise such capital on
beneficial terms or at all this could restrict our
growth.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may, in the future, require additional capital to help fund all or
part of potential acquisitions. If, at the time required, we do not
have sufficient cash to finance those additional capital needs, we
will need to raise additional funds through equity and/or debt
financing. We cannot guarantee that, if and when needed, additional
financing will be available to us on acceptable terms or at all.
Further, if additional capital is needed and is either unavailable
or cost prohibitive, our growth may be limited as we may need to
change our business strategy to slow the rate of our expansion
plans. In addition, any additional financing we undertake could
impose additional covenants upon us that restrict our operating
flexibility, and, if we issue equity securities to raise capital or
as acquisition consideration, our existing shareholders may
experience dilution or the new securities may have rights senior to
those of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR LICENSING AND ENTERTAINMENT
DIVISIONS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">The failure
of our licensees to adequately produce, market, import and sell
products bearing our brand names in their license categories,
continue their operations, renew their license agreements or pay
their obligations under their license agreements could result in a
decline in our results of operations</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
future revenues from our licensing division will be substantially
dependent on royalty payments made to us under our license
agreements, in addition to compensation under any consulting
agreements we may enter into with the third parties for services by
either our licensing division, our entertainment division, or both.
The failure of our licensees to satisfy their obligations under
these agreements, or their inability to operate successfully or at
all, could result in their breach and/or the early termination of
such agreements, their non-renewal of such agreements or our
decision to amend such, thereby eliminating some or all of that
stream of revenue. It is possible that the milestones to be met
under the terms of licensing agreements may never be achieved which
also could deprive us of additional revenues. There can be no
assurances that we will not lose the licensees under our license
agreements due to their failure to exercise the option to renew or
extend the term of those agreements or the cessation of their
business operations (as a result of their financial difficulties or
otherwise) without equivalent options for replacement. Any of such
failures could reduce the anticipated revenue stream to be
generated by the license agreements. In addition, the failure of
our licensees to meet their production, manufacturing and
distribution requirements, or to be able to continue to import
goods (including, without limitation, as a result of labor strikes
or unrest), could cause a decline in their sales and potentially
decrease the amount of royalty payments (over and above any
guaranteed minimums) due to us. Further, the failure of our
licensees and/or their third party manufacturers, which we do not
control, to adhere to local laws, industry standards and practices
generally accepted in the United States in areas of worker safety,
worker rights of association, social compliance, and general health
and welfare, could result in accidents and practices that cause
disruptions or delays in production and/or substantial harm to the
reputation of our brands, any of which could have a material
adverse effect on our business, financial position, results of
operations and cash flows. A weak economy or softness in certain
sectors including apparel, consumer products, retail and
entertainment could exacerbate this risk. This, in turn, could
decrease our potential revenues and cash flows.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">10</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">From time
to time we may compete with kathy ireland Worldwide&#xAE; in
securing advisory or representation agreements with potential
clients for EE1 which may create a conflict of interests for the
managing directors of EE1</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide is an
established company which has significant experience in assisting
companies in the promotion and management of their brands through
licensing and advisory agreements. Affiliates of</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide are
responsible for the day to day operations of EE1 and</font>
<font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. Part
of EE1's business competes with</font> <font style="font-style: italic; color: #000000">kathy ireland</font>
<font style="color: #000000">&#xAE;Worldwide in identifying and
securing clients for its advisory services. For example, both EE1
and</font> <font style="font-style: italic; color: #000000">kathy
ireland</font> <font style="color: #000000">&#xAE;Worldwide are
parties to substantial identical representation agreements with
Dada Media, Inc. and David Tutera. These affiliates will be able to
determine which entity, either</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide or EE1,
is referred to the potential client.</font> <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide has
more experience and resources and there are no assurances that
conflicts of interest which may arise will be resolved in our
favor. As a result, it is possible that we may lose out on
potential business opportunities.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We could
become a party to litigation involving our licensed products which
could result in additional costs to us. Certain licensed products
may be more likely to lead to product liability lawsuits than
others, which could expose us to additional unknown
risks</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Although
we are not responsible for the manufacturing, sale or distribution
of licensed products, it is possible our company could be named as
a defendant in litigation related to licensed products. Certain
licensed products may, by virtue of the industry in which they are
sold and the governmental regulations to which they are subject,
such as vaping products, could be more likely to be the subject of
litigation than others. Notwithstanding that our standard form of
license agreements requires the licensee to indemnify us against
ligation involving the licensed products and to maintain product
liability insurance policies, it is possible that a licensee may
fail to maintain this coverage during the term of the license
agreement. While we would then have a right to terminate the
license agreement as a result of this breach of its terms, there
are no assurances we would not be required to expend significant
funds and management time defending our company in any potential
product liability insurance claim. There are no assurances that we
would prevail in any such litigation, which could subject us to
judgments and costs of settlements which could adversely impact our
liquidity and results of operations in future periods.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">As a result
of the intense competition within our targeted licensees&#x2019;
markets and the strength of some of their competitors, we and our
licensees may not be able to compete
successfully</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Many
of our targeted trademark licenses are for products in the apparel,
fashion accessories, footwear, beauty and fragrance, home products
and d&#xE9;cor, consumer electronics and entertainment industries
in which licensees face intense competition from third party brands
and licensees. In general, competitive factors include quality,
price, style, name recognition and service. In addition, various
fads and the limited availability of shelf space could affect
competition for our licensees&#x2019; products. Many of our
licensees&#x2019; competitors have greater financial, importation,
distribution, marketing and other resources than our licensees and
have achieved significant name recognition for their brand names.
Our licensees may be unable to compete successfully in the markets
for their products, and we may not be able to compete successfully
with respect to our licensing arrangements.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Our business is dependent on market acceptance of our brands and
the potential future products of our licensees bearing these
brands.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Although
some of our targeted licensees might have guaranteed minimum net
sales and minimum royalties to us, a failure of our brands or of
products bearing our brands to achieve or maintain market
acceptance could cause a reduction of our licensing revenue and
could further cause existing licensees not to renew their
agreements. Such failure could also cause the devaluation of our
trademarks, which are our primary intellectual property, or
&#x201C;IP&#x201D;, assets, making it more difficult for us to renew
our current licenses upon their expiration or enter into new or
additional licenses for our trademarks. In addition, if such
devaluation of our trademarks were to occur, a material impairment
in the carrying value of one or more of our trademarks could also
occur and be charged as an expense to our operating
results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
industries in which we target to compete, including the apparel
industry, are subject to rapidly evolving trends and competition.
In addition, consumer tastes change rapidly. The licensees under
our licensing agreements may not be able to anticipate, gauge or
respond to such changes in a timely manner. Failure of our
licensees to anticipate, identify and capitalize on evolving trends
could result in declining sales of our brands and devaluation of
our trademarks. Continued and substantial marketing efforts, which
may, from time to time, also include our expenditure of significant
additional funds to keep pace with changing consumer demands, are
required to maintain market acceptance of the licensees&#x2019;
products and to create market acceptance of new products and
categories of products bearing our trademarks; however, these
expenditures may not result in either increased market acceptance
of, or licenses for, our trademarks or increased market acceptance,
or sales, of our licensees&#x2019; products. Furthermore, while we
believe that we currently maintain sufficient control over the
products our licensees&#x2019; produce under our brand names through
the provision of trend direction and our right to preview and
approve a majority of such products, including their presentation
and packaging, we do not actually design or manufacture products
bearing our marks, and therefore, have more limited control over
such products&#x2019; quality and design than would a traditional
product manufacturer.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">11</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OUR PRODUCTS DIVISION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">Our
revenues from our products division have been declining. We
recognized asset impairments of $502,000 in fiscal 2018 related to
this division</font><font style="color: #000000">.</font></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">Net sales from our products division were lower in
each period in fiscal 2018 as compared to the same periods in
fiscal 2017, with an overall reduction in fiscal 2018 of 126.3%
from fiscal 2017. This decline continued into the first quarter of
fiscal 2019, with a 10% decline as compared to the first quarter of
2018.</font>&#xA0; As a result, during the fourth quarter of fiscal
2018 we recognized an impairment of $502,000, including an
inventory and prepaid marketing supplies write off of $262,000 and
an intangible asset impairment of $240,000. In addition, 78% of our
net sales in this division occurred in September 2018 and were made
to an entity affiliated with <font style="font-style: italic; color: #000000">kathy
ireland</font><font style="color: #000000">&#xAE; Worldwide. cbdMD
will also be reporting under the products division and it is
unknown if there will continue to be impairments, similar to what
we have had historically in future periods.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The majority of our net sales to date in our products division are
generated on the basis of purchase orders, rather than long term
purchase commitments; which could adversely affect our financial
position and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
operating history is not long enough to evaluate the likelihood of
future cancellations or deferments of customer orders related to
product sales in our products division. Manufacturers and
distributors are currently contracted on a per order basis. The
lack of long-term purchase commitments creates a risk that product
demand may be reduced if orders are canceled or deferred or, in the
event of unanticipated demand, an inability to timely produce and
deliver our products. We do not have long-term agreements with our
distributors, manufacturers or suppliers and these parties may
disrupt or cancel a purchase order or defer or delay shipments of
our products at any time. Furthermore, because of our inability to
rely on enforceable purchase contracts, and our limited visibility
into future customer demand, actual net sales may be different from
our forecasts, which could adversely affect our financial position
and results of operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">We may be
unable to protect our intellectual property rights and/or
intellectual property rights licensed to us, and may be subject to
intellectual property litigation and infringement claims by third
parties</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
intend to protect our intellectual property through limited patents
and our unpatented trade secrets and know-how through
confidentiality or license agreements with third parties, employees
and consultants, and by controlling access to and distribution of
our proprietary information. However, this method may not afford
complete protection, particularly in foreign countries where the
laws may not protect our proprietary rights as fully as in the
United States and unauthorized parties may copy or otherwise obtain
and use our products, processes or technology. Additionally, there
can be no assurance that others will not independently develop
similar know-how and trade secrets. We are also dependent upon the
owners of intellectual property rights licensed to us under various
wholesale license agreements to protect and defend those rights
against third party claims. If third parties take actions that
affect our rights, the value of our intellectual property, similar
proprietary rights or reputation or the licensors who have granted
us certain rights under wholesale license agreements, or we are
unable to protect the intellectual property from infringement or
misappropriation, other companies may be able to offer competitive
products at lower prices, and we may not be able to effectively
compete against these companies. We also face the risk of claims
that we have infringed third parties&#x2019; intellectual property
rights. Any claims of intellectual property infringement, even
those without merit, may require us to:</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">defend
against infringement claims which are expensive and time
consuming;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">cease
making, licensing or using products that incorporate the challenged
intellectual property;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">re-design,
re-engineer or re-brand our products or packaging; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">enter
into royalty or licensing agreements in order to obtain the right
to use a third party&#x2019;s intellectual property.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">12</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
the event of claims by third parties for infringement of
intellectual property rights we license from third parties under
wholesale license agreements, we could be liable for costs of
defending allegations of infringement and there are no assurances
the licensors will either adequately defend the licensed
intellectual property rights or that they would prevail in the
related litigation. In that event, we would incur additional costs
and may deprived from generating royalties from these
agreements.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="font-weight: bold; font-style: italic; color: #000000">A
disruption in operations or our supply chain could adversely affect
our business and financial results</font><font style="color: #000000">.</font></font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are subject to the risks inherent in manufacturing our products,
including industrial accidents, environmental events, strikes and
other labor disputes, disruptions in supply chain or information
systems, loss or impairment of key manufacturing sites or
suppliers, product quality control, safety, increase in commodity
prices and energy costs, licensing requirements and other
regulatory issues, as well as natural disasters and other external
factors over which we have no control. If such an event were to
occur, it could have an adverse effect on our business and
financial results.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We rely on third-parties to manufacture and to compound some of our
products, and we have no control over these manufactures and may
not be able to obtain quality products on a timely basis or in
sufficient quantity.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Some
of our products are manufactured or compounded by unaffiliated
third parties. We do not have any long-term contracts with any of
these third parties, and we expect to compete with other companies
for raw materials, production and import capacity. If we experience
significant increased demand, or need to replace an existing
manufacturer, there can be no assurance that additional
manufacturing capacity will be available when required on terms
that are acceptable to us, or at all, or that any manufacturer or
compounder would allocate sufficient capacity to us in order to
meet our requirements. In addition, even if we are able to expand
existing or find new sources, we may encounter delays in production
and added costs as a result of the time it takes to engage third
parties. Any delays, interruption or increased costs in the
manufacturing or compounding of our products could have an adverse
effect on our ability to meet retail customer and consumer demand
for our products and result in lower revenues and net income both
in the short and long-term.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
RISKS RELATED TO OWNERSHIP OF OUR COMMON STOCK</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We are subject to the continued listing standards of the NYSE
American and our failure to satisfy these criteria may result in
delisting of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
common stock is listed on the NYSE American. In order to maintain
this listing, we must maintain certain share prices, financial and
share distribution targets, including maintaining a minimum amount
of shareholders&#x2019; equity and a minimum number of public
shareholders. In addition to these objective standards, the NYSE
American may delist the securities of any issuer (i) if, in its
opinion, the issuer&#x2019;s financial condition and/or operating
results appear unsatisfactory; (ii) if it appears that the extent
of public distribution or the aggregate market value of the
security has become so reduced as to make continued listing on the
NYSE American inadvisable; (iii) if the issuer sells or disposes of
principal operating assets or ceases to be an operating company;
(iv) if an issuer fails to comply with the NYSE American&#x2019;s
listing requirements; (v) if an issuer&#x2019;s common stock sells
at what the NYSE American considers a &#x201C;low selling
price&#x201D; and the issuer fails to correct this via a reverse
split of shares after notification by the NYSE American; or (vi) if
any other event occurs or any condition exists which makes
continued listing on the NYSE America, in its opinion, inadvisable.
If the NYSE American delists our common stock, investors may face
material adverse consequences, including, but not limited to, a
lack of trading market for our securities, reduced liquidity,
decreased analyst coverage of our securities, and an inability for
us to obtain additional financing to fund our
operations.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
The issuance of shares upon exercise of our outstanding options and
warrants may cause immediate and substantial dilution to our
existing shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
presently have options and warrants that if exercised would result
in the issuance of an additional 833,255 shares of our common
stock. The issuance of shares upon exercise of warrants and options
may result in dilution to the interests of other
shareholders.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">13</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
The price of our common stock may be volatile, and you could lose
all or part of your investment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Stock
markets have experienced extreme volatility that has often been
unrelated to the operating performance of particular companies.
These broad market fluctuations may adversely affect the trading
price of our common stock. In addition, limited trading volume of
our stock may contribute to its future volatility. Price declines
in our common stock could result from general market and economic
conditions, some of which are beyond our control, and a variety of
other factors, including any of the risk factors described in this
prospectus. These broad market and industry factors may harm the
market price of our common stock, regardless of our operating
performance, and could cause you to lose all or part of your
investment in our common stock since you might be unable to sell
your shares at or above the price you paid. Factors that could
cause fluctuations in the market price of our common stock include
the following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">price
and volume fluctuations in the overall stock market from time to
time;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">changes
in operating performance and stock market valuations of other hair
care products companies generally;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">sales
of shares of our common stock by us or our
shareholders;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">failure
of securities analysts to initiate or maintain coverage of us,
changes in financial estimates by securities analysts who follow
our company, or our failure to meet these estimates or the
expectations of investors;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
financial projections we may provide to the public, any changes in
those projections or our failure to meet those
projections;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">rumors
and market speculation involving us or other companies in our
industry;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">actual
or anticipated changes in our results of operations or fluctuations
in our results of operations;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">actual
or anticipated developments in our business, our competitors&#x2019;
businesses or the competitive landscape generally;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">litigation
involving us, our industry or both, or investigations by regulators
into our operations or those of our competitors;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">developments
or disputes concerning our intellectual property or other
proprietary rights;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">announced
or completed acquisitions of businesses or brands by us or our
competitors;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">new
laws or regulations or new interpretations of existing laws or
regulations applicable to our business;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">changes
in accounting standards, policies, guidelines, interpretations or
principles;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
significant change in our management; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">general
economic conditions and slow or negative growth of our
markets.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
addition, in the past, following periods of volatility in the
overall market and the market price of a particular company&#x2019;s
securities, securities class action litigation has often been
instituted against these companies. This litigation, if instituted
against us, could result in substantial costs and a diversion of
our management&#x2019;s attention and resources.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">14</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We are an &#x201C;emerging growth company,&#x201D; and the reduced
reporting requirements applicable to emerging growth companies may
make our common stock less attractive to investors.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are an &#x201C;emerging growth company,&#x201D; as defined in the
JOBS Act. For as long as we continue to be an emerging growth
company, we may take advantage of exemptions from various reporting
requirements that are applicable to other public companies but not
to &#x201C;emerging growth companies,&#x201D; including, but not
limited to:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">being
permitted to provide only two years of audited financial
statements, in addition to any required unaudited interim financial
statements, with correspondingly reduced &#x201C;Management&#x2019;s
Discussion and Analysis of Financial Condition and Results of
Operations&#x201D; disclosure;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">not
being required to comply with the auditor attestation requirements
in the assessment of our internal control over financial reporting
under Section 404 of the Sarbanes-Oxley Act of 2002, or
&#x201C;Sarbanes-Oxley Act&#x201D;;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">not
being required to comply with any requirement that may be adopted
by the Public Company Accounting Oversight Board regarding
mandatory audit firm rotation or a supplement to the
auditor&#x2019;s report providing additional information about the
audit and the financial statements;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">reduced
disclosure obligations regarding executive compensation in our
periodic reports and proxy statements; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">exemptions
from the requirements of holding a nonbinding advisory vote on
executive compensation and shareholder approval of any golden
parachute payments not previously approved.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Investors
may find our common stock less attractive if we choose to rely on
these exemptions. If some investors find our common stock less
attractive as a result of any choices to reduce future disclosure,
there may be a less active trading market for our common stock and
the price of our common stock may be more volatile.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
Our executive officers, directors and their affiliates may exert
control over us and may exercise influence over matters subject to
shareholder approval.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
executive officers and directors, together with their respective
affiliates, beneficially own approximately 7.8% of our outstanding
common stock as of March 20, 2019. However, when issued, the
aggregate of 15,250,000 shares which are part of the merger
consideration, including following the voting rights vesting over
five years of 8,750,000 of those shares, may result in a change of
control of our company. In addition, the merger agreement also
provides that we may issue up to an additional 15,250,000 shares of
our common stock as part of the merger consideration upon the
satisfaction of certain aggregate net revenue criteria by cbdMD LLC
within 60 months following the closing date. A change of control of
the company may result over time in the event of, and as a result
of, the issuance of those earnout shares. Accordingly, these
shareholders, if they act together, may exercise substantial
influence over matters requiring shareholder approval, including
the election of directors and approval of corporate transactions,
such as a merger. This concentration of ownership could have the
effect of delaying or preventing a change in control or otherwise
discourage a potential acquirer from attempting to obtain control
over us, which in turn could have a material adverse effect on the
market value of our common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-style: italic; color: #000000; font-size: 13px; font-family: Times New Roman">
If securities or industry analysts do not publish research or
publish unfavorable or inaccurate research about our business, our
common stock share price and trading volume could
decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">An
active trading market for our common stock will depend, in part, on
the research and reports that securities or industry analysts
publish about us or our business. We may be unable to attract or
sustain coverage by well-regarded securities and industry analysts.
If either none or only a limited number of securities or industry
analysts cover us or our business, or if these securities or
industry analysts are not widely respected within the general
investment community, the trading price for our common stock would
be materially and negatively impacted. In the event we obtain
securities or industry analyst coverage, if one or more of the
analysts who cover us or our business downgrade our common stock or
publish inaccurate or unfavorable research about us or our
business, the price of our common stock would likely decline. If
one or more of these analysts cease coverage of us or our business,
or fail to publish reports on us or our business regularly, demand
for our common stock could decrease, which might cause the price of
our common stock and trading volume to decline.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">15</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Public company requirements may strain our resources and divert
management&#x2019;s attention, which could adversely impact our
ability to execute our strategy and harm operating
results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
are subject to the reporting requirements of the Securities
Exchange Act of 1934, the Sarbanes-Oxley Act, the Dodd-Frank Wall
Street Reform and Consumer Protection Act, which we refer to as
&#x201C;Dodd-Frank,&#x201D; the listing requirements of the NYSE
American and other applicable securities rules and regulations.
Despite recent reforms made possible by the JOBS Act, compliance
with these rules and regulations will nonetheless increase our
legal and financial compliance costs, make some activities more
difficult, time-consuming or costly and increase demand on our
systems and resources, particularly after we are no longer an
&#x201C;emerging growth company.&#x201D; While the members of our
board of directors have substantial experience relevant to our
business, they have limited experience with operations as a public
company upon which you can base your prediction of our future
success or failure in complying with public company requirements.
Our management may fail to comply with public company requirements,
or may fail to do so effectively and efficiently, each would
materially and adversely harm our ability to execute our strategy
and, consequently, our operating results.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Furthermore,
as a result of disclosure in filings required of a public company,
our business and financial condition will become more visible,
which may result in threatened or actual litigation, including by
competitors and other third parties. If these claims are
successful, our business and operating results could be harmed, and
even if the claims do not result in litigation or are resolved in
our favor, these claims, and the time and resources necessary to
resolve them, could divert the resources of management and
adversely affect our business, brand and reputation and results of
operations. Our new public company status and these new rules and
regulations may make it more expensive for us to obtain director
and officer liability insurance, and we may be required to accept
reduced coverage or incur substantially higher costs to obtain
coverage. These factors could also make it more difficult for us to
attract and retain qualified members of the board of directors,
particularly to serve on the audit committee and compensation
committee, and qualified executive officers.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
Some provisions of our charter documents and North Carolina law may
have anti-takeover effects that could discourage an acquisition of
us by others, even if an acquisition would be beneficial to our
shareholders and may prevent attempts by our shareholders to
replace or remove our current management.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Provisions
in our articles of incorporation and bylaws, as well as provisions
of North Carolina law, could make it more difficult for a third
party to acquire us or increase the cost of acquiring us, even if
doing so would benefit our shareholders, or remove our current
management. These include provisions that:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">permit
our board of directors to issue up to 50,000,000 shares of
preferred stock, with any rights, preferences and privileges as
they may designate;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">provide
that all vacancies on our board of directors, including as a result
of newly created directorships, may, except as otherwise required
by law, be filled by the affirmative vote of a majority of
directors then in office, even if less than a quorum;
and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">do
not provide for cumulative voting rights, thereby allowing the
holders of a majority of the shares of common stock entitled to
vote in any election of directors to elect all of the directors
standing for election.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">These
provisions may frustrate or prevent any attempts by our
shareholders to replace or remove our current management by making
it more difficult for shareholders to replace members of our board
of directors, who are responsible for appointing the members of our
management. In addition, North Carolina has two primary
anti-takeover statutes, the Shareholder Protection Act and the
Control Share Acquisition Act, which govern the shareholder
approval required for certain business combinations. As permitted
by North Carolina law, we have opted out of both these provisions.
Accordingly, we are not subject to any anti-takeover effects of the
North Carolina Shareholder Protection Act or Control Share
Acquisition Act. Any provision of our articles of incorporation,
bylaws or North Carolina law that has the effect of delaying or
deterring a change in control could limit the opportunity for our
shareholders to receive a premium for their shares of common stock,
and could also affect the price that some investors are willing to
pay for our shares of common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-style: italic; font-size: 13px; font-family: Times New Roman">
We have additional securities available for issuance, which, if
issued, could adversely affect the rights of the holders of our
common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
articles of incorporation, as amended, authorizes the issuance of
150,000,000 shares of our common stock and 50,000,000 shares of
preferred stock. In certain circumstances, the common stock, as
well as the awards available for issuance under our equity
incentive plans, can be issued by our board of directors, without
stockholder approval. Any future issuances of such stock would
further dilute the percentage ownership of us held by holders of
common stock. In addition, the issuance of certain securities,
including pursuant to the terms of our stockholder rights plan, may
be used as an &#x201C;anti-takeover&#x201D; device without further
action on the part of our stockholders, and may adversely affect
the holders of the common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
addition, the issuance of preferred stock may be used as an
&#x201C;anti-takeover&#x201D; device and may adversely affect the
holders of the common stock. If our board of directors and
stockholders approved the use of &#x201C;blank check&#x201D;
preferred stock, our board of directors would be authorized to
create and issue from time to time, without further stockholder
approval, a certain number of shares of preferred stock, in one or
more series and to establish the number of shares of any series of
preferred stock and to fix the designations, powers, preferences
and rights of the shares of each series and any qualifications,
limitations or restrictions of the shares of each series. The
authority to designate preferred stock may be used to issue series
of preferred stock, or rights to acquire preferred stock, that
could dilute the interest of, or impair the voting power of,
holders of the common stock or could also be used as a method of
determining, delaying or preventing a change of
control.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">16</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
USE OF PROCEEDS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Unless
otherwise indicated in an accompanying prospectus supplement, the
net proceeds from the sale of the securities offered hereby will be
used for general corporate purposes, which may include working
capital, capital expenditures, and development costs. We have not
allocated any portion of the net proceeds for any particular use at
this time. The net proceeds may be invested temporarily until they
are used for their stated purpose. Specific information concerning
the use of proceeds from the sale of any securities will be
included in the prospectus supplement relating to such
securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DESCRIPTION OF CAPITAL STOCK</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
authorized capital is 150,000,000 shares of common stock, par value
$0.001 per share, and 50,000,000 shares of blank check preferred
stock, par value $0.001 per share. At March 26, 2019, there were
10,170,356 shares of common stock and no shares of preferred stock
issued and outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-weight: bold; font-size: 13px; font-family: Times New Roman">
Common stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Holders
of common stock are entitled to one vote for each share on all
matters submitted to a shareholder vote. Holders of common stock do
not have cumulative voting rights. Holders of common stock are
entitled to share in all dividends that the board of directors, in
its discretion, declares from legally available funds. In the event
of our liquidation, dissolution or winding up, subject to the
preferences of any shares of our preferred stock which may then be
outstanding, each outstanding share entitles its holder to
participate in all assets that remain after payment of liabilities
and after providing for each class of stock, if any, having
preference over the common stock.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Holders
of common stock have no conversion, preemptive or other
subscription rights, and there are no redemption provisions for the
common stock. The rights of the holders of common stock are subject
to any rights that may be fixed for holders of preferred stock,
when and if any preferred stock is authorized and issued. All
outstanding shares of common stock are duly authorized, validly
issued, fully paid and non-assessable.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Preferred stock</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
board of directors, without further shareholder approval, may issue
preferred stock in one or more series from time to time and fix or
alter the designations, relative rights, priorities, preferences,
qualifications, limitations and restrictions of the shares of each
series. The rights, preferences, limitations and restrictions of
different series of preferred stock may differ with respect to
dividend rates, amounts payable on liquidation, voting rights,
conversion rights, redemption provisions, sinking fund provisions
and other matters. Our board of directors may authorize the
issuance of preferred stock, which ranks senior to our common stock
for the payment of dividends and the distribution of assets on
liquidation. In addition, our board of directors can fix
limitations and restrictions, if any, upon the payment of dividends
on both classes of our common stock to be effective while any
shares of preferred stock are outstanding.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Limitations on liabilities for our officers and
directors</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Sections
55-8-50 through 55-8-58 of the North Carolina General Statutes
permit a corporation to indemnify its directors, officers,
employees or agents under either or both a statutory or
non-statutory scheme of indemnification. Under the statutory
scheme, a corporation may, with certain exceptions, indemnify a
director, officer, employee or agent of the corporation who was,
is, or is threatened to be made, a party to any threatened, pending
or completed legal action, suit or proceeding, whether civil,
criminal, administrative, or investigative, because of the fact
that such person was a director, officer, agent or employee of the
corporation, or is or was serving at the request of such
corporation as a director, officer, employee or agent of another
corporation or enterprise. This indemnity may include the
obligation to pay any judgment, settlement, penalty, fine
(including an excise tax assessed with respect to an employee
benefit plan) and reasonable expenses incurred in connection with a
proceeding (including counsel fees), but no such indemnification
may be granted unless such director, officer, agent or employee (i)
conducted himself in good faith, (ii) reasonably believed (a) that
any action taken in his official capacity with the corporation was
in the best interest of the corporation or (b) that in all other
cases his conduct at least was not opposed to the
corporation&#x2019;s best interest, and (iii) in the case of any
criminal proceeding, had no reasonable cause to believe his conduct
was unlawful. Whether a director has met the requisite standard of
conduct for the type of indemnification set forth above is
determined by the board of directors, a committee of directors,
special legal counsel or the shareholders in accordance with
Section 55-8-55. A corporation may not indemnify a director under
the statutory scheme in connection with a proceeding by or in the
right of the corporation in which the director was adjudged liable
to the corporation or in connection with a proceeding in which a
director was adjudged liable on the basis of having received an
improper personal benefit.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman"><font style="color: #000000">In addition to, and separate and apart from the
indemnification described above under the statutory scheme,
Section&#xA0;55-8-57 of the North Carolina General Statutes permits
a corporation to indemnify or agree to indemnify any of its
directors, officers, employees or agents against liability and
expenses (including attorney&#x2019;s fees) in any proceeding
(including proceedings brought by or on behalf of the corporation)
arising out of their status as such or their activities in such
capacities, except for any liabilities or expenses incurred on
account of activities that were, at the time taken, known or
believed by the person to be clearly in conflict with the best
interests of the corporation. Our bylaws provide for
indemnification to the fullest extent permitted by law for persons
who serve as a director, officer, agent or employee of Level Brands
or at the request of Level Brands serve as a director, officer,
agent or employee for any other corporation, partnership, joint
venture, trust or other enterprise, or as a trustee or
administrator under an employee benefit plan. Accordingly, we may
indemnify our directors, officers, agents or employees in
accordance with either the statutory or non-statutory
standards.</font>&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">17</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Sections
55-8-52 and 55-8-56 of the North Carolina General Statutes require
a corporation, unless its articles of incorporation provide
otherwise, to indemnify a director or officer who has been wholly
successful, on the merits or otherwise, in the defense of any
proceeding to which such director or officer was a party. Unless
prohibited by the articles of incorporation, a director or officer
also may make application and obtain court-ordered indemnification
if the court determines that such director or officer is fairly and
reasonably entitled to such indemnification as provided in Sections
55-8-54 and 55-8-56.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Finally,
Section 55-8-57 of the North Carolina General Statutes provides
that a corporation may purchase and maintain insurance on behalf of
an individual who is or was a director, officer, employee or agent
of the corporation against certain liabilities incurred by such
persons, whether or not the corporation is otherwise authorized by
the North Carolina Business Corporation Act to indemnify such
party. We have purchased a standard directors&#x2019; and
officers&#x2019; liability policy which will, subject to certain
limitations, indemnify us and our officers and directors for
damages they become legally obligated to pay as a result of any
negligent act, error, or omission committed by directors or
officers while acting in their capacity as such.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">As
permitted by North Carolina law, Article 6 of our Articles of
Incorporation limits the personal liability of directors for
monetary damages for breaches of duty as a director arising out of
any legal action for breach of duty as a director.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Transfer Agent</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
transfer agent and registrar for our common stock is VStock
Transfer, LLC, 18 Lafayette Place, Woodmere, NY 11598.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Listing</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
common stock is listed on the NYSE American under the symbol
&#x201C;LEVB.&#x201D;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
DESCRIPTION OF WARRANTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may issue warrants for the purchase of preferred stock or common
stock, or any combination of these securities. Warrants may be
issued independently or together with other securities and may be
attached to or separate from any offered securities. Each series of
warrants will be issued under a separate warrant agreement. The
following outlines some of the general terms and provisions of the
warrants that we may issue from time to time. Additional terms of
the warrants and the applicable warrant agreement will be set forth
in the applicable prospectus supplement.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
following descriptions, and any description of the warrants
included in a prospectus supplement, may not be complete and is
subject to and qualified in its entirety by reference to the terms
and provisions of the applicable warrant agreement, which we will
file with the Securities and Exchange Commission in connection with
any offering of warrants.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
General</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
prospectus supplement relating to a particular issue of warrants
will describe the terms of the warrants, including the
following:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
title of the warrants;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
offering price for the warrants, if any;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
aggregate number of the warrants;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
terms of the security that may be purchased upon exercise of the
warrants;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the designation and terms of the securities that the
warrants are issued with and the number of warrants issued with
each security;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the date from and after which the warrants and any
securities issued with the warrants will be separately
transferable;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
dates on which the right to exercise the warrants commence and
expire;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, the minimum or maximum amount of the warrants that may
be exercised at any one time;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">if
applicable, a discussion of material United States federal income
tax considerations;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">anti-dilution
provisions of the warrants, if any;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">redemption
or call provisions, if any, applicable to the warrants;
and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
additional terms of the warrants, including terms, procedures and
limitations relating to the exchange and exercise of the
warrants.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">18</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
Exercise of warrants</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Each
warrant will entitle the holder of the warrant to purchase the
securities that we specify in the applicable prospectus supplement
at the exercise price that we describe in the applicable prospectus
supplement. Holders may exercise warrants at any time up to the
close of business on the expiration date set forth in the
applicable prospectus supplement. After the close of business on
the expiration date, unexercised warrants will be void. Holders may
exercise warrants as set forth in the prospectus supplement
relating to the warrants being offered. Until a holder exercises
the warrants to purchase any securities underlying the warrants,
the holder will not have any rights as a holder of the underlying
securities by virtue of ownership of warrants.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
MATERIAL FEDERAL INCOME TAX CONSEQUENCES</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">A
summary of any material United States federal income tax
consequences to persons investing in the securities offered by this
prospectus will be set forth in any applicable prospectus
supplement. The summary will be presented for informational
purposes only, however, and will not be intended as legal or tax
advice to prospective purchasers. Prospective purchasers of
securities are urged to consult their own tax advisors prior to any
purchase of securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
PLAN OF DISTRIBUTION</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
may sell the securities from time to time pursuant to underwritten
public offerings, "at-the-market" offerings, negotiated
transactions, block trades, or a combination of these methods. We
may sell the securities in one or more of the following ways from
time to time:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">to
or through underwriters or dealers;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">directly
to one or more purchasers; or</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">through
agents.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
prospectus supplement (and any related free writing prospectuses
that we may authorize) will describe the terms of such offering,
including:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
name or names of any underwriters, dealers or agents;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
purchase price of the offered securities and the proceeds to Level
Brands from the sale;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
over-allotment options under which underwriters may purchase
additional securities from us;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
underwriting discounts and commissions or agency fees and other
items constituting underwriters' or agents' compensation;
and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">any
initial public offering price, any discounts or concessions allowed
or reallowed or paid to dealers and any securities exchanges on
which such offered securities may be listed.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Any
initial public offering prices, discounts or concessions allowed or
reallowed or paid to dealers may be changed from time to
time.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">If
underwriters are used in the sale, the underwriters will acquire
the offered securities for their own account and may resell them
from time to time in one or more transactions, including negotiated
transactions, at a fixed public offering price or at varying prices
determined at the time of sale. The offered securities may be
offered either to the public through underwriting syndicates
represented by one or more managing underwriters or by one or more
underwriters without a syndicate. Unless otherwise set forth in a
prospectus supplement, the obligations of the underwriters to
purchase any series of securities will be subject to certain
conditions precedent, and the underwriters will be obligated to
purchase all of such series of securities, if any are purchased
(other than securities subject to any over-allotment
option).</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">In
connection with underwritten offerings of the offered securities
and in accordance with applicable law and industry practice,
underwriters may over-allot or effect transactions that stabilize,
maintain or otherwise affect the market price of the offered
securities at levels above those that might otherwise prevail in
the open market, including by entering stabilizing bids, effecting
syndicate covering transactions or imposing penalty bids. A
stabilizing bid means the placing of any bid, or the effecting of
any purchase, for the purpose of pegging, fixing or maintaining the
price of a security. A syndicate covering transaction means the
placing of any bid on behalf of the underwriting syndicate or the
effecting of any purchase to reduce a short position created in
connection with the offering. A penalty bid means an arrangement
that permits the managing underwriter to reclaim a selling
concession from a syndicate member in connection with the offering
when offered securities originally sold by the syndicate member are
purchased in syndicate covering transactions.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">19</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">These
transactions may be effected on the NYSE American, in the
over-the-counter market, or otherwise. Underwriters are not
required to engage in any of these activities, or to continue such
activities if commenced.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">If
a dealer is used in the sale, Level Brands will sell such offered
securities to the dealer, as principal. The dealer may then resell
the offered securities to the public at varying prices to be
determined by that dealer at the time for resale. The names of the
dealers and the terms of the transaction will be set forth in the
prospectus supplement relating to that transaction.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Offered
securities may be sold directly by Level Brands to one or more
institutional purchasers, or through agents designated by us from
time to time, at a fixed price or prices, which may be changed, or
at varying prices determined at the time of sale. Any agent
involved in the offer or sale of the offered securities in respect
of which this prospectus is delivered will be named, and any
commissions payable by Level Brands to that agent will be set
forth, in the prospectus supplement relating to that offering.
Unless otherwise indicated in such prospectus supplement, any such
agent will be acting on a best efforts basis for the period of its
appointment.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Underwriters,
dealers and agents may be entitled under agreements entered into
with us to indemnification by us against certain civil liabilities,
including liabilities under the Securities Act of 1933, or to
contribution with respect to payments that the underwriters,
dealers or agents may be required to make in respect thereof.
Underwriters, dealers and agents may be customers of, engage in
transactions with, or perform services for us and our affiliates in
the ordinary course of business.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Other
than our common stock, which is listed on the NYSE American, each
of the securities issued hereunder will be a new issue of
securities, will have no prior trading market, and may or may not
be listed on a national securities exchange. Any common stock sold
pursuant to a prospectus supplement will be listed on the NYSE
American, subject to official notice of issuance. Any underwriters
to whom we sell securities for public offering and sale may make a
market in the securities, but such underwriters will not be
obligated to do so and may discontinue any market making at any
time without notice. We cannot assure you that there will be a
market for the offered securities.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
LEGAL MATTERS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
validity of the securities offered by this prospectus will be
passed upon for us by Pearlman Law Group LLP, 200 S. Andrews
Avenue, Suite 901, Fort Lauderdale, Florida 33301. Certain matters
under North Carolina law have been passed upon for us by the Law
Offices of Jason H. Scott.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
EXPERTS</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Our
consolidated balance sheets as of September 30, 2018 and 2017 and
the related consolidated statements of operations, comprehensive
income (loss), shareholders&#x2019; equity and cash flows for the
fiscal years ended September 30, 2018 and 2017 incorporated by
reference in the registration statement of which this prospectus is
a part have been audited by Cherry Bekaert LLP, independent
registered public accounting firm, as indicated in their report
with respect thereto, and have been so included in reliance upon
the report of such firm given on their authority as experts in
accounting and auditing.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">20</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; color: #000000; font-size: 13px; font-family: Times New Roman">
INFORMATION INCORPORATED BY REFERENCE</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">The
Securities and Exchange Commission allows us to &#x201C;incorporate
by reference&#x201D; the information we file with them, which means
that we can disclose important information to you by referring you
to those documents. The information incorporated by reference is
considered to be part of this prospectus, and later information
filed with the Securities and Exchange Commission will update and
supersede this information. We incorporate by reference the
documents listed below that we have previously filed with the SEC,
except that information furnished under Item 2.02 or Item 7.01 of
our Current Reports on Form 8-K or any other filing where we
indicate that such information is being furnished and not
&#x201C;filed&#x201D; under the Securities Exchange Act of 1934, is
not deemed to be filed and not incorporated by reference
herein:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Annual Report on Form 10-K for the fiscal year ended September 30,
2018;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Quarterly Report on Form 10-Q for the period ended December 31,
2018;</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">our
Current Reports on Form 8-K/A as filed on February 22, 2019 and
March 21, 2019; and</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; display: table; margin-left: 24px">
<div style="text-align: left; display: table-row">
<div style="text-align: left; display: table-cell; width: 24px">
<font style="font-size: 13px">&#x25CF;</font></div>
<div style="text-align: justify; display: table-cell"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">the
description of our common stock contained in our Registration
Statement on Form 8-A as filed with the SEC on November 15, 2017
and any further amendment or report filed hereafter for the purpose
of updating such description.</font></div>
</div>
</div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
also incorporate by reference into this prospectus additional
documents that we may file with the SEC under Sections 13(a),
13(c), 14 or 15(d) of the Securities Exchange Act of 1934 prior to
the completion or termination of the offering, including all such
documents we may file with the SEC after the date of the initial
registration statement and prior to the effectiveness of the
registration statement, but excluding any information deemed
furnished and not filed with the SEC. Any statements contained in a
previously filed document incorporated by reference into this
prospectus is deemed to be modified or superseded for purposes of
this prospectus to the extent that a statement contained in this
prospectus, or in a subsequently filed document also incorporated
by reference herein, modifies or supersedes that
statement.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">This
prospectus may contain information that updates, modifies or is
contrary to information in one or more of the documents
incorporated by reference in this prospectus. You should rely only
on the information incorporated by reference or provided in this
prospectus. We have not authorized anyone else to provide you with
different information. You should not assume that the information
in this prospectus is accurate as of any date other than the date
of this prospectus or the date of the documents incorporated by
reference in this prospectus.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">We
will provide to each person, including any beneficial owner, to
whom this prospectus is delivered, upon written or oral request, at
no cost to the requester, a copy of any and all of the information
that is incorporated by reference in this prospectus.</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may request a copy of these filings, at no cost to you, by
telephoning us at (704) 445-5800 or by writing us at the following
address:</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Level
Brands, Inc.</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">4521
Sharon Road</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Suite
450</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Charlotte,
NC 28211</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">Attention:
Investor Relations</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 48px"><font style="color: #000000; font-size: 13px; font-family: Times New Roman">You
may also access the documents incorporated by reference in this
prospectus through our website at www.levelbrands.com. The
reference to our website is an inactive textual reference only and,
except for the specific incorporated documents listed above, no
information available on or through our website shall be deemed to
be incorporated in this prospectus or the registration statement of
which it forms a part.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pn" style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">21</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; page-break-after: always; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
<div id="hdr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">500,000
Shares</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">8%
Series A Cumulative Convertible Preferred Stock</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-weight: bold">Liquidation Preference $10.00 Per
Share</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">_________________</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><img src="ycbd_424b5013.jpg"></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">PROSPECTUS
SUPPLEMENT</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;&#x2014;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font>&#xA0;</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0; <font style="font-weight: bold; font-size: 24px">ThinkEquity</font></font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-weight: bold; font-size: 13px; font-family: Times New Roman">a
division of Fordham Financial Management, Inc.</font></div>
<div style="text-align: justify; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;<br></font></div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left">
<table cellpadding="0" cellspacing="0" style="text-align: left; margin: 0 auto;width: 100%;; font-family: inherit; font-size: inherit">
<tr>
<td style="width: 50%">
<div style="text-align: center"><font style="font-weight: bold; font-size: 19px;"><font style="font-weight: bold;">&#xA0;</font><font style="font-family: Times New Roman; font-weight: bold;">Benchmark
Company</font></font></div>
</td>
<td style="width: 50%">
<div style="text-align: center"><font style="font-weight: bold; font-size: 19px;">&#xA0;WestPark Capital,
Inc.<br></font></div>
</td>
</tr></table>
</div>
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;&#xA0;<br></font></div>
</div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">October 10,
2019</font></div>
<div style="text-align: center; margin-left: 0px; margin-right: 0px; text-indent: 0px"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
<div id="pgbrk" style="width: 100%; margin-left: 0px; text-indent: 0px; margin-right: 0px">
<div id="ftr" style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px">
<div style="text-align: left; margin-left: 0px; margin-right: 0px; text-indent: 0px; width: 100%"><font style="font-size: 13px; font-family: Times New Roman">&#xA0;</font></div>
</div>
<div id="pb" style="margin-left: 0px; margin-right: 0px; text-align: center; margin-bottom: 6px; width: 100%; height: 1px; background-color: #000000"><!--page break--></div>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>ycbd_424b5000.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5000.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  M +4# 2(  A$! Q$!_\0
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M*U;4[>PAM[I99VVJ748'ZUQ/Q(\2_P!K:H-.MGS9VK?,0?OR=S]!TK&\$?\
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M%7?^_P#TKRG2(8[CQC;P3('CDN]K*>A!8UZMX#_Y!5Y_UT_I7ENA?\CQ9_\
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M/$8:C0A9N\C;!8[$8NJG%)06YYOJ_P#R&;S'7SF_G7>>'?$]M>6B074JQ7*
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AF:Z(98WZHHSC\3FBO0:*\VI7G4FYM[GIT\-2A!12V/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ycbd_424b5001.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )+ <8# 2(  A$! Q$!_\0
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M0ZU-;R1T%%4+#6],U3_CROH)R.R.,_E5^I::=F6I*2N@HHHI#"BBB@ HHHH
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MB9+6S#23%>C,HY)]E_G6A\1?#TMC<Q^)=+WQR(0+@Q<$'H'_ *&IM%\+G1?
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MC.UF=G>S/!X8N)T.'2S9P?0A,U\O7-XUQ(7D8L[?,6/<U].:O_R)U]_UX/\
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MQD4IC8=UHYAW9ZEX+\32ZWXT\LL3$MNY4'IVKT234;..1X9KF!' !9'< X/
MXKQWX6JR^,AG&#;O_2O2/$6EV"P7&KW$4SRQJHVK)M!P<#^=&Y<=2X]Y8LC2
M0I920!A\_F#&.Q_/BK%K=Z;!&9!+9P2/S(%F7@Y/O7*10VMY8R!;%0EPD>X_
M:L$A>1VIEIH.E:MJLEE+#<Q2Q1AA()0P('0=*IIC<+=#N[BY2*R><L-@Q@@Y
MS7/ZC?R&-?D98VZ =6J+QS(=)\ 7"6[,/+,<:,>O4?X5XU+XBU&:6*1[J3=&
M/EP>*A[";L='JMZLVIN!N7:<8:B&;(ZURCZC+-<--(Q+MUJ>+5WC/*Y%38BY
MV439(J]&W'.:PM)ODO(R0,$=16PAXII!<O1FO1/AGUU'_@']:\VCD]:]'^&)
MS_:7/_//^M"W!['G/Q<'_%P;KG'[B+_T&N+*YCQ7<?%C_DH%U_UPB_\ 0:XB
M53L*H=IQP:Y*GQL]&E_#1"G !/- (#_-QGI2Y**.<G%1O&2JG[W.6QV%"U8V
M[(LK;/<7L<"*2&[YZ^P/KC-%T6FU)(85$@ Q'CN!P./6KMI(EGITC3-E78B-
MR. "/O#W'2HM2OK>&\A%DDDTP01I(B9^8CJ .O-=$(KELSG=76Y(;86\;@[7
M6!@T\JG.UL<)^=4A<RW%R92%53T &!7<V'PM\1:MI4;[8;-G4EWF8JTI[$J/
M;UKB9EDL;N2QN5"2V[M&X!R,@XX-*MK&R1I1J*3NV6-V0W'..#5?S?-;&,'.
M:E@ N%GC68"=(S(L8&?, ]#ZUI6^BQV^G1ZA>AC"4!(4@'=GW]*PA2D;SK1N
M43:R+9&X.%"M@ \$_2LN\DQ\G&&Y8U9U+49KPAN6V#C"X"K6+(L\DN&!W$XV
MXK105[HQJU=+&YI+2V4,Q,?R3#:@XX./O?2J4ER(H$MS;.)9&7<RRG:<'(&.
M^*M,(IM.MHCE;R'JZO\ *4^M3:;I,VLAXK*V=[A6R2K  8Z$9Z5KH<4G=G36
M/@^;4[ W&IRF)IG!5=OS(/7\:[#3O!^F:1<*#9@Y "RL-Q_'ZUJ^'[.XM]+@
MM[MA+*L>6E( W-GD8]OUK<5)F \Q0,BG9"YF5[>Q=<^5A..@%%;%B@Q\QP:*
M9)8SR![#^5/&1WJ+)##..@_E3U//K699,II)[6WNHRDT22*>H89H!YZ=:DP
M:8'+7WP_L)G,^GS2V-QV:%L#\JS_ #?&'ADXDC75+5?XE'S@5WZGBG]JKE)N
M<GI?Q TJ]<0W.^TGS@I*,5U4,\-Q&'BD613T*G-9FJ>&M(UA"+RSC9NSJ,,/
MQ%<K<>"]8TB0S>'M4<J#GR)FZ_C1J@T-+XD^%AXJ\(7%O$O^F6_^D6Y]64=/
MQ&17RJ<J<,"I!P0>Q]*^E(?'6K:1<+;:_IDB<X\P+@'\>AKQ?Q5X<NKKQ-JU
MYID3W%DQ:Z5PN#M/)&/4'BCF0K')Y/('X5HV<=Q$8KE'6,AQM8MC!]:IV\9\
M_P N4;'7LW&W\*['2/\ A']/:.:XF\ZZ/S $;B/8#H*QK5>172N;X>C[1ZNQ
M[/\ #33I%T5M6O'$E_>L3(ZX"%1TP!WQZUW%>7^!O'%F]])IGV6XC\UC+DKA
M4/'RX[$\FO1!JEFTBIY\>6.%^;K2C5BUKN*=*49,N8I,4ZBM3,:0:,&G44 )
M12T4Q"4J_>%%*OWJ:W \N^,9Q)I'_;3^E>'^(SE8OK7MOQF.)-'_ .VG]*\0
M\0<I%]:KJ+H852 MCH*8H)8 5>%K(0,+D>U)M+<(IO8K8+<;<GL!WKO(?A-K
MSV<<YDM59T#F(L=RY['CK7,:3;LNMV&^/*_:8\@CC[PKWO5)M4B .FI$_)W^
M8?RQ1S*US6%/F=C@?!'@[5="\5)=7D2+$(G7(;/)Z5WVHZIIUM)]CO<L9$W%
M-FX$5E/>>(98V2>TBP>/E?\ ^O7/SZ9J\DN]],+D<9\[-*,UU-O96>GYG2_:
M_#0'-J@_[8U/;ZGH%I)OA587;"EA&0?I6#)X?@BN;(R!MCW,:NN>N>U;U[H>
MEVSH(]',X/.58\5JVDB8IR=D9OQ.@N+GP7+%;P232//'\J*2<9SFO$?['U08
M!TZ[!/\ TQ;_  KZ.M+S[,-R:?.I(P0[%L?G4W_"12*V!ITWU"5GS(;PTWT/
MF:>RO;,!I[6>%2<9DC*C/XU"I+FO?/BM(L_@*Z,Y.5EC:, #AL__ *Z\,LHO
M,?FJLCE:L;^@1F)"Q/+5T2/6/9+MC K21^U)@BZC\UZ7\+#DZG_VS_K7EJMS
M7IWPH;/]J?\ ;/\ K26XWL>>_%F<+\2KN-C@?9X3_P".UR?#*'!X*UVOQFT:
M5O%DVJ0@L!#&L@'\.!P?I7GMM<B5=K?>'K7+4M)MQ.VE)QBE(FE*GY0>IQ6A
MI>@ZI?7+0V-G<37"'@1KN7Z$]!64D9DE"YQD]SBO=?AGXJL9].M= :);:]BB
MRI# K/ZD'UK6G33C<BM-F3I7PGOK_3(;;6;F.R@4<Q6XWOUS]X\#]:]#T+PA
MH7AN%$TZPC1E&/-<;G/XFKM[JUIIZDW$N"O4*,\UD?VSJFJ,$TRR,41ZSR\8
M']*Z$CDU9T,D\4/S32*@]SUKY>\16MM8:YJD5RZLIG<PNK8<+N].GYU]"V>D
MPO?,UW?O/=8P41N!W_.O(_BQH=EIGBN&ZDB86]W%O&3QO7@C/OP?PJ9QNBH2
MML<:;\7-O'9Z?II2+.QF8Y8G_:856OLQ!+1W=Y(QE@&)0_[H_K2CQ#';K)&E
MJOER'?( ?OGW)YQ7HGA/X>3ZOI4>L7#1PRW(WP@ G"=LYZ?A4M)+E+C.S/-;
M2[GMB=BX!Y8,.N.U:LFOV0C#R6>9F)<X QNQ@?A77ZA\,KZQ#N\4ER=V[.[Y
M6]B0.*XO6K"[MX9(O[)9<R[O.C;><>A Z4XN45N:<R:*B7X^U2H%C6W1#M"C
MCW(]ZZ[X7V]M+XAO[BSD?8EL-T3?WB>M<#;C<<<#L<UU'@G4CH?BJ"4$BWF'
ME3'L%/0GZ&DIKX;"</=NCW.V0,#QSUJWN(&"/P(JH+@%L*"1UR#Q6E LGE[@
MH.1_%UIF R"?:Y!':BI8F=I&W0)@"B@0_(R/7:/Y5(HJ$_>7/H/Y5*I/0UF6
MR=,=_P ZE7DU #A:>K'IFF!9&*7-1K3P>*LD?GVI<TT&EH$-FABN(C%-&DL9
MZJZ@@US.H>!-+N#YEB7L)LY'E?<)]U_PK3UGQ-HWA^+?JE_# >R%LNWT4<FN
M"U3XJZA>,T7AW2?+CZ?:K_Y<^X0<_G4RE%?$-)O8\V\:Z$D'CF2QFN$DN71=
M[0?=#'NV>_M7-0B32KZ3,4:W"MQGH/<9J>%=;U[Q)/>JK/=/.999"<*I)ZFN
MV?P_I,-TEY?(;BX8C]WU4'UQWYKFJ2M*VZ9T0^"^S0_1K-M=LYKHW,L#J0 .
M4WMC).%_G74>&](TT"Z@%Z]Y=]29)2WE_P"Z/;UKG+B:\OY5@L&>& $QNBIR
M%Q@DYX__ %5J:>L/A*'^T;F\+PVP;RD(Q][&1GJ2<5C"DHRN]WT-)5W->7<]
M!\$:Y_:VCM;S2;KRR<PRYZG!X/XBNFKP?P[K_P#PC_C7[6)";#4?WA.>-K'_
M -E->[JRN@93E6&0?:O0M;0X_,6BBBD 4444 %.7K3:5?O4UN!Y/\:C^\T;_
M +:_TKQ#7'SY:U[;\;2%DT<GH!+_ .RUX'>W!GN6;/RC@53W)Z%8'#UJP7RQ
MJN8V^N*S((C/.L8[FNC\M$0)M' QTJ914MRHR<=A^FZK$=4LP5_Y;IU'^T*]
MUEN(T=D=T4G) 9@"17A5I%$+^V;8.)D.?^!"O7]<TFTOU>ZN5E+0QM@1MMW#
MJ0:48J"T-5*4PDM+.0LN7D0D;BD@Q5S3[*VMHV:)W <Y(=L[>>E<G;QVEU:R
M;(C&)HQ&W^D ' .?3KD4ZVT.TU2]D@\Z\A=$#[PX93CI]3S1&LI.US:6'E%7
M:V.DOMOVC3U_O7L8'ZUT)88(!()Z$"N6O!LN]&BR<"]49/4X5JLZSIUY-<M>
MPZHUK J!60 G.&SV/?BM=C&S;T-&:*7!C-_+'\V<J.?6IM/BEMX6\Z[>XW'*
MLW^?\XKF#:7YM)(X-5ERYC,;,C?)C[W/4YIL>F^(+J4BUUX*J,"T9W<#ZD4<
MURG2<5>Q'\5U>3P48XQEFN4X^F37CFEPOSN4BO6_BS.;?PK9IN?<]T!\@ZX4
MUY!97;02Y8G Z@\XHT,9G30_*H]*D28F8)&,@'DFLY+I73C.T*,@FIFN/W&R
M'*Y'4=A0^XB^MT#(Z@?*HY8>M>I_"&X6236(OXHS%G\0:\765$^Z>5X(!R#7
MKWP47_D,2%LL_E$CT^]0D)[&AXSA67Q!.& *M$JD'H017B?B;09-%N_M$ )M
M93E3_=/H:]@\=ZM!:>*)X&.9/+CXZ=17*WTT-W!+;S R*X!5 N2:\CWZ=:4N
MESV(1C4H1CUL>?:86O6/^J^7_GKG%;MK#/!(IL[N$3QCS(S'\IWCI]/3%8_V
M9_#VIR17,3/!<#Y>Q(]1V)]J()!+,)43 $IV("0&8#MW&1VKTXSCR7B>;/FB
M^6>Y](^$=1M?$OAZSO9E$DP&UU8?<<<%3ZX-:FH(ZH[R3,EJ !LC'.#ZUXQ\
M/_$CZ-XPDL9R4L=5(D3/2.4]/P(X^M>@>+?[3226Z-X(M+C5)"7.%1@<8. <
MY/\ Z%[5<)7V,''FT+T6O:=I3NC6\<<B1X6-"&D)SC!/09ZUQWQ5C'B7X;QZ
MO#%B2SG$A4\E%SM8']/RI)9+>,[%MEC@NW+*UQ^\(&%.U(QR1E05+=*Z"QBN
M+KPGJ]AK^V-;DN(&= DDB,.K(.00:N47:[+=-Q5]CYMT;3GU;6K.P3<?M$RH
M<=0">?TS7UQI+6HM8;:UD0I @15!Y  P.*\%^#^@O)X^N)9T/_$JC?=D=')V
MC^M>U7<FCV%^@FD^RW4PW(R?+NP?7I6/470ZE<;>M4KW1M.OU_TFTB<_WMN#
M^=9'V[6?-!LC!>(1D)(-I/KAAQ5PZVT"9N[.>$]\#<*IZ;B7D<=XM^%^B7NE
MWEQ9@VU['$TB2 \$@9PWJ*^?8;]O+D4YRZ[<Y[5]%_$3Q-;V?@#4)H9MLUQ'
MY,2X(8[CCI],U\XW.G7.GM&ES%Y?F('3W%39;HTBY(][\"WCWOAFQEGD$D@3
M#-G/3H*[>%SMZ'I7@7PQUW^S]1N-.DD 2<!X0QP"XZ@>Y'\J]H@U'S%1,%2Q
MQBFB&:T,@\T@MVHJM;H?-9B>,44 3Y).6'8=_:I 6  R#484\<]A_*I5S^59
MECT+X^G>I4SCIG!I5QTZTYW2",RRNL4:C)=S@#\:I"%7=G.?RIXSV^M<-K'Q
M2T2RD:VTI)=6O!P%MQ\@/NW2N0O]2\3^)B?[3OC863?\N=HV"1_M-UK.=:,-
MV.--RV/1-<^(&@Z&Y@:Y-Y>]K:T'F-^..!7$ZEXN\6:]E8770[(]!%\\[#W8
M\#\*H6ME8:3 ?(BCA7^)SU/U/>LC5/%ME9J1$1(W8DX7_$UR2Q52H[4T;JC&
M*O-EM-+M;9VG8--<'EKB=][G\36=?>)+#30?F$L@[ UGV.G^+/',VS3;246V
M<&9QLB'X]_UKT_PK\&M*TB1+O69/[2NQ@A6&(U/T[U<,.WK49,JR6D$>,6UU
MJVGZ@=8M[.6.UG)(#J0DBYY&:ZJW\5:'?8>YEE@?;MDC8<,.N#BO9_%_AN+7
MO#4NGPQ(DL2[[8 8"L!T^AZ5\MWEJ\5Q(C(R2HQ5D(Y4CJ*Z>2,GJ8\S2/0;
MOQUI%E#LLD>8@?*JC:M<7J_B"^UZ=3</B+/R0KPH_P#KUGI!O"D\DG&T=<_U
MK0ATRYE,<941>8K211DX,FW[R@]F]C5QIPAJ0YRGI_PQ<TZ6:>VBL#NEFC;?
M#&H^8@_>4?S_  KWKX;^(?[6T/[%,^;FS^3)/++V->*PZC8Z)/;B"V62WE03
MK(#EV_NX/4,.0>U:WA?Q4;#Q1_:4<7DQLP$\8/!4]?UYQ5-N6J0[<JU9]%>U
M%1Q3+/"DT;!HW4,I'<&G\]J@8M%)C\#1BF 9I5/S"DQ2J,,*%N(Y'Q]X9M?$
M<=HMP6!C#A2#ZXKRR[^#*')MKUQGH&&:]OUO_EC^-95:V!+0\8M_A/J-E*SB
M=9.,#BNF\.?#^TA!FU;9<3L?DA.0JCW]37H:YK UFR^WQ7%K]HF@\P_ZR%L,
MOTJ7IJ6DCF=1^'ZF_$UL\"1APPC VX .>O>M35-?M--*1N5E+$A@#]WZUCRZ
M&UH'A_X2#4LCG+9;\*IIX=?4IBL.O7:LJY.^'&>_?ZTFI-=ATWRO8ZC3I+34
MK87'V*-8V/RY4'=[UJ1>5 H")&B^BKBL6UE$,*1;P0BA<D8SBKBWI4 8!%=,
M*:BC5R<F:$T,,\D3O&K-&VY"1]T^HJ&]F@2,QW)_=.<<]ZA6[);Y><^]5]4,
M4MGY=PN]78< D'KUR*52"<0AI(GC_LPX"SR*.P#D5=LQ80RL89@7DP.6R2:X
M[0AIRQ:E<3":2*&YD^7>20J]AS6M9:SX6NF4Q&YC92#R7&TUR)VW.IIS3M=F
M-\7?-_LO2XXT9@9W8D+G&%_^O7DSV921MC-(#U*H<"OH*X?PQ?*AN]0E8)]W
MS)V %:&F6.@VV;G38(YM_P K2AM^?;)JU)O0Y)T4HW=[^A\X0K&)%5#\N>23
MRW_UJN_+*W+*"",*N!Q7I?Q7-G'H<*K'#'-+<+AD4 @ '/->3[-RY20949SG
MFMXNZ,+6+T-LB7*NNQ@#QNZ5[!\$G=CK(>/81Y1_]"KQ!Y);;;@AE89&#T->
MU_ V^>].M;QC9Y/X\-1/;0);&;\2H5NO'5W&ID,J0Q$!5!'3KFJ&C6C11%[B
M(HX. 6ZM[UJ?$B #QK<W E*L(HP-IQV[UJ>!_#-SK-E]NU.9_LA8B)1PSX[G
MVKR,2IUI>S@>IAYPHTU.9@:WI%MK6G&"0 ,.8WQRK?X5PUO<)I>H);7]L&6)
MMCJ3RF>K#U'<&OI)_"FD-"8UMRA(^^K'->0?$?PI<V%S$Y19E<%(I]N"1_<;
MW]#2HTJM#2>L?R,Z]2EB5[NDOS.)UR2<:/IUU%*LC1ML$J=E!RA/O_A7MWAK
MQ':^+/ _^F6\EU)*OV:X@BZEL=?;/!S7B3S6D/A^TMI#^]DD\IDQRNWJ?KFM
M7X>>(9/"?B<6]U(!9W3^3)SQ_LM^M=L),\^UGKN>X:1X?_L\KY<<%G$O!$1\
MR9QV#2-T_"MRVT^UAW>3$J.PY<_,Y_$T>:/LF44;5&3CM6++XILEO8K2%Q<3
M2<")#R6]">@_$_A70KR$E*3.;L[G3O".IZS>16KSQW=P)+QX?F:#@ 97KM/)
MS3M1\G7+O^TK*>*]M)$"H(Y<,F >WKGV-<-XS7Q.M[+XIL+1]+@MVQYB$Y?)
MP00?O#UXQ67I_CRRE8'6M),$P'-YIS>6?J8S\I_"EI%V9LK1T9Z!I%M>KK%O
M#$US!(\R[EC8C"9SD]N@YKU*0G;SWZUYS9WNNQ6EK/I.M6EQ \8:*'48#&X4
M]/F%:]CXAUF5[B+5[.PLXTA++<1W:L"WICKZTW%M71,XWU1YY\7[M=0\NUAB
M<& ^9)\W&.0#CZ#]:XO4;%;S0+*\BB)=(\22&0D #L,GWK7\5+ ^JW5TMW'=
M).5W('P4QT&/2M&#2=+CTI8IYI3 N':+=EMQ''R_YZ46=@5DM3SR*Q9N5!##
MD<]*]*^&5QJM[J5PUS=2S6-M'M!D.=KGL#]*FL_#&C26TF89FED<);HLIW/N
M]?I7J/AKPW8Z!HL5A!& J_-(3R68]23WK+V<HO4)N-K(?;2[7.T%N/2BMBVM
MHE<A5 &.E%49&?MR01SP./PJ.]U*PTJ#S]0NXK>(?WVQ7E;>.O$^L)]FTVSB
MM5&!]I8=1CL*K+H0GF%SJ]U+J%QZS-E5^@KDGB(0.B-*4CI]1^)[7&Z#PSIK
MW+CC[5<#9&/H.IKE[NVU37)/.\0:K+<@G(MXCLB7\.]6Y[FWLH\$I&H'  _I
M7,:EXPBB+1VPW,.XY/\ @*YO:U:ND59&O)"&K.DC2STV#;&D4$8] !6-J7BZ
MVM28X#N?'4C/Y#_&N(OM=NKQB7E//\*'G\3_ (5F9D?.YL GH*UAA.LW<SEB
M/Y39U+Q'=7KG<[ 9Z9R?\!7I?PD\&:-K>G/K>I6S75PDYC2.9LH,8YQW->.J
M@'2OH/X+@Q>#W[$W#G!_"NFT8+W=#&[D]3TZ.*.*)8XXUC11A508 IW?!J,3
M \'BI X YYJM!:ATZ5X3\8O"W]GZJNNVD>(;KB8*.CCO^->[AE/3\JRO$>BP
M^(-"NM.E _>+\A_NL.AH ^9K&2TMQ#+NC:VFB,=PO_+17]1W]",>E/)U+5RJ
M0PB-=^XSMP2^,,P],@C(K(U&RETK49K:9&1XG*D?W2#5R/6[F"Q=;9]K-]X^
MA]OK32ZE1:V9LIIFCZ1;$W<YDG<8P!ROKQ_6L 7:B[4QD[1P<]ZJ1I-=,[SR
ME%7EF?\ 2M6QTNXU)#!I5C+<,?O7## 'T/2KC[JU)J3OHCW#X8>(OM^EG2YI
M,S6PS'GJR?\ UJ] +#N:\"T72M:\(20:Q<26T:0L-R>;RRGJ .]>Z6EY#?VD
M-S&P,<BAE([@UDVN@)/J6-^.O2E#\<&H3E/NX*^E 93TX;T%*X[$V[GWI4;,
M@!J$'=PW7U%31C##-5'<31GZWU@_&LFM;6_^6/XUDBM@CL.!KG==O7L/.GC@
M>8JP^1.ISBNB%<_J$R&\=UD4J#]Y6&/SJ9O0UIJ[,2+5+K5)TACM+BWSD;SC
MY?<Y'^<UH12O'$Y>1G8DX8J ?I533K&WTR:YN_->26ZD9V9CT'91[5,+A=_
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M^C#\ZE%VCG 85Y]'>2IQN/-:^FW$CM\Q)-6KBN:VK@-&3FN,-MYMYCMFNPO
MS0$>U8UO8L)<^II30$MEIZL<XZ5OVT2Q@ 57AC$48]:M1=*J(F7X3S^%%01O
M@]>U%6![ P^8?0?RI!3F'(^@_E1BH$+BG 4"EH *4"BG4 )BE%&*=0(**6B@
M!**<!2TP&XHI:* $S13J2@!M&*=24@&D<5X9XW\.R6&O2705OL\[EA@>_->Z
MUSGC&R6XT&XDVY*+N)QDXK.I&\36E+ED>=^#G/\ :)?)S#;NP [9.!_.JEV\
MRZW,DN5:920OH:U?A]9%[?4M4EF,4>!%&Q_B.<G^E87B*4_;_M"N7._EC6*5
MH&K=Y%;6=;72KN",,6?&YN:W?#_B&VUB5Q S;E7]X&[5Y=X@L;VWU*6;+21R
M'<C'G&>U:G@Z=M-,TMPY3SL 9."0/:K=--7)522=CUN1$6&2<]D.>:YG6&6R
MT@%XB[."W7'7H*EFUCSK+YE>WM1R[.,%_85AQW;:K+ND.Z*,],_E6?+8M.XS
M0DD\U963ZJ>XKV'0$062O&WRE>1Z5YO9P['88_=_PG'2NPT&^:%A&>03TJX.
MS)FKHZ^FFE1MZ XZTIK<YR,BFM4AIC4#(CUK3TS_ (]V_P!ZLT]:TM-_U#?[
MU"W$SS3X^_\ (G:?_P!?Z_\ H+5\\U]#?'W_ )$[3_\ K_7_ -!:OGH#I39)
M:LUR^3VK>68+;E1Z5B0*>,5=;=Y?X4XRL.Q5N&#2$TV-BC9%7-'L8]2UVRLY
MW98IY@CE.H'M7KEM\,O"V_+)?O[&<?X5-]1V/(&N'"U3EG9F.17OW_"KO"4J
M8%O>+GN+@_X5SGB_X6Z#I/A>_P!2L);T7-N@=1)(&5N0"#Q3;N%CG?A4D5SK
M-_#-NYMPP"MC.&_^O7L4>CZ?+AGMU9L8R3DXKQ?X5AX_&#*> ]K(/RP:]B>\
MG0R1QX7;MQE22W/)X[4E'F>@.?*M2S_PC^F8S]C04W^P].S_ ,>R_G4%UJ5^
M;9_*CVLOW2(R?,Z\CV]C5=[S54N85N6\F-DY,46_G!_F>U:>Q9"K)AXKM;>V
M\':Q,JD%;5L'<:\)TV79/P:]M\<S3#X7:I+,OES-;KO4=B6&:\!TN9C<BLY*
MVAI>YZ+9*)X^?2EGTM'!^6H](?Y!]*W$ 8<T12L-G(2Z3LDX'%:NGV*H 2*T
MY8%)Z4T+Y:\4]A$4Z@D+4"QJ'SZ4Z1]N2:IFYV@\U#=V-%TG<P [5)N XJK;
M-N7)I7DQWK1"+#3!2.:*H-,":* /?3U'T'\J*5NH^@_E5/4-5L-)B26_NDMT
M=MJE^YI DV[(NTZN?_X37PX/^8I%^1_PH_X3;PV#SJL/Y&JY)=BO93['0TM<
M^/&_AO\ Z"T/Y&GCQKX;;IJT'ZT<LNP>SGV9OT5B#QAX>_Z"MO\ F:MVFO:3
M?EEM=0MY"HRP#CBE9D\DUNC1I:A%W;8S]IA_[[%.%S;GI/$?HXH%9DM&*:)$
M/1T/_ A3\^XH$&*,444 )BBEI*!!2$<4M% QN*IZG%%/I\T,P8QNN&V]<5>J
MIJ6/L,VX#&VD]AK<X&Y,%IIJZ98QF.VCS@=S7&ZNA"G,>X>A[5V$RDL2!DUS
MVJP&:)NS>E<TF=$4<:^H3Y\MT1HU]1S4)U-4=)H[.(^K'K3KNV?S2BKSGIZT
MEK8839(Q&.,$47'8=<7=S>_/,S<?P]A6YI-HL 55ROF#))I^E:6"^=F0#GGO
M6^FGAG#^O;%2V5$(49,#.#U![5J6Q52" 5(.:ACM@, YXZ5."J'/0THA(ZO3
M+@R1JI?/'2M(USN@L6G.,8 ]:Z(]:ZHZHYI*S&XJ-JE-0M3$,K2TW_CW;_>K
M--:6F_\ 'NW^]0MQ/8\U^/O_ ")VG_\ 7\O_ * U?/L2[F%?07Q\_P"1.L/^
MOY?_ $%J\'M(>-YZ"AB1HVEM@ GTJ2XB 4\46LP+8["KSP"9<YJTE;496\-H
M!XHTPC_GX6O>;4]_>O'/#U@$\0V+9SB4&O8K3I6;1:->(_+6/XV4R>"=67UA
M_J*UXNE9WBF/S/"FIIZPF@FQY-\/X5B\7VQ'>*0?^.UZY!,H;&\<>]>6>%46
M'Q5I[9'+E1^(-=1JUSK\%[(-/#_9@% *1@D'(W'IGIGU^E-E6.S35+43"%IB
M'+^7]T_>Q5CSX70/&^0>,UQ$$VN/*K,)@YF.6:*,*#G"^^W;R?>HI;KQ8XQ!
M')&SH-D:JNU2'(.>#U S^-2FRG%6T1I?$M\_#G4PI!WM&AQ[N*\#T^/9<"O=
M/'+2R?#H_: 1-*\'F C!W=3Q]:\ACM0KA@,5JDK&;U.CTJ4  5T-NX:N0MY/
M+P0:U[34%&/FJ%H!O..*H7$G84]M00QDYK.,IE?(/6G+8$%TQ*X4<UBR><9<
M;3C-=1%8EH]Q[TW^R><U"112MODA&?2J\\X'>M&:Q98R :S)M.E8=:NX%,7.
M9#SVHJ6#2)2[$^E%*X'T8PY'T'\J\Z^*Y?[)IB@93S')/OCBO1SU'T'\JYGQ
M5H%IK<MFUTT@\G=M"''6M*;49)LO#S4*BE(\<AAO)E#K+&.3C<P!XJ0:5<RR
MAY'A;)Y_>CD5W$GA?P]%=K;R7+"8]$,H!-7D\&:2/^6<Y_X'74ZR/3>,IKO]
MQCV\_A1()8AX>B<2* S/= G\#V_"N9O+2%[V>XL%@M8 <I$90^!]3UKT)O!6
MCA"3#+S_ --*KOX/T*-"[QR(@ZL9<"H52*,H5Z47>[//Y&OH$\PSQ,"<94JQ
MYJBIFDNSM8*[G!).!7J#>#-$C7+K+&"0H)EQDGH*9)X*T"V@>:=IDC499FEP
M *SJS4E9'33QM%:/\CSS[/>/'M\^+:W82"MC1+#0DC+ZU/=-,KC"03+M9?<U
MU%MX2\-WD?FVKR3)TW)+FI6\#:+C.RX_[[K&P5,50:Y;M?(X_6[736FC&A37
M,>XL7$]R-H'8#FJ'VW5K>#>LV(U[K+_]>NW?P-HN"3]H ').^FCP+H942>=.
M$;&&WC!STI$QQ.'2L]?5%?0-2U%K**X:YFRP))\P@#GT-;R:Y>J?^/R9OQ%+
M_P (F8;*VM[211$BD_O&.3FI!HNI(#\UNW_ A_A7;'DY4?)XCVKK2<;V;'6^
MK:U=2>5;7!>3&=I"]*OM+XGMX!))L?(R0%4E?K66-&U0*24AW=04(IJZ=JX)
M+6Y8]AOS_6AJ+>EC.+J)>\F6H_%=[D!O+8>OEXJS_P )7.@!=+?![DD5F&WO
M$7#::_X+5:XCD95 LIX_4E"11[. _:U4CL]%U5M6BE=HA'Y; <'.:;KS;;$G
MFCP]9M:6#(RL&+<Y&.U2ZU"9;%@,<5RU$KNQZ%%MQ3EN<%(2K\#OQFH+BV26
M,L<J3Q5EO*,YC+_-Z8JO,X@)Y+M[]JY&KG8FT8-SI023>0O'.3206J2;H]JY
MZ\59>?S'(G7&>E6+%%W;P  .,"DD-M]32M[!$B78<-BH(9-TC<@C..F,4IU%
M$LYF129(R,UES7CLCM&$P3D9.,4-!$W]K-'\I <=/>H&F5/E="'Q^%4[*YD*
MC)V^HST-6Y9MR%2P+=Q22&]S=\-[3*S<;L<5TQKG?#D(&&'.171UT1V.>6XP
MBHFJ9JA:J$1FM+3?^/=O]ZLTUI:;_P >[?[U"W$]CSKXZIYGA+3U_P"GY?\
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M3TSZ59=?,ASN;'/.?\\5DM&=^\[3D]CSGM4LI(L)K5RVX>HYJZ;F#6(#:W:
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MX'3L:DT!UDN+@I</*%X*,"-I_&J,A9\R3:9O;=@!200,>O?M6IH'V=EN9;>
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M (131/\ H'Q_F?\ &J0FSR^UF*LRG'3-%>HCPMHBG(T^/\S_ (T4"N;%%%%
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2B@!:*2B@!:*2B@!:*2B@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ycbd_424b5002.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )+ <8# 2(  A$! Q$!_\0
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M9B[^R&ZA%P?^66\;ORI\LK7L0JD&W%/5#/[5L_[[_P#?I_\ "C^U;/\ OO\
M]^G_ ,*NU6;4+-;L6ANH1<'I%O&[\J6I3:6Y'_:MG_??_OT_^%']JV?]]_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 52L/\ 77O_ %\'_P!!6KM9<%W%;7-XDV]6,VX?
M(3D;1Z"@"SJ.G6^J6C6URFY#W'4'U%<R/!$R@Q)JTRVY/^KQV_/%=+_:=K_>
M?_OVW^%.CU"VDD5$9]S' _=L/Z5I"K."M%F%7"TJKO-:F->>$;:?3+:RAG>)
M8'+9QN+$CG-59_!?S$6>HSV\+?>BZC/YUL:SJQTQ8@@C:1R6*NV/D')_'TIT
MNH337:6]EY/S0"??+G!!/ &*:K36S(E@Z,G=Q&Z-H=KH]NT<0+N_WY&ZM_\
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M&O\ ]_1_A1]4K?RB_M+"_P WYG<T5PO_  L9/^@8_P#W]'^%'_"QT_Z!C_\
M?T?X4?5*W\H?VGA?YOS.ZHKA/^%CI_T#'_[^C_"C_A9"#_F&/_W]'^%'U2O_
M "A_:>%_F_,[NBN#_P"%DI_T#'_[^C_"D_X64G_0+?\ [^C_  H^J5_Y0_M/
M"_S'<-;0/-YS1(TFW;N(SQZ5#)I=C+%'$]LA2,808^Z/3Z5QG_"RT_Z!;_\
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M2V_Z!\W_ 'V*/^%BVW_0/F_[[%<%BFD>U'UVMW#^R<+V_$[[_A8MM_T#YO\
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M'1T@MW<*&DA&"<< <^U<K/.;B=79$7& %08 YJHQ5R)2?*SZ2T#_ )$K0_\
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MCDNVFW*ID)3@G()S7/4UV.FC6I)N\D<QXQ\C^U7N841?-V!B!@MM&,FJ-C.
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MF:;DH[DP@YWMT,^K)_Y!6._VC_V6G6%NEP;GS 3Y5NTBX..1TJK$-TT:MT+
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M&I?\^-Q_W[->OT5X/U^7\J/H/[$I?S,\?_LC4O\ GPN/^_9I?[)U+_GPN/\
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M^S7MU%-9C-?90?V%2_F9X@=$U;_H'7/_ '[--.B:K_T#KG_OV:]QHH_M*?\
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M^'-;+'&DW?3_ )Y&BOHJBC^TY_RH/[&I_P S"BBBO,/8"BBB@ HHHH ****
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M9'MUF>V*6WS,XMY?,+[E.!@=.@&.:]#HH 9")!!'YVWS=HW[2<9[XSVI]%%
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MT\?F?SKUZN<L_"-M9^.+_P 4)<S-<WENL#PD#8H7'([YXKHZ8'G'Q9!-MI8
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M-D,21+_=10H_2@#@/#_B2)+RU%RJ27.I2$Q3B?Y6B8EMK]A(G"[3C/:O-I]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6I@SO+#_ )"<7X_^@FJ0Z"KMA_R$XOQ_]!-4AT%<2^-@_@0M3VL<#LWGN5
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MD2X9RLS[<@J!Q^51_P!FC_G_ -/_ ._W_P!:B,TFTQRIRDDUV,^DK0_LU?\
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M&$!YZD#J:U* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MR2,8SG- =64,K J>A!ZT!<=1110 4444 %%%% !1110 4444 %%%% !1110
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MG#_D9&_Z\Q_Z&:.;FW'&FH.Z;-*J%U_R%M/_ .VG_H-7ZH77_(5T_P#[:?\
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M^9^1*HQ\Q^FV]Y LOVR<2LSY4@G@>E7JSO-U?_GUM?\ O\?\*/-U?_GUM?\
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K!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@!:*2B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ycbd_424b5003.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )' <,# 2(  A$! Q$!_\0
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M]J9N^GY4LA^;\!_*F=:U.87?]/RII;Z?E1BD./6F ;C[?E2%C[?E2$@=Z87
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M?XU5GV(=EU*QDED8$N[$=,GI3)"V?G8D^YS6EY]JO_+E%_W\;_&JLUW;;O\
MCQB/_;5O\:>JZ&?,GU*9-!=RNTNV!T&>*G^U6W>PB_[^M_C33=6O_/A%_P!_
M6_QIZ]A:=R$SR_\ /:3_ +Z-1N[.<LQ8^YS5@W=K_P! ^+_OZW^---W:_P#0
M/B_[^M_C35^Q+?G^95))I":L_:[7_H'Q?]_6_P ::;NU_P"@=%_W];_&JN^Q
MBTNY5)II-63>6O?3HO\ OZW^-,-Y:?\ 0.B_[^O_ (U:OV,I*/?\RHQJ-F]*
MMF]M3_S#8O\ OZ_^-,^UVO\ T#HO^_K_ .-5=]CGE9_:_/\ R*HZ]*F"L>BX
MJ47EID?\2V+_ +^O_C5HWEKM_P"0?%T_YZM_C5J3[&4H)=5^/^13$8Q\W)IL
MV!%Q@5;^WV>[)L(NG_/5O\:8VHVC# TV(_\ ;5O\:?-Y$JEK\7Y_Y&;3S_JJ
ML_:[3/\ R#8?^_K_ .-/^UVA0_\ $MA_[^O_ (U/,[;&K@OYOS_R,ZBKOVNS
M_P"@;#_W]?\ QI/MEG_T#8?^_P _^-+F?8KDC_-^?^13I_6*K/VRSQ_R#8?^
M_P _^-.%W:>6?^);#Q_TU?\ QIJ;["<%_-^?^11[TF#5S[7:'_F&P_\ ?U_\
M:=<K;R:?%<16XA<S-&P5RP( !'7ZT.;35T5[-6=F4:*#UI*LR)4^Z**%^[13
ML2>E2GYZC)J1U)8G' Q4>&(X4UX1]NV317;Q\')JT=2"H<@Y["J2!HY%+KA:
MT(;1+NY5L?)'R?<]A0W97$H\SL.T^UMYW>XU .<C]W&!^IJ1?#\,H:2/3X&7
M.<F)>:T! *N'[5!;.L>" IV\>U<[;;.Z,5%61X-X^\123:C_ ,(]X?L4#;Q'
M)+#"-\KYQL7CI6GX<^$"Q6QU#Q.SS2(AD^PPMQP,X9NY]A74^!/"8M+7^VY(
ME;5KDMF64@K;J3V']XCDUZ!;VS+!MD<RD@@NPQG\*11Y;8^+VL],CN-.\(0P
MZ844[U0JJ D ;F*@'.>V:DU_5]*UO0UMAI1M-7N;;SHWA10T3<$'(P64CN,]
M_2O34L;6"SCM1'&MK&-JQ%1L4#M@UG:IIWA_48ECNI+-)$79'(LBJ\8]%/;F
M@#+TW3[:TM2L*'9<$2R*QR"2.?PKC_''@I-.C.K:1N^RMS- "?W7^T/;V[5W
MR1^6BJK*ZJ,!D((('N*<X+1LK %2""",@UK2JRIRNC#$8>-:'*SP'<W]YOSI
M0S8^\?S-;/BC1?[&UAXX_P#CWF'F0GT'=?P-8HKWH2C.*DNI\G6A*G-PENAV
MYL?>;\Z-S?WF_.D[45=D8W8JL0V2Q_.K7F8'WC^=5HH9+B9(85+R.P5%'4D]
M!6S_ ,(;XE[Z-=_]\C_&I=2,-V6J-2I\*;,E[@X(RWYU!N;^\?SJWJ&EWVER
MB._M)K=CR!(N,_2G7.C:C:6$5]<6<L=I+CRY6'RMGD8HYXOJ-4YJZML4LG^\
M?SI-S>I_.KFG:3J&KO(FGVDERT8W.(Q]T4^PT/5-4:9;"QFN&A;;($'W3[U+
MG!;LI4YNUEN4-Q]3^='S=<G\ZW&\'>(HP7?1KL*.2=E4H;"XNKE;.W@=[EB5
M6(#YB1U%.,H25TQ2A4BTFGJ4,GU/YTNX^I_.MS_A"_$F<?V-=_\ ?(_QK*N[
M&ZL)S!>6\MO*.J2+@T1G"3LF.5*I%7DFB#)]3^=&X^I_.K5AIE[JEP;>PMI+
MB4+N*1C) ]:BN;2>RN9+:ZB>&>,X='&"*:E&]B>27+S6T(MQQU/YTH=AT)_.
MF_PT#K5$CM[>K?G06;U/YU?T_3X[O3=4N&9@UG$CH!T8LVWFJ31@+G-).]QR
M7+;S&;F]3^=&X^II..YZ5O1^#=;E2%TMHRLR!U;S1@ KN&[TX!-3*<8_$QPI
MSG\*N863ZG\Z,GU/YUL_\(GK(:56MD#(=H4R+F0[=V$_O''/%3+X*UMF1!#
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M]U')R>(-4G\/6NBFV3[%"@0AD)+X.1GTQ5>&5(E _LFV)]2C_P"-=[]BNO\
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MXQ]<R"_UW3["Y>VECE+J 257CFJS>*+1-+21!<*K7##@8_A%<[XA5SK4W/\
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M;^8Q?)_*: \.S-;O<+=VQB&W:QR-V1G\.O>H_P"PS'J-Q:3S*OE(K!\84[F
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M6A1)8EB4#@;]Q_.NPT$J-.39]W)Q7!Q7DM]/DQA$'\([UW&@,@T](U;E#R*
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M/J>GW=UJ,DL40*D#!W5%%:ZU:H5@>2-2<D))@$UUW3BK,X'!J;;6YF?9Y_\
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M )_KC_OZ:CWV^AM&5.VYGB";_GC+_P!\&CR)_P#GC)_WP:T/M>K_ //[<?\
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M,J_NK89VHI:2NH\X***0TP)4/RBBD7[HHH).\E8>::KR-E:2:4>8<&H2Q:N
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M'_OZ?\*0Z8>HOK'_ +^G_"LG[>_=%IIOW_NK3Y'W#E_N_B:WV#L;^Q_[_?\
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M'*@#_P >'/UK+MM/O+T,]I$[A<AMAP1@9/Z"KT?AV^D2(F1$5G2)E=^5+,5
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MB#@FM.#7;JVLX[>-5'EH8UDW$':7#XZXZC\C2ZCKUSJ5DEK-'&B*Y8;.!U)
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M;+_P&3_"B\NP:]RF+2+9]YOSJ#[+%_>;\ZV1KCE#\ME_X#)_A4)UU\_<LO\
MP&3_  IMR[$QOW,XV<('WC^=!M(0OWFS]:T/[=D_NV7_ (#)_A1_;K_W++_P
M&3_"B\NP[/NS,^RQ_P!X_G2&VC_O-^=:9UV3^Y9?^ R?X4'79/[EE_X#)_A2
MO+L/7N9ZVL7]X_G3EM8LGYF_.KXUV3^Y9?\ @,G^%/777.?ELO\ P&3_  II
MR["=^YD&VCS]X_G3?LT7J?SK5.NR?W++_P !D_PIO]N2?W++_P !D_PI7D^A
M6O<S/LT?J?SH^RQ_WC^=:?\ ;LG]RR_\!4_PH.NR?W++_P !4_PHU[#5^YGK
M;Q#^(_G3U@C8_>/YU<_MZ7!Q'9'_ +=4_P *JW6J7%TFQDMT3/\ RRA5#^8%
M8U<5&EN=>'P%7$:IV7<0Q09^9R/QIC"V'20UG7%TL+*B@O(QX45KZ/H%]JLJ
MK)*$)_@C7^IKCEF4W\*/2ADT$O>FR-4MS_RU-2"UB(R&)'UK>U;P!J.FV+7D
M3B>-!EEQ\P']:Y1)&3!5B*J&9._OHBKDVG[N>OF7?LT9Z9%'V6/U/YU'%=;C
MM?@^M6/QKTJ5:%57B>'B*-:A+EJ:#4B6(DJ3SZTZBBM#F;N(12=.M/'2FMWS
M0!*NW:**C0':**8FB_*1YC?6H1DFG."TS4TGL*Q2)D[LSKPXN6J>89T2Q_ZZ
MS?\ LM5[H;KEL^U6KCC1;$?]-9O_ &6A[H[Z;]SY%$>E'/KTHZ"@D%<BK(ZB
M[:"1T[UW^NZ!IEI\,K'5(+54O91%OE!.3GK7GHZ<#FLJ595$VNAT5J$J32;W
M2?WCP>U!Z<FO1M)\&Z+H>@QZUXJ=F:4 I;@G ST&!R6JQ:1> ?%-Q_9]M9R6
M-TPQ$V-A;Z<D$^QK%XM:V3:74W67RT4I)-].IY@.> 3S1M//3BNF;PL^D>.K
M+1[\">WDG7:QX$L9/\_6I_B/I%CH>OV]OIUN((6MP[*I."=Q]:T6(BY**ZF3
MPLXPE-Z6=CD,8/(ZT8YQ5[2=-N-:U6WT^UP99FP">BCN3]!7HEYIO@?P;Y=K
MJ<4FH7Y7<RXW'ZXR **E=0DHVN_(='#2J1<V[)=6>6D$=<F@9'6O4'\+>&O%
M^ES77AAC:W</6%L@$^C ],^HKS&1'CD:-P5="593U!%.E652ZV:Z"KX:5))M
MW3ZH2FD4]6 X8<&MJ*",^$+^3:-XO8@#CD#::UD[*YA"-VS IG4U(X^;&:8O
M!H&AP@F.S$,IW_<PA^;Z>M(8905!BD&[.W*GG'7'K6S;:[';6$5JL=Q]UEE;
MS>>1C*<?+@?S-3)XJ03^9-IZ3+OD)5I""%<C(!'0D#GZFL'4G?1'0J<+;G/A
M'8 JK$$X! SFE,,PVYBD&X97Y#R/4>M:5EJ\5G%L-L6,<SS0[7P 67;@^HQC
M\JO1^)DCDAN19&6ZCC\M99).,< \#V&/QH=2?8%3IVNY'/I')(3Y<;O@9.Q2
M<#UXIF#GC)^E;-GJ\5G)+L@E2)KD7"+#+M(QT0GNM6(/$44+><ECLF(VR.A
M &UQ\HQP?FS^ INI/^4%"#^T<_M;R_,VG9G;NQQGT^M-_&NC7Q+ L$<(L6 0
MY&TK\AVA<J,>Q/.>IIJ^(X%C&S3(U(9BO *H3NY''7YAG/'%+VD_Y1^SATD<
M^48('*D*20&QP2.M-_$5MV.N)9::MG-:^>1*TAW$;6W;>O&>-O&#WJ5/$<0P
M\FG1NXF\P\+M^]N!Z=<?+Z8[4>TGV%R0:^(P,>]'XUT$/B.%(OWMBLCLT;2@
M[=DFWKD8X)XSCTJ'^WT35+B]CLXU\Y$0*57C# D],9(&/QIJ<^P.$/YC+'^K
MZU$48*'*D(Q(#=B1UKI1XCB\F<2:;"9)$*[RHZ98@8QTP0/^ BG+XJM08]^F
M>8D8?"%EVC=MRH&.F%^O-#J3_E"-.G_,<T\$L2JTD;HK="RXSWIA!!YXKH$\
M10@%9;'>#%Y?WAG[BKU(X^[^M9NK7YU.^^U%2K&-%*G'50!QCMQ3A.;=FB91
M@E=,SS]:7%+MH%:F=Q *D3O3!3T[T(3&&FXIQ^]24#0F.:.IP.IHSCFD1QG(
MKFQ-;V4+]3LP>'=:I9[(F4 #@4$X'2@'(JCJUT;6S)7[S\ UX;;D[L^F45%6
M10M':YU568Y+-U[ 5ZCH$YA8.@E,A;RX8H@"TC_4\ #%<"FC-IUK:WF6<NVX
ML!QM'4C\37HO@/7+<E$DB5HU;)R.0?6D,[2U\0SW^A&R>W:+49%^7?A0?Q[5
MX_JD;1ZG.K6QMFW'=&6R >^#W!KV[5[6WU![*Y@G2"/=\[8R1CIQ^=>>_$8P
MR7-C*D@EE(=6<*%S@^E '#8!J>"4@A">.U0XHK6C5E2ES(Y\3AH8BFX2-$45
M% ^Y #R1UJ2OHJ<U./,CXFK3=.;C+=!1F@GFH"VXU39*C<LJXQUHJ)?NBBBX
M<J+\^/,8"HQR:?)S*WUI5&!6=C%F;=#_ $EL>U3W'&C6)XYEF_\ 9:@OB/M#
M?A4L_.BV/_76;_V6E+='?25X_(HEO7)H()!I0!2XXZ8JK"OJ>I^(R/\ A3FF
M9](.M>80R1I/&S$%5=6('IGFN[L/B3:VNAVNE7.BQW*6\:H=\@PQ'?!%5M3\
M<Z9J&EW-I#X;MX'E0JLRE<H3WZ5PTO:0O'EW;/5K^QJ\LU/5):'0_%.":^T;
M2]1M TMG'EG*<@!@,-_GUK@/"]G<ZAXCL8K,,9%G5RZ]$ .236KX<^(-_H5J
M+"6*.]LEX$4C<H/0'T]C6Q/\4(K>V==)T."TD?K(Q& ?H!S2A&M3@Z:C?S'4
MGAZTU6E*S[6-;QE<0R?$?PW N#+$X+X[9;C^1K"^+1'_  E%L"0/]%'_ *$:
MY2VUN=?$$.LW+-=3).)GW-C?CM[5VMQ\3K"]F#W/AN&:11C=(ZL0/Q%)49TI
M1<5>R&\12K0FIRY;N_R,;X93P0>-8?-90987C0G^]P<?I5;XAV5W9^,KZ:='
M\NX8212?PLN,8S[4WQ%XIM=9:T:PTR+3)+9R_F1,,D\8Z =,5NVGQ0=[1;?6
MM*@U#:,>8,#/U!XS]*IQJ*I[51^1,9T72="4NMTR;X16=U_:-]J&TK9^2(MQ
M& S9S^G]:XGQ#<0W?B/49[?!BDN7*$=QFNCUWXCWFI6+:?IMM'IULPVMY;?.
M1Z C@?A7#YV]N!6E&$W-U9Z7,<14I^SC1IN]NH\CC%;EHY_X0N_SVOH?_06K
M!#]<?K6U;<^"M0_Z_H?_ $%JVJ;+U1STEJ_1F&Y(D//>C&X4C#)S0AYQ6AGT
M-ZSUBSM]/M[=I)C,H<&3R5)A8C *<\@>_4GVJTGB'3%E#FTD">9N\D1KC._=
MYF?7'&*J6NI64=A!'<V\$C(DX<>5M+?*/+!8<]<\TZ/_ (1OST619/+(=B2S
M=<C:I]L9Y^E<;BKZIG=&;LK-#)-7MI-6NKE5>'SH%C29(P6C<8RP4GOC'7/-
M6FU/2;N"3S+<8A#R(K@!I)#C;P.Q()85G7O]ABPA^R_://)._G)[\$'CTY%7
M9KG06WE8%,>2Z0J749*H.3UZ[N^*'%;V8KOJT-.J:3-^Z.G1HI. PCP0,+@D
MY_O!B?8U)-J6AK-(BVA>,R EDC"J0"VWY<\XR/K3%_X1@R2LR3*H#!%#MSAC
MAL_WBN/:JEK+I@L$:?9YT:2JT;(29"Q&PY'8<T[+LPYGM=#+?4Q:2ZAY3,(K
MB,JFR,*-V1SCG'&?SK0AU30S,WVFP;[.)'*1(@P%.T#OUX/-2O<^'#=R2S$,
MLL8B$<4/RQ9)RP/&2!CGK]:SK232DT[9=1^?,CR$ ;EWCY0N2.<?>.*/==]&
M)-Q=KH6^U'3;G3/*6W8782-%?8,X4 ')STZU875])C\Q$L@T$ICS&80"JC.1
MG/+<_>XIZGPW%!)"I9EDD4;FW;^"WX!?N].>M1JGAKG<9,;ANPS\?=SM_P!G
M[W)YZ4M-K,O7>Z$;4M#CA@\G3RTJ1E6,D8P3E>O/)P&Y]Q4R:AH$D$TCV2HV
M_ C$0.Y,MP.?E."H)]:S+4Z8?M3RH$?S0849F(5/;'5NG7BM%F\-W5S/-(&@
M5_,VHF_&=QVL/0XQQTIN*6EF)-]T.CU316*M-8.Y&S<K*"6P%&=V> ,,,=\U
MC7UQ;W$R/! L),8$BJ,*6R>0/IBM+?H#1^4L3H^,>:)&Z[5(.#QRVX?2K,Z^
M'(IYH$<[?,_@9F0@%MN2>?3./PIQ:B[I,F47):M',&D/TK:NO["%O,ENC^:5
M=EDW-A6&W:H']T_-UYQBL6NB,N8YY1Y>H9(%)FEQ2;:HD0'FI$[TW:!2KWH$
MQIZTF*4]:,\4#(I6VQFJJ2\U+=MB,U15^>M>1CY7FD>_E44J;D:<4F>*R_$#
M$B%1TY-7+=993^[C9OH*DU+1[RX6)A PX/7TK@/4'Z'XEE@TS[%+#!<A4=81
M-G*$CL:V?!EY:[)%FD$<@[GBN.ATYS:SR!OFMF7.WOFM^VT2":R@G#/OE;#
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MQT91FMJWTN9%DB128XW#_2M3P1;_ &;PLLFY6\R9V^N#@']*[BVMK.31A<L
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M-:7VRWZ?V/;_ /?<G_Q5--Y;XP='M_\ ON3_ .*I7?8I6_F,WBC K0^V6_\
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M..L=K?F=*P]2$_=EO?\ *Y4T[QEK&DZ"VD6:0I;,K OY1W'=U.?6N; . >2
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M2?[E]_WVG^%2!M*[)??]]I_A1!J.R%4BY;LKY%7K'6KK3TC2 IM5G;:P^]N
M!!_*H\:6>JWW_?:?X4H_LD?\L[W_ +[7_"K;4M&B(KE=TRVGB.^61)2(6E3<
MN]E))1LY0\].3[^]2?\ "2W@2,HD0F4DM*06+9?=CKTSCWXJANTK^Y>_]]K_
M (4;M+S]R]_[[3_"HY*?\II[2I_,3G7KQ8S&B0!0N(_E/[O@@XY]"1SFJ[:W
M>/=Q7#%/,BD>5>#U;K^%*6TK^Y>_]]K_ (4UAI77R[W_ +[3_"APATB'//9R
M+,?B*^%M%;OY4D*1^458'$B]@>>WJ.:#X@O3 8OW2AD,;,JX+#:5'Y D"JP.
ME?W+W_OM/\*<#I7]R\_[[7_"A0A_*#G/^8FGUNZN#;EUA#02^<&"GYWP!D\^
M@'2H;K5[JY0+(4P'1P .Z#:/THSI7]R]_P"^U_PIK'2L?<O?^^T_PI\L%]D.
M:;^T2R^)M0GC\JY\F>'+YCD3(8,02I[X! QZ4R/Q'>0QK"D5L+= -L'E#:"&
MW!O7.?>JY;2<_<O?^^T_PIN=)_N7W_?:?X5GRP_E->>?\Q(^N7TTR7$K(\R1
M20^9L )5\YSCN,G%3_\ "2WY2166%A(A4[ER.0!G&>3QWJIG2?[E]_WVG^%+
MG2?[E]_WVG^%%H?R@I3O\1;7Q3?I)Y@2W$F_<&V'()QN[]RHS^F*KW.JRSZ9
M;V&T@1RM,[DY+,3D#_=&2<>I-1YTG^Y??]]I_A1NTG^Y??\ ?:?X4<L/Y1N4
MGO(M'Q)<+=M/'!"#YKS)N!)1V #'((].AIS^)+R6W\B98V"Q-&I QR5VYQTZ
M=A@53W:3_<OO^^T_PIQ;2?[E]_WVG^%+EA_*'//^8H-P,4VM#=I/]R^_[[3_
M  I,Z3_<OO\ OM/\*UY_(RY/,H45?SI/]R^_[[3_  I,Z1_<OO\ OM/\*7/Y
M!R>97MOOGZ5KW!_XDMG_ -=9O_9:K6YTK<<)?=/[Z?X5-=W$$EM;VUM'*JQ,
M[$R$$DMCT^E%[M:$223;N4Z506;%)WJ>-<5JD<TG8G1<(**<GW116ECG;=R:
M3B5C[TSH!3I?]:WUJ,]:R1(HZY]Z7/!]Z!CT-*%SUQ0 QXU8 .,Y%5D%[ILS
M3:7=RVLC##&)B-P]_6K8'S#-'&/<=:B=.,U:1K2K3I.\694UY<MI>HV5U;+,
M+N$1AP<%&#;@WO\ _7K)MI;F*U%O<@OM& PZUU!12W(IOV:$DAE'Y5R2P$&]
M#U*><UHZ2U.7MXUAE+I =QYZ5J6%UJ=IJ$=_ 0L\9_=EQD1G&,@>M:@AB'\(
M)IX 7' ^E$,#!;BJ9Q6DM-"C]DDNKAKJ]D:>X<Y9WY.:MK$H7 51CVJ4\,>V
M:3!SC-=D(1@K(\RI6G4=Y,:508&T?E0$0G!4?E2\$@9H''Y\59G<;L0<[5_*
MC8G)POY4YCSG;UIO./H>E [L0JN#E5/X4FU=N-@S]*<W4#UHYS0%QN%'\(_*
ME* \;1^5+@D^E(>,#OWH'=AL4#H/RHVKTVC\J/0=*#P>!1J%V)L0# 5?RI&1
M<_='Y4\=,4TG.?>F";(BJY^Z/RII"]-H_*GGK24B[C-J_P!T?E2[5_NC\J6B
MEJ.[#8H'W1^53(B;?NC\JB)SBGHV*:)=[$NU1_"/RI"%Q]T?E32V1FEXQ]:J
MY&J$VKUVC\J< GH/RI*0'FBX]1Y1?[H_*DVK_='Y444Q78FQ?[H_*C:O]T?E
M3J2C4+L3:O\ ='Y5'(% ^Z/RJ6H9C294;MD.U?[H_*DVKZ#\J6BHU-KL;M7^
MZ/RHV+_='Y4ZBF%V-V+Z#\J3:O\ ='Y4ZB@+L;M7^Z/RIVQ<=!^5%!/% 78W
M:O\ ='Y487^Z/RIU-H'=AA?[H_*DVK_='Y4M%(+L  .@%+GG-)10 Y%RV?2K
M ID:X7ZT_O6D3*3NR9/NBBD7[HHJS-DLO^M;ZTP<T^3F5A6?=,PFPK$<#O7.
M.,>9V-#I31G/%9GF.!]YC^-&]A_$WYTR_8^9J#(ZYH(([=:RA(^>7;\Z7>YZ
M,W'O3N/V+[FIM^7IS1SM ].M9F]B.6;CWI-[9^\P_&@/8ON:0 W 8YI3][\:
MS&=^S'\Z!(_4EOSI![!]S4." 1Q3<^]9I9\?>;Z4>8VT#>V?K3%[%]S2Z\C\
MZ0YR#UK-:1]OWF_.CS'SRS# ]:!^Q?<U"<C&.!3>>HZUF%VY.X_G2!WS]YO?
MF@?L7W-/!R:.]9N]^N\_G2>8_P#>/YT!['S-'GI1R#GUK.+/Q\S?G2AVY^9L
MX]:!JB:!Y'O0:SO,;H"WXFEW-_>/'O0F/V1HY-(<YZ=:S]Y'&6^N:;N?LQY]
MZ&Q>Q9>;BFU28MW8G\::6/J?SI-EJD7J6L\LW]X_G2;F_O'\Z!^R9H4H.*SM
MS?WC^=&]O[Q_.@7LC5!I0>W6LL,_]X_G3P7'\1Y]Z:9+H^9I=N:<N*S-S]-Q
M_.E#N.,G\Z:9+H^9IXHQ6=O?^\?SI=[?WF_.J3%[%]R_16>9&[%OSHWO_>/Y
MT7#V3-"F/&'Z\&J.]L?>/YT;V_O'\Z!JDUU)F4H<&DJ$DD8))_&H6#KT8D5#
M1HH7+=%4=S$_>/YT;F_O'\Z5RO9%ZBJ.Y\_>-!8]BWYTKC]DR]251W-ZG\Z-
MS>I_.G</9%[-)5$LP[G\Z-S_ -X_G2N/V7F7J*H[G_O'\Z,OZFBX>S?<O4Y%
MRWM6?N?^\?SJ92P'4_G36HI4[(T@.**H[V_O'\ZN1\QKGTK5'/*%M29?NBBE
M7[HHJKF3)I.)7^M9MT#Y_3J*TI?]:WUK-NS^_P#PK!&E+XB#_)I<\?2D//>@
MY! H.FP<DU/911S7]M#*VV*255<YQP3@U /UHZ4GJK#6C.RLO"]F;ATOEFC
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MH*0G:S;6.<@_+W'TK/N+^_G9V>ZD<NK*VX]0Q!8?B0*8-5U!(4@6YD6-.%4
M#L1SZ\$CGUJ'"K:US12I7V+R^%=3>W>>,0R1#!C99.)00#\OX$4Z/PQ<RVUZ
M\4T$C69'G>6V5C&&W;CV(V_K6:-4O_LQMQ=2>25";.P &!CT_"I&UO5&?>;Z
M7=P<@@9QG'UZG\Z7+6[E7H]C0D\)WOEM-;M&\(5"&=@I8E58X'MN%8]Y:/97
MDMJ[QN\3%&:,Y7(Z\U*=6U QM&;N0HQ!(XZK@#'IT'3TJL7>:9I)&+.[%F8]
MR>IJX*HG[S(FZ=O=0]1Q3Z04M="1RO<6KD?^J7Z52J['_JE^E-&=38F7[M%"
M_=HJSG99ER)7.:S;S_7=.U7Y?]:XSWK/NL>?@>E8%4OB(#D4H.*,8]Z0>M!T
MAMSU[UU,GBU)9)R;%1YJHC."-S*I4J#],'\QZ5RW:MS3;2ROM.BB:!$NI;G[
M.LP=B<E<J=N<?>P#QTK&JHVO)&U%SO:++'_"31H1)!#+#((Y$5%*[%+!@''&
M<\\_2G_\)-9?9YD?3#))(R.VXC:S#;STXSM/3UJ)=!L-Z1K=S23$R@QIM&XQ
MX!5<]RQ.,]A3;O0["WM[CR[]Y)XTED7 780C ;3WW')Z>E96HO34WO56N@W6
M-=AU.":&.W,0=XW4G /R[N#CK][CZ5=O/%=M<[\64IWL[_/MPI9 O8<],Y-,
ML-&TF^L+9VG$,]TGEQ@R<1R(<R,WL5QCW--70=.N1'-%>-%'*^4W%2&!+?(N
M3G< !G/'-)^RVL] 7MK736I8D\3Z>\4LGV:;S7D7,7RXD 1A\W& N2.!Z53?
MQ)$Z");/$11E=6P0Q**JGIV*Y_&K4/A_3HEDE>9Y0(9&,;,H\A@F0LF#RV3Q
MCCBBX\/:8(VN1J#(K7/EK%&H8(-VT ]\]_I4KV-^I3]LU?0I^(M3LKZ"TBM'
M,CH\DCG'"AL84<#@8/';UKGLX.#5W4K-=.O7LQ)YDD0"2L.F_P#B ]ATJD!Q
MFNNG%**L<E63E)W'<8--YP*4\\^E)Q^=:&9?M\_V!??]=H?_ &:J'.W)[5?M
M_P#D!7W&/WT/_LU4!W]ZB.[_ *Z&DME_7454>1T5!EG8*H'J>E=+>>&K6%E>
M.]9;>*%S.ZXD/F)C( !Z'/&?2N9Z$<D8.1BE#,,@,>>O/6E.,GL[#A.*6JN=
M,GA))[X6T6H[EWM&\GD@;6&WG&>1\PJ'_A&$++ -07[2-ID4Q_*%+%>#GDY7
MI[USXD<'(D<'/4,:-S9SN;\ZCDJ?S%^TI_RG43>$8WM?.AN)(O+M!*PFCP6?
MYB01G*\#WJC:Z3%<:?9ND,TKW1(-P' CMCNP PQZ<GZ\5C>;)\Q\USG[WS'F
MD#D(5#L%)Y4'@T*G.UG(;J0OI$Z.Y\*Q6\_E-J:L6EBA7$7.YR1SSP!C-0/X
M;B=&DAU$-$L9F<O'M98U9E9L9]5''^T*Q'D<MGS'/N6IXN[B.VDMUE812XWI
M_>Q1R5/Y@YZ?\I5'3/2BG=:,5LD8W+VK'_D'?]>,7]:SP.>*T-6'_(._Z\8O
MZU1 J:?PEU7[S-[0M#M-5M<RW!BN&NTAC4G"NN,L,]FQT_*KD/A*.2VAN)KR
M14EW@1)&"^0K,N.><[<5S 8@<,1SG@TX2R  "1_EY'S'BLW2FV[2+C5A;6)T
M)\,6]S-"MK<NI\N$SHR [2T98D$GGH<CM5:]\,I9K<JVH!YXO.**(OE=8]N<
MG/!.[CZ5BK(^[(=L^NXTV0N3N+L?7FCV<_YA^TI_RF_::3ILEIIF]E,]U"\C
M@S$,,;\87&,?*.]%SX7CMH6FEOR%CC9F/D_>("G*<_,IW8W>QKG S9'S,,=,
M'I3B[D %V( V@$]!Z?2E[.?217M(=8G47/A6WL6Q/JH*K&&8QP[CDLJ\<\CY
MNOM21^$V:XAMWO<-([ R"+,8"EAC=G[QV]/>N8WN<9=S@8&6/ ]*>DDGW=[X
MSN W'KZ_6FH5/YB'.G_*7-2LQI^H36JS"98R!O QGC/(]:HG@Y'>I"Q.2Q))
MZDGDTQNE;]-3%V;T+^GG_B6:M_UQC_\ 1@JA5W3R/[,U?_KA'_Z,%9X-1!^\
MRYK1#P<4H--X:CI6IE8?FNH70H'LX UI+;W,L#3%Y)"8U7 VYX^\>N.PKE@:
ME\Z1EVM+(5]"QQ6=2,I6L[&E.:C?F5SH6\+Q1L6FU!XXPP3YH/GW%]@.,_=)
MY!]*KZ7HUC=-=_;IRBV,W^D,AZQ<@E??=C\ZQ#(Y.2['@#)8]NE)D\_,>>O/
M6H]E-JSD5[6"=U$Z%_"UM;W<$$ET3*)HX94QD.SY(Y!X 4#\326WA.W7RY[F
M[=H3PY6/Y?FC9P5;/S8VX(XYK W-_>;KG.:GEO[N>VCMI+AC!']Q.@';MUJ7
M1GI:1I&O#6\2QJ.B066D+>17$L[M*@'[L*H1D# GG@\X_"LE%P,T\CMN;:<<
M9X]J3I6L(.*U=S*I-2>BL.HI*6M#$*N1?ZI?I5*KD?\ JE^E-$5-BPI^444B
M'Y!15&#1/+_KV^M9UT/WV/:M"1CYC9]:S[L'[1^%8E4OB(.AQS001UI>>M%!
MT"\>]7=-M[AS)=0W2VBPX5KAG*X+9  QSD\U1&<^U6K2^ELUE14BEBDV[XY4
MW*2.A^HJ9WY="X6OJ69]"OHH8)EB$L4X!21&&"22!U^G6F_V'J0+@V4JB)@K
MDCA<XY]QR#Q3X->O8)%=#""JHH!08 0E@,?4FIY?%6K2QR(SJ%E(/0C& !QS
MW '6LOWR[&UJ+ZLJC1;EFOLR1JMDY25CD_-ST !XXZGBD&B:DS(OV)QYB[@6
M('& >>>."#S2V^L7=K>SW4:1"YF8N7*\J3G./SZ5)-KE[/!+$YA F0B;:F#(
M2 -Q]\ 4_P![?2POW5M;D+Z)J<<1D>QEV*Q4],Y!P>.O4@?C4\>BZU;W.Z*T
MGCFB (=2 1G.,'/)X(Q[4C^(M1:Y^TAXUEVLH95Y&6#']5%23>)-1GF6:0IN
M$B2@8.-RDD=^F2:+U>R#]TM=3';)+;B2Q.2Q.23WI,#'6AV+,6./F.3^-&<@
M"MEL8,,\>U-.,?SI3P/2F9XZT :5N?\ B1WQS_RVA_\ 9JH$]Q5^V_Y -_\
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<DA2444 )43/SQ114R9<%=CUD.VBBBG=E\J/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ycbd_424b5004.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "> 0,# 2(  A$! Q$!_\0
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M].NS#;_9$E95'WV+8^;U&!TH0J=13C='1ZY:7$&HQ3VD5[<?:"S2E9FV1>F
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MEQ?31BRTS3M-P &$=TSEC]3FNV\)VU[IUT$DDB+,0IV\X -="ZO &^S6%NH
M') S3U<,(2 @)92VSIG-'L^5W8_;N2Y>A:UG3[2_U ?:8!+LC&T9Q5"?1[.*
M,"#2U<GJ&DQBK'BA;\$R6$IAD1 2_EELCG QCU(KDWGU^*/?*L@90V62+&.!
M@CY?]X]*:DD82]3O-#MHK4/'#$L0*@E0<X-:4>TRF;R5+XV[NY%8GA;SC9[[
MB3S)&7<7)Z@DD?ICBL[6'UF75&71[LQ6Y49^Z1N[XR#6E.G*IHB*M:%)7D;U
M]:619I)+* M(?G.P$M]:GT^"WMP7@M(8V8<E5P37-::VI"*5=3G,TQ;*DLN
MH_"N6UG6];GUETT.]E2UV@8!ZL.I QTJ*D'3=F=>"I2QBO2/4VE9IFA.U5,9
MP!UKY5\6^)+[7M7D2^"R16KR10JB[0!GVZ]*]V\!Z])+%/::S<EM09V='=\C
M8!T![8YKC+WPYX)O[^X>.PF>1MSDP;@I]2,5E*I&*U-*F%JPFX-;#?A3XHU'
M4K>]TZZ\F2VL+53#E!E0,CD]^E>9>(_$5WXFU0WMZD8=5\M%B&%50>U>U^$;
M7PIID-XNG1BWE:$FX,S<F/GOZ#VKQ+5[.PN-=O\ ^Q!,=.0DQ'!;C_#/3-.,
MXM71DX23LSV#P?XRO/$?@;5&U+R)9M,($:E?O((S@L._(KQK5=8N-;U W]S%
M&DA55"Q+M50.F!7KGPV/AA/ =W!A8]0(SJ@E8Y9,D C_ &<'M7FVH^'X&U"\
M.F";[$LA,(()^3MR/ZTI5(QW'"E*>QZ9X*UE=;\)7]Y>V]K]KMG8(1&,X"9!
M/XUY-K_B;4O%-^M_J6V29(5B4H,!5'2O6O W]AZ=X*N(MZI(HW:B)#R>V?IC
MCBO(M4L[&YU74[C1[>;^RXY"8.&.V,GC)Q_,U2DGJB'%IV9ZKX&\:7>I:3/'
MJ1>::%T6,HG"I@#G'O7L.GS,+>/"(#MYP,5XCX+A\-'0H&@NI;:\5=MRK G>
MV>"?;TKUK3+:6*"/R]:0J5X61!0GJ1?6S.A,YV_=7\J\U^*.GV9T>"XAM;>&
MY%PH\Q(P&88/!/>N]:.[V_\ (3M?KM_^O7GOQ$L+D6<=[+K"SPQ/@VP "9(.
M#]:4]CJPK:JK4\3U#5;YH&MG?$<PW.F,9P>*S+?:UPD+J=DC@,%.#^%6;YTE
ML886B9KOS"=W?:>BU EI)8:J(KV-H9$*D+,I4YZ]#2C;E%4O*I>YO7]]<Z+H
M_P#8D"A8+N+=,#RY^;CG\*Q]-NFM;G9&N!,RH=QZ<]?UK5\4ZK8ZO:6;+&1J
ML7R3,@X:,#C\<UBZ?"G]KP17:\ @[9&*@GMUHTY=29Q:F=CXNNY?#VS2[,JR
M7%NPEDQ\W)QQ6'X2\37/A?5&N;2%)/.01.DAX(S6QXYDTV[L;>0MC5(F"_*>
ML??(^M8?AW2["ZU^SAU.Z>*U9P7=7'3MSV_I4TY)1'4BV[H^J+,Y4-_>4'\Z
MLU6L]HB 0Y0* ISGC%6:W1@6X/\ 4K11!_J5HI@57^\/]T?RH%#_ 'A_NC^5
M)G%2!EZE_P ?<?\ N?UKF+^ZU&.\G6'2$G7CRY6) ;CN<_6NEU%MUU'Q_#7/
MZ_H#:K)9SBZ$"VI8E70LK9^E"LWJ-&;-J6O!25TRR@&& ,CC('8'+5WVBQVT
M5A"7V&8J"S;0.3SQCM7 7'A."Z@^SS7D0$@QF"SY_,]*ZVWNDM(8H1!,41 J
ME!N& ,4-)#:.I!A8Y+XI2\*]R?K7/?VS"AQY%T?I#FECU<S[O)M+D@=V4 4K
M$Z,N:A=1*DHC0!C"_('H*Y&TENI%#PMMXXYQ6E>7%V[.)(EC4Q2$<Y/"FN4B
M>_\ *62-5(0?N\'D^O%=N'GR0;L>?BJ"K5(Q;2]787Q/<W-K8L3(R-CJ#7.Z
M5INHWT0EM6(XQN+[>?:M;Q&\L^F.9R3@$<@#_/>FZ0[G3K8P^67B4$<_G4XF
M7/9L]C)YRP=.<:;3U770QY;.ZL=7MH+C>C.VTD'J&!'!KHX_"-U!\T,DREE(
M8AU4@&J.MW!DU;3E=LRK,H(Q[UU:ZU;2WAM&M9=XX)*Y!Z^_M7GNG"4O?/0Q
M^)JR4)WW1P?BKP^=(T26Z9WPR")R'&0"0"./;-/M?A+;O:?:])\1ZBUM=1@X
MBC4^8IYP<$#\#6IXVNXKWPE>".'RMC#*[<9.>HKC--AOK.R'V/7'MT?@I%<E
M1G/7%;4:4+61X]6K-V=]2U/X.T_0O$FG:8-0NKFXOHW%U')A2B<%?N]R1G\*
MZ5_A[;PQ2B+5;J**4 3*;EOFY] *X[2K?[/XUTV47@NFF+,S[RS#COGO7IZ:
M[>I.8'TYS@'YP>.F?2BI"">J",YVT9SX\ :/#:/!&99([T>4S&9L\'/?W [5
MG/\ "EK9)(K/4;N*WF7$J?:0 WU&.:[.WN[F\2WEGM?)99OE7/4;335U\37$
ML+V3#8I8EER#@9QVI)1'[[,70?!%CX=+3))+.SQE=SNK ?3BNYM;"VN=.B$T
M7F?)@8.,@USEW.UWI:&#?:XD*C:!QT/Y5L:A+=V^A)-;R1HT:[I6;&,8]^V?
MQIZ$VU?<+C0[%,%-)ED..?WA&*Q?']C"GA<1)$4\R>,L"<D<T?VY?C3VD::W
M$NY3]X[=N#D_3I3/%,TDG@ZRDN BR,\189RI/;D=C1/5;&E%.,TV4-'\$^$M
M>TB*YO[-5N26&Y)S&SE3CUY/2EM_AGX0O8_.N;6[6XR0(YKUF)]/?V_"F^ +
MRVGCO=.O+6.YE25GMT*@G!QN4$_3-=7OLC=JT>G1Q2 %0[ ;DP.G6GRM*QFZ
MBE+1G#6WPDT768?[0T[4+JRWNPV* ZJ0<<9Y[53'PEC\0227<_BB\N2K!&:6
MW^8X''4^E='X+N[;4;*\LKN2:)K6>26,Q2LA*EN>G7!_G6XHTM[J&2&ZO)&R
M%7,K!6(YY'?\:5BN9O0X)/@[8ZPC7=KKEU$Z,8F,T8?E/ESD8(Z4P_"J\UHB
MY'BJ.98@(L_9"IP!P,9]*ZKPG<I>G5+:6_FM7M+J5P8W #*S9R<^A'ZUM)#;
M)-&+?6)BA8#9&4VR'CTHY?(MW6A=\-0'3-(@TQIWG:T01F5Q@M^%;8:LVTBV
M/(^<F1LXJ^ ::,V:,!_<K138 ?)6B@"!_O#Z#^5-*[A2N?F'^Z/Y4F:0'+^*
MS/%921Q!U:5"HD4'Y?Q'0UYS%/XB@&T7L[;2>7G(S^M>T3\\YZ#I5?RU/_+-
M/^^10F^A496/&;G_ (26[&WSV((_Y^&;'X UZSHH9=*M58?.(P&'OBKQA#+M
M&%SZ"L>_TS7_ #T?3=1BMT"X,;0AU)]?6GJ]P;N96I:SJ<>JW4"W$:P1OA$=
M "!@9YP<U9\,7U]<Z@\<\I,9C+&-5 53D=L=:5M'\2SK^_NM.=\YWBT(-2KX
M=UMHU1M<:W7N+:%4)_$\T[!9%_4=HN07''D3#_QVL+35A^PHLGWP.:Z'2?#]
MMIWG%YYKF2;_ %CS2%V)QCJ>GX5$WAR#/R7,JKV&T&NJA.$4TSS<91G.2<-3
MC_%7E#3CY?0*<UF:+-8Q:<1-,ZRG^[G!7\*]"/AJP<8N3)<#^ZQ 'Z5DO\/]
M*9\QW%U&O]T$$#]*C$S4FN4]3*.2E"4:_7L<7?2VSZMIWV=F)61=Y8GGYN.O
MM7:/_95Q.;O^T""Z@%0,@8';-6K/P1HMK*)76:XD X,K<#MT%67\*:>SE@\J
MY[ #%<34KW.K'U:=;EC#9=SC/%K:=%X;O;>WN3/(ZF7![=!QV_"N<T71_%$%
M@GV?3W".-^);4,?8\UZR_AC29;=HIH#(K(4.[C@_3O6(?AQ I_T37M:MXNT:
MW&0/SK:E)Q6J//<>S/,X[2]T7QA:7.L0O;(^YA)*FQ6]<=J]/34]*DC$B.6W
M_,2) !3H/ASHD:S?;'NM0DFB,1>[F+E5/7'H:PY/@QH;,3%?W\:_W?E./TJ*
MR=1E0]W<O77B31+:ZAA^V11[&,C!G&6X.?K3B^@S,TZWSXF;>1QU/U%%A\)O
M#-K#,DT4]VTJ;"\S %1G/&!UJN_PCT7<3'?:A&O90XP/TJ.1VLS>E5C#74T(
MGM)X?L6EW0D:$%GW<Y!.:V)[W28;);#4I8U2>(CRWS\R]^E1>&O!^F>&?-:U
M,TLDJ[7>9LDCTK9GTNQG4+-&DBC[JRH'Q]">:TBM+,RDTYN1S3_\(L8O+,C^
M6PPR>>V,>_/2DU*/2==L([.VD\VTB8)B!B-A XY_*MH^'-))S]DM/^_1_P :
ML6^F6=HO[A$10<A(T"KGU]Z;LT/FL[GA]O=PZ3K-ZL-UY-Q;3GRR[?-P>,^M
M>L2:]83:;#=O>V4,<D0=]TB@J2.>]5]:\ >'=<N7N;JT=)VY:2&0J3]>U9$?
MP?\ #2OND2\E7KL>08/Y"KE+F21SPI\LG*^YPVDZFUO?/J%C,IDBE9EP?E(R
M?YBO7(C9WEC;7L%K@7""0$,>#7-W_P *=%FD:33[BYTYFZK$=RG\#1#\.M5B
M@6W'B_4A:*,")%VC'IUJ7JC1:,Y"WU";2/$]W>V^&,<S;HST92>0:]4CATZZ
MBM[V".3;.%FC*G@9_E7%7WPBA$C2Z5J]Q;.X^=9OG#'US4UMX2\<6EM%:0^*
MH$M8QM51%R!^5.4KI6-YU%)*QZ'I\,@,S2RAE9LQKC&T>_K5_;5'2;5[/388
M)[AIYD4!Y6ZN?6KV14F)<@!\E:*2 _N5HH INWS#Z#^5(#3S YVD%>5'\A2?
M9W]5I 1-]X4A8#@]ZF:V?/5?SIAMWSU6F S>!R,TH < G/3UIWV5^N5IZP.!
MU7\Z (?E!Q\WUS3D"EON_K4GV<YSQ^=.6W=>1M_,T 1\!N..*8#Q5C[-(3R5
MZ>M1BV?U7\Z:)>Y"QR* >.E3&V?U6@6S^JT/4I$)Z]*DW<XP*>;=R1ROYT[[
M,_'*_G2L#(6Y!J,>QQ5AK9\=5_.@6DG]Y?SH$5^CBI,BG_97#=5IXM7]1^=
M$0Q2%O:IOLS^J_G2?96]5_.@=R+.13\C;DTIMGQU6G?9G*XROYT 0_N^O]*2
M7&SY:F^R28^\M(]L^P<K0!54%CBIBPQ@'I3TMG"]5-!MF[;?SH$50,L0.YJ7
M("@;JD6U<#JIR?6@VS?[/YT#*A^^0.]3@ (!Z"G);,,D[<GWH^S-GJ/SH :A
@ZT[=3EMWQU6E^SOZK0!9@/[E:*=!;R>2O*_G10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ycbd_424b5005.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #> 4T# 2(  A$! Q$!_\0
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M'Q$\;3:E:V,.I+=>:V%6ZC5P!W)/7@5Z3/XVO-,!:32=/O+N!A)(BJT+E?\
MGHO4$5XYX%D\OQ3;ER2K1LHX[D5ZU+"MSJP8/S#:JP#'@AF(/\JXZM62G9'L
MX/!0JT7*6Y)'\5-(FEDN7T?4$:0?O!;7*D./0@XXK>M/C3X;N()"]GJ4!C7A
M# &S],&O(OL@%[>H JCS2B8ZL,G%=]I^G6]E:1AHD#J@W,%''%54JV5V8X?
M.<FEI8Y[XDZE;>-M0T^_TEV\B" QOOP.2V>U<6--6-2LS%B.A7M6OXLM/*U5
M9-%0PW3GYPC<-]5[5B7.HW-DI&I11AP_EG:WS CVK6G/FCH<V(IJG+E94N!%
M:D>83M;@'%(98AU5S_P&M"T4ZE!)/;1220QKO<[/N@=S3=JN@9)U0YZ,I/%:
MI)G))6V*+S1M&62%^.V*K&<N !;,/J*Z*;2KQ+3[4'C:%461FBB8_*V<9/0=
M*H2VMW:V<5W/<1>5<9\KC!!!YS6D>1Z(S=^IA72RL0R0''H!4;:?=.JMY &1
MQ@<UK_:2%S]MM@?0@UTEBMK%IAU.=EDB!VH.S&MI>QIP<ILJ"G*2C$X%M)ND
MV[TV[G"#/K6S%X&UBX1O*2-F7DQA\G\J]*TD27.N:7#?V<8LY5;C8!@D9']*
MZJWTO3[);B0QC=%+RXX9 >A!KR:N:4(?#!W]3OA@IOXI'SK-HVIV8W7&GW4:
M_P!YHFQ5,OSQUKZ<CU*XM)@LB^;:M_$.58>_I6/XF\#Z!KB>9) MK-(NY+JW
M7!^I7H16-+,DW:2L5/!.UXNY\\F0^E30PO,A==H4=2S8JWX@T&[\.ZM)I]X
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M"IA>?:]'NA(B+*VT($3&[FLN.U5[@1!R['@*HR2:Z[08)XRMC9K%+=@9FE8
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MOJ:N3:II5PHC2SMP <@^9S^>*JR#3"V?L:GZ2BGKW"ZV<3"BEC@B8M"DK,V
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M&@92F#M:R0D%))!Y0W'KV_# S3EE(@;=*"K#& P#,3P /PI[;HI3$-S2^8S
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3U4@&T4=Z4#FJ$.I:3%2!: /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>ycbd_424b5006.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "# :D# 2(  A$! Q$!_\0
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MEE[UG6:G[5-VW1G_ !KURZ\(^%M\TJ6>HVGEJK!K6X$@&>QSG&*Y7Q3X8M-
MDMY[6XG<R2%)(YU7*Y4,""O!!!H52,Y+HRXU%+8;X5OA!K4$C'Y)5V-^(_QK
MT&&^%G(PW9C;M7CNG3F)ASS&X/ZUZ \Y< @G!&:^8Q\73KNQWY=JIP?1D'C3
MPO:^(X6O;,*FHHN<CCS0.Q]_0UY#)$T3M'(A1U.UE(Y!%>T6UPR/UXKB_'ND
M $ZK;J.NV<#]&J*56^C.NK3MJCB<"EP*B\PTA8UT7,+$P(##ZUVUO,DAV!L2
M <HPPP_"N"7F1!G'S"O5I+&UF9PFRXA4#YF'(..Q'.?I2DY)72N7"G&;LW;\
MB.W!! ]Z]L^'VD_8="^UNH$MT<@_[ Z?F<FO([+0[DJDEI<K)AL-!<'!^@?_
M !'XU[-I/BW1V\G3;A)-(NU4(EK>KLW8&/D?[K?@:SC5A/X1SH3I/WD2>,]3
M_LSPW/M;$EQ^Y3\>I_*O$;B;+8KN/B;JWFZQ'8(_R6L>6P?XFY_EBO.W?GK3
M8X[&EIH^=Y,\_=']:U #DY!; SBLVS39:QG."W)STY]_I5I9&4  _+Z&H8R#
M62K6&P')9APWK6$63RW;YO+8'([DDX_+BM'6K@.\$>">K8]<>M9B$[E  +%E
M5LKTP,FH8%DE5*J2S,90 O9<#BHV<H 9.7:?Y1NZ>GZ=J;"PW1!-K9+.6]?I
M4";8$MHV"RL\I(;/ /?ZF@1T'AH7"^(;B55WGRR$ /.*S];U?[3K"2*9=L#D
M,"V0Q!YQS6?Y=S]J9%D:-KJ=8E.XCY3QS[5V,/PNUET5S)9PJ. )GP3]?6NN
M%9QIJ*1S_5TZKJ29@6=^MS?2>:"R&!Q$O'RM_"?KFM^-QOM7OMSVI1E 5N0
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M2:2;4" 9&R0%'2NW+Z=?"0I55RN-3E7FM+:=#&LX5'*.MU<XK/>KFERQ2K+
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M8^>&VP_U+'-<]G*UU/C"'[1<7EW%AH8+DP9'3ID?KFN6Z\^M>SD4N;"+NO\
MA_U.:H_??88.7Q[UZ39Z/=ZY\.-,L[/8'^U,S,[85%!.2:\YC4%BQZ"M*3Q%
MJ!T>/2HYC#9H6++'P7R<_,>_TKIS/"5\1&G[!I2C).[^8Z%2$.;GV:.D>+P=
MX<=4NGDUF]C_ ($_U2'T]/YU'K?BAM<M8K2UMQ9::HRT"D9=O?'&!Z5Q2\L
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/#XSBY  M+DT4570X3__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ycbd_424b5007.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !, &<# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BB@\#-
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F%)*R%HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ycbd_424b5008.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  V ' # 2(  A$! Q$!_\0
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>ycbd_424b5009.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !  &0# 2(  A$! Q$!_\0
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? Z_0"BMCP\;T^'K ZB9#>>2OFF1-K%O4CL?:B@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>ycbd_424b5010.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# $D# 2(  A$! Q$!_\0
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M3^)0=OO.L/P@LL<:K=>_RBMKQ-80Z/\ #>[L8V9HX8 BLYY/(I/^%F^&./\
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>ycbd_424b5011.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  T #0# 2(  A$! Q$!_\0
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M/@NRUI!>N%CG=/EY.,CU&: /1?BU\18/']W8Z3H5O-)9P2%E8I\\TAX&%ZX
MKE]&U;2=)MSI6OZ ))(IG:1W4^8,C&TKQSZ'.!G.*BO+6[\%:GI6H6F^.X:)
MF=)EZ.K%)%(_NGM[&M[0/"E]\5?&LU]#!+:Z464W,SG(B4 #8I[GC ]NM &K
M\/?A/+XM\-OJS'R(I+EUA5SR4 &#^>1^%%?26CVMC8:5;V6FJBVEN@BC5.@
M_K10!=QD5B>)?".B>+;#[)K-DDZC[C]'C/JK=1110!\I>//#MMX6U:ZTS3[F
M[-IYF2DL@()'3. ,XKD-SML5I'(7[H)^[]/2BB@#USX8>!],\=7[W/B"YO[L
MPJ,(T_# = >,X^AKZ1T_3+'2;&.RT^UBMK:,82*)< 444 6418QA%"CK@#%%
%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>ycbd_424b5012.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q +$# 2(  A$! Q$!_\0
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(H **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>ycbd_424b5013.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 ycbd_424b5013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P ,,# 2(  A$! Q$!_\0
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M6,X0P492B[N6QM"4\;.,);1W/)/%%E#IGB*^LH%VQ0,$7UZ"O3/%?_))[?\
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M5]&U\^Z#I6I)XGT]VTZ[5!=J2S0, !NZGBOH*L<RDG*-GT/1RN+497[G'3^
M;.;QFFMG;Y&-[P8X:4=#].]=C117GSJ2G;F>QZ4*<87Y5N?/7CG_ )'+5O\
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
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
